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Abstract 
Background: Percutaneous procedures are now the predominant tracheostomy 
technique within the critical care setting. Complication rates for various techniques 
appear to be equivalent to those achieved with surgical tracheostomy. There is a 
paucity of data when comparing percutaneous procedures, particularly when 
considering late complications (tracheo-innominate artery fistulae (TIF), tracheo-
oesophageal fistulae (TOF) and tracheal stenosis (TS). Given the severity of illness 
and associated mortality in many of these patients the incidence of these 
complications remains difficult to define. Confounding factors present in survivors of 
critical illness may present difficulties in diagnosis such that underlying tracheal 
pathology may go undiagnosed.  
 
Aims: To determine: 
 The incidence of common early and late complications of percutaneous 
dilatational tracheostomy (PDT) in relation to surgical tracheostomy (ST). 
 The role of peri-operative events that may contribute to the aetiology of late 
complications of TS, TIF and TOF. 
 The incidence of early and late complications in relation to percutaneous 
tracheostomy to define the safest percutaneous technique. 
 The utility of adjunctive techniques (bronchoscopy & ultrasound scanning) in 
reducing complications of PDT. 
 The prevalence of sub-clinical TS following PDT using the single tapered dilator 
technique (STD). 
 Aetiological factors for sub-clinical TS. 
 Whether sub-clinical TS may present atypically in critical illness survivors. 
Methods: We have conducted a systematic review of all prospective studies reporting 
late complications after tracheostomy performed in the critically ill. We have also 
extracted data to assess the role of peri-operative events and monitoring in causing or 
preventing late complications. We have undertaken an eleven-year review of all PDTs 
performed within our unit to define the incidence of complications arising within our 
own population. Finally, a prospective study to identify the prevalence of sub-clinical 
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TS and identify atypical presenting features in survivors of critical illness has been 
performed. 
Results: All surgical and percutaneous techniques are broadly similar in terms of 
early and late complications. There is a higher incidence of wound infection when 
comparing ST to the multiple dilator PDT. There are few studies assessing late 
complications between percutaneous techniques. The TS rate varies from 2.8 to 0.6% 
for ST and the STD technique respectively. Due to limited data we were unable to 
identify peri-operative events that may lead to late complications. There is a very low 
rate of complications attributed to the STD technique with only 9 significant late 
adverse events. The rate of sub-clinical TS is low with doubtful clinical significance. 
Conclusions: We have not found a significant difference in the incidence of TS 
between PDT and ST. Our pooled proportions meta-analysis may indicate a tendency 
toward a higher rate of stenosis for ST. The reported complication rates presented 
within our cohort study may indicate that the STD PDT is one of the safer techniques 
available. The rate of sub-clinical stenoses following STD PDT is low and of doubtful 
clinical significance. Further work is required to define the role for percutaneous 
tracheostomy outside the critical care setting and to gather qualitative data to assess 
the  patient’s  perception  of  tracheostomy  in  the  critical  care  setting. 
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A history of tracheostomy 
The earliest possible use of a tracheostomy may date as far back as the Bronze Age 
description of a healing throat incision described in the book of Hindu medicine, the 
Rig Veda1. Later examples of its use have been attributed to the Imhotep (c 2650–
2600 BC)2, an Egyptian polymath who lived in the 27th century BC, Alexander The 
Great (356–323 BC) and the Greek physician Aretaeus of Cappadocia who practiced 
in the first century AD1-4. The procedure may have been relatively common place 
around 100BC with reports continuing until the second century when Galen of 
Pergamon (AD 129 – c.200) credited Asclepiades of Bithynia (129 – 40BC) as the 
originator of the operation5. 
From the second century onwards little further is reported on the procedure. At this 
point it appeared to fall in to disrepute partly from a belief that incised cartilaginous 
tissue does not heal. It was referred to variously as a scandal of surgery, semi-
slaughter4 and a futile and irresponsible idea5. 
At the height of the Renaissance, interest was renewed in airway surgery. In 1543 
Andreas Vesalius (1514 – 1564), professor of surgery and anatomy at the University 
of Padua and imperial physician to Emperor Charles V, passed a reed in to the trachea 
of a dying animal and maintained respiration by blowing in to it4. The significance of 
this intervention was not, however, appreciated for many years. In 1546 the first 
description of a successful tracheostomy performed in a human and described by the 
operating surgeon was recorded by Antonio Brasavola (1500-1555) in a patient with a 
tracheal abscess5. In 1620 Nicholas Habicot (1550-1624), surgeon to the Duke of 
Nemours, who had previously documented the first tracheostomy for the removal of a 
foreign body and the first procedure in a paediatric patient, published the first book 
solely for the description of the procedure6. From the sixteenth to nineteenth centuries 
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frequent descriptions of the operation continue to be made but it was still regarded as 
a useless and dangerous procedure. During this period Goodall found evidence of 
only twenty eight successful operations in the literature all but three of which were 
performed in adult patients6. 
At the onset of the nineteenth century tracheostomy was used cautiously for upper 
airway obstruction resulting from diphtheria. In 1851 Armand Trousseau (1801-
1867), a French physician from Tours, reported the first large series of tracheostomies 
inserted for diphtheria related upper airway obstruction7. From 215 procedures he 
reported the survival of forty seven patients3. Consequently the process of acceptance 
of tracheostomy as a legitimate surgical procedure had begun. Descriptions of the use 
for upper airway obstruction due to diphtheria, croup and foreign bodies increased. 
Indications also widened to include cases of laryngeal syphilis and tuberculosis3. The 
mortality remained high, however, and the procedure remained feared and its use was 
largely attempted only for hopeless cases. 
At the beginning of the twentieth century the issues of timing and technique of 
tracheostomy were largely resolved by Chevalier Jackson (1865-1958). Jackson was 
an American laryngologist who studied at the Jefferson Medical College in 
Philadelphia and was later at professor of laryngology at the same institution. He is 
frequently referred to as the “father  of  endoscopy”.  In 1909 he reported a series of one 
hundred tracheostomies of which eighty six patients survived, ten died from non-
tracheostomy related causes with four dying as a direct result of the procedure8. 
Jackson detailed the important factors in this significant improvement on previous 
outcomes. He advocated the avoidance of general anaesthesia or any sedative agent to 
allow preservation of spontaneous respiration and the cough reflex. Similar to 
Trousseau7, he advocated an earlier operation than had previously been commonplace 
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thus avoiding the extreme dangers of hypoxia and hypercarbia when the procedure is 
performed in patients in extremis. He also outlined the importance of meticulous 
attention to detail during the operation itself (a luxury not afforded if the patient is in 
extremis) with particular reference to a midline dissection and careful haemostasis. 
He also suggested standards for post-operative management and cannula care.  
In a later paper Jackson outlined the aetiological factors related to the development of 
tracheal stenosis namely, high tracheostomy (cricothyroidostomy), damage to the 
cricoid cartilage and ill-fitting cannulae9. Lessons that had to be re-learnt by 
intensivists some sixty to eighty years later10. 
1.1. Terminology 
According  to  Goodall’s  detailed  history  the  earliest  descriptions of tracheostomies 
referred to by Galen and Aretaeus in the second and third centuries AD were 
described using  the  phrases  “cut  to  the  larynx”  and  “make  an  incision  in  the  artery”6. 
At  this  time  the  “artery”  and  “bronchus”  both  referred  to  the  trachea  including  the  
larynx. Around this time Antyllus (second century AD) refers to the procedure as a 
pharyngotomy. Later descriptions of the operation by Caelius Aurelianus in the fifth 
century and Paul of Aegina in the seventh century refer to laryngotomy. In 1620 
Habicot described the operation as a bronchotomy. Goodall considered the first use of 
the  term  “tracheotomy” was by Thomas Feyens (or Fienus)(1567-1631), professor of 
medicine at the University of Leuven, in the  “Libri  Chirurgiae  XII”  published in 
16496. However the term was not adopted and laryngotomy and bronchotomy 
remained in common use. In 1718 Lorenz Heister (1683-1758) published his best-
known work,  “Institutiones Chirurgie”.  In  this  text  he  re-introduced the word 
“tracheotomy”  to  describe  the  procedure  and  also  gave  his  opinion  that  the  other  
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terms should be discarded. Following  Heister’s  work  the  usage  of  tracheotomy  to  
describe the procedure became increasingly common place6. After Armand 
Trousseau’s  paper, detailing the use of tracheostomy in a series of diphtheria patients, 
the term tracheotomy largely replaced the other terms7. 
1.2 Development of tracheal cannulae 
Early non-human descriptions of the use of tracheostomies highlight that rudimentary 
cannulae in the form of reeds were most likely utilised (see below)11. None of the 
documented descriptions of tracheostomy prior to that of Fabricius of Aquapendente 
(1537-1619), also a professor of anatomy and surgery at the University of Padua, 
detailed the use of a tracheal cannula, leading Goodall to conclude that none of the 
earliest operators used them12. At the beginning of the seventeenth century Fabricius 
described the use of a small straight cannula with two wings to prevent it entering the 
trachea12. Fabricius stated that the tube should be short to prevent trauma to the 
posterior tracheal wall and not too wide to prevent too much air entering the lungs. 
Following this description, cannula use appears to have become accepted and more 
widespread. Fabricius’ pupil and successor as professor of anatomy at Padua, Julius 
Casserius (1561-1616) later introduced a curved tube with tapes to secure it in-situ 
although these were not adopted at the time and the straight tube remained in use (fig 
1). Casserius’  tube  was  made of silver, although other operators also recommended 
gold and lead as alternatives. Later, in 1620, Habicot developed a slightly curved 
flattened tube designed to fit between the tracheal cartilages. Following this the use of 
curved rather than straight tracheal cannulae came in to favour12. 
The first suggestion of the utility of a dual lumen cannula, in an attempt to keep the 
tube clear of bronchial secretions without the need to remove it from the trachea, was 
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described by George Martin (1702-1743),  a  Scottish  ship’s  doctor, in 1730 – a 
modification that was suggested to him by a lay person. Goodall, however, was 
unable to find any evidence that Martin had actually used such a tube12. By the 
beginning of the nineteenth century  around  the  time  of  Trousseau’s  work  the cannula 
had the curve of a quarter circle. However, Robert W Parker, surgeon to the East 
London Hospital from 1876 – 1902, noted in 1880 that such a tube did not conform to 
the anatomical relation of the trachea and the skin of the anterior neck12. As a 
consequence of this the tip of the tube tended to impinge on the anterior tracheal wall 
causing ulceration. Parker therefore modified the design of the tube to allow the 
tracheal portion of the cannula to pass posteriorly and inferiorly within the tracheal 
lumen without impinging upon the tracheal wall. Interestingly, the tube designed by 
Parker had the same configuration as that proposed by Julius Casserius much earlier12. 
1.3 Changing indications 
From the earliest descriptions of the use of tracheostomies to the middle of the 
nineteenth century the overwhelming indication for the procedure was the presence of 
upper airway obstruction. This was largely due to the acute infectious causes 
prevalent at the time and foreign body impaction. In the late nineteenth century 
Friedrich Trendelenberg (1844-1924), surgeon in chief at the University of Leipzig, 
reported twenty five tracheostomies using a cuffed tube inserted to facilitate 
operations on the jaw, mouth and larynx4. In  Jackson’s  series  of  one hundred patients 
described above there were eleven laryngectomies and other major operations8. 
Isolated reports advocating the use of tracheostomy for the resuscitation of drowning 
victims, along with the use of intermittent positive pressure ventilation (see below), 
were published as early as 1769 by Scottish physician William Buchan (1729-
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1805)4,13. In the first edition of his book “Domestic Medicine” Buchan advocated 
mouth-to-mouth ventilation with expired air or tobacco smoke along with insufflation 
of tobacco smoke in to the intestines. In 1880 Karl Heuter (1838-1892), professor of 
surgery at the University of Greifswald, suggested the use of a tracheostomy for 
tracheal toilet and artificial respiration following its use in two patients with bronchial 
catarrh14. However, despite such reports, the use of tracheostomy for lower airway 
pathology at this time remained uncommon with the majority of procedures still being 
performed for upper airway obstruction. 
In one of the earliest descriptions of tracheostomy use for lower airway disease 
Wilson described its use for patients with bulbar poliomyelitis15. In his report of 
seventy patients with pharyngeal paralysis he states that a tracheostomy was 
performed in `a few cases`. As a result of this he claimed there was an improved 
ability to remove tracheal secretions, a reduction in the aspiration of said secretions 
and improvements in ability to provide nutrition. Although Wilson did not use 
intermittent positive pressure ventilation in any of his patients he clearly documents 
the importance of positioning, pressure area and bowel care, fluid administration and 
glucose control some sixty to seventy years before the introduction of care bundles in 
to  critical  care  practice.  Following  on  from  Wilson’s  report, Figi reported the use of 
tracheostomy for myasthenia gravis (one case in a series of 206 tracheostomies)16. 
Although the initial insertion was because of upper airway obstruction its utility for 
secretion clearance and muscular weakness became evident later. 
Through the 1940s and 50s bulbar poliomyelitis became an increasingly accepted 
indication for the use of tracheostomies. Its use was said to improve respiration, allow 
secretion clearance and facilitate positive pressure respiration (see below). Following 
Henry Lassen’s  report  on  the  1952  polio  epidemic  in  Copehagen17 the indications for 
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tracheostomy expanded significantly to incorporate trauma patients, poisonings, 
thoracic and neurosurgical patients. 
1.4 Positive pressure ventilation 
Similar to tracheostomy the oldest references to the use of artificial respiration date 
back to Egyptian times when Isis is said to have resurrected Osiris with the breath of 
life18. The relevance of this and other biblical references though remain unclear. 
Some of the earliest work using artificial respiration was conducted by Galen who 
used a bellows to inflate the lungs of a dead animal via the trachea but failed to realize 
the significance of his findings. In 1472 Paolo Bagellardo (c.1410-1492), also a 
professor at the University of Padua, appeared to have appreciated the importance of 
mouth to mouth artificial respiration when he advised midwives to blow in to the 
mouths of newborns they found to be warm but with no respiration. The insightful 
advice, however, has to be viewed in context when considering his succeeding 
comment  “or  into  its  anus”18. 
In 1543 Vesalius published an account detailing a mechanism to keep an animal alive 
whilst its thoracic contents were examined11. Up to this point, progress in relation to 
cardio-respiratory anatomy and physiology had been hampered by the fact that as 
soon as the thoracic cavity was opened the animal’s lungs collapsed and death 
inevitably followed. By performing a basic tracheostomy (using a reed inserted in to 
the trachea) on an animal whose thorax had been opened Vesalius found that he was 
able to keep the animal alive by blowing intermittently through the reed. He thus 
described lung inflation and the associated improvement in cardiac output that this 
action caused in the near dead animal whilst simultaneously noting the relationship 
between lung collapse and diminution of cardiac activity.  
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In a similar experiment the English polymath Robert Hooke (1635 – 1703) 
demonstrated the beneficial effects of artificial respiration at the Royal Society in 
166718. He performed a tracheostomy in a dog and kept the animal alive, after its 
thorax and abdomen had been opened, by ventilating the lungs with a bellows. 
Despite these advances showing that the heart's movements and those of respiration 
were independent, the use of artificial respiration was not accepted for human use. 
The most likely reasons for the failure to pursue or accept these ideas were probably 
in part due to fear of infectious diseases being transmitted by mouth to mouth 
respiration and that of public or religious reprisals that would follow human 
experimentation. 
Perhaps the most startling failure to realise the utility of artificial respiration came 
with the experiments of the Scottish Surgeon and Fellow of the Royal Society John 
Hunter (1728-1793) in 175519. He exposed the thorax of dogs by removing the 
sternum. He then performed artificial respiration with a dual chambered bellows – one 
for inspired air the other for expired. He noted that when he stopped moving the 
bellows the heart became gradually weaker until movement ceased. On resumption of 
movement of the bellows the heart began to move again. He repeated this experiment 
ten times on the same dog stopping ventilation for varying time periods up to ten 
minutes at a time. Each time the heart beat returned with the resumption of movement 
of  the  bellows.  The  lack  of  application  of  Hunter’s  findings  to  clinical  practice  at  this  
time is evidenced by the failure to publish his findings for twenty-one years. When 
presenting his findings to the Royal Humane Society, Hunter suggested that a similar 
situation of reduced cardiac activity as a result of hypoventilation may exist in victims 
of drowning and that all that may be required to restore cardiac activity and life was 
the restoration of breathing. Hunter also suggested that the use of dephlogisticated air 
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(oxygen) might be more efficacious at resuscitating these drowning victims, that a 
trial of electricity to stimulate the heart when other methods have failed may be 
worthwhile and the injection of stimulating substances in to the veins. 
During the eighteenth century, drowning became a major public health issue with 
several societies founded to promote the recovery of such individuals with subsequent 
reports of successful resuscitation using mouth to mouth respiration (of an apparently 
dead Scottish miner James Blair)20. The use of a bellows or tracheostomy was 
advocated by William Cullen (1710-1790), professor of Medicine and President of the 
Edinburgh College of Physicians (1773-1775), in a letter to the then Lord Cathcart 
President of the Board of Police21. Cullen describes the experience and preferences of 
Alexander Munro (1733-1817), Professor of Anatomy and Surgery at Edinburgh, in 
resuscitating victims of drowning. Within the letter are described techniques to 
achieve mouth to mouth ventilation, alleviate upper airway obstruction, perform 
tracheal intubation using a male catheter and perhaps the first description of cricoid 
pressure to prevent gastro-oesophageal reflux.  
By the end of the eighteenth century, books by Edward Coleman (1765-1839)22 and 
the Danes John Herholdt (1764-1836) and Carl Rafn (1769-1808)23 demonstrated the 
advances in the practice of resuscitation at this time. Coleman had attended the 
lectures by John Hunter at the Royal Society and was interested in models of asphyxia 
following his work with  dogs  and  cats.  Coleman’s  suggestions  for resuscitation 
included the use of a gullet occluder and an endotracheal or tracheostomy tube for 
lung inflation. It was suggested that the latter might be best used with a bellows and 
oxygen if available. Following institution of artificial respiration an electric current 
could be passed through the heart by placing electrodes over the apex and base. This 
was over a century before Prevost and Battelli published their account of reversal of 
 25 
ventricular fibrillation using electric shocks24. Herholdt and Rafn also advocated the 
use of chest compressions and recognized the difficulties posed by upper airway 
obstruction from either the tongue or inhaled foreign bodies. In 1793 the Dutch 
Humane Society published their results of attempted resuscitations describing 990 
successful cases over twenty five years25. 
However, in 1827 the French physician, Jean Jacques Leroy d’Etiolles  (1798-1860), 
in reports that predated the ARDSnet* investigation26 by 173 years, demonstrated the 
ill effects of over vigorous bellows ventilation of drowned dogs in inducing 
emphysema and pneumothorax27,28. Following this report, positive pressure 
ventilation was largely abandoned and would not re-emerge as a therapeutic modality 
for many decades. 
*The ARDSnet investigation was a landmark critical care randomised controlled trial published in 
2000. Patients requiring mechanical ventilation for acute lung injury / acute respiratory distress were 
randomised to receive tidal ventilation at either 12ml or 6ml/kg predicted bodyweight. The trial was 
stopped early, after recruiting 861 patients, due to a lower mortality in the lower tidal volume group 
(31 versus 39.8 percent). 
 
1.5 Tracheostomy and positive pressure ventilation 
Although the usage of tracheostomy and positive pressure ventilation had many 
associations through their development from antiquity onwards, their combined utility 
in the clinical setting outside the operating theatre was not realised until the 
poliomyelitis epidemics of the 1940s and 50s. 
The first use of tracheostomy and positive pressure ventilation for poliomyelitis on a 
large scale was reported by Albert Bower (1890-1960), Professor of Medicine at the 
University of Southern California, and Ray Bennett a biomedical engineer29. During 
the Los Angeles polio epidemic of 1948-49 Bower noted that a respiratory acidosis 
was a frequent finding despite the use of Drinker-Collins negative pressure 
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respirators. Bennett, therefore, developed a positive pressure respirator attachment, 
which enabled the Drinker-Collins respirator to provide intra-tracheal positive 
pressure respiratory support either via a facemask or a tracheostomy (figures 1.1 & 
1.2). Using the positive pressure respirator attachment, Bower and Bennett were able 
to demonstrate a significant reduction in polio mortality for those cases requiring 
ventilatory assistance from 78.9% in 1946 to 16.3% in 1949. 
Figure 1.1.  The Bennett positive pressure respirator attachment mounted to a 
Drinker–Collins respirator 
 
 
Front view of the (Bennett) positive pressure respirator attachment mounted to a 
Drinker–Collins respirator. The bellows providing positive pressure ventilation via 
face mask or tracheostomy can be seen on the base of the respirator. 
From: Bower AG, Bennett VR, Dillon JB.29 Reproduced with due 
acknowledgement to V Ray Bennett, Albert Bower and their publisher. 
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Figure 1.2. Bennett positive pressure respirator attachment: Shows installation of 
auxillary bellows unit(1), pressure control box (2) and air filter (3). 
 
From: Bower AG, Bennett VR, Dillon JB.29 Reproduced with due 
acknowledgement to V Ray Bennett, Albert Bower and their publisher. 
Despite the work of Bower and Bennett, the outcome from poliomyelitis requiring 
respirator support in Northern Europe remained decidedly poor. In August of 1952, 
twenty seven out of thirty one cases admitted to the Blegdam hospital in Copenhagen 
with respiratory paralysis died30. At this time in Copenhagen, up to seventy patients 
were requiring respiratory assistance at any one time with fifty new patients being 
admitted each day, of whom ten per cent were exhibiting signs of bulbar dysfunction. 
When faced with this bleak scenario, Henry Lassen (1900-1974), chief physician at 
the hospital, requested the assistance of Bjorn Ibsen (1915-2007) a freelance 
anaesthetist. Ibsen had spent time at the Massachusetts General Hospital and was 
aware of Bower and Bennett’s  earlier  work31. He embarked upon a similar strategy 
using positive pressure ventilation and tracheostomy during the Copenhagen epidemic 
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of 1952. From 26th August, ultimately using a team of thirty five to forty medical 
staff, 600 trained nurses and 250 medical students working in relays, 321 patients 
with respiratory insufficiency were treated. Of these 265 patients had a tracheostomy 
and 232 had positive pressure ventilation. Over this period the mortality reduced from 
eighty seven per cent in July / August to twenty two per cent in November / 
December30. This episode is now felt to be the beginning of modern intensive care 
practice. Ibsen  was  later  offered  a  position  at  Copenhagen’s  Kommunehospital  where  
he set up what is widely regarded as the world’s  first  dedicated  intensive  care  unit  in  
195331. Lassen and Ibsen also provided an insight in to the future problems of critical 
care with their description of an increased mortality in those patients presenting with 
shock, renal failure and pulmonary oedema. 
1.6 Percutaneous tracheostomy 
The Italian surgeon Sanctorio Sanctorious (1561-1636), using a technique described 
and condemned by Trousseau7 as the expeditious method, has been suggested as the 
first surgeon to have  described a percutaneous technique in 1626. Although the 
procedure described used a small dagger-like ripping needle and a silver perforated 
cannula it is doubtful that it was ever performed by Sanctorious32. These same 
instruments were also used at this time for the tapping of hydrocoeles and ascites. 
Using the needle, the cannula was inserted in to the tracheal lumen and the needle was 
withdrawn  in  a  manner  that  appears  remarkably  similar  to  Shelden’s  description  in  
1957 (see below)33. Although similar methods were later described by Dekker and 
Heister it is unclear how often a percutaneous technique was used by such luminaries 
if at all7. The French physician, Bauchot, has been credited as the first to perform a 
percutaneous procedure in the mid eighteenth century using a bronchotome (with a 
cutting edge) fitting in to the lumen of a flattened silver cannula32. Bauchot reportedly 
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used this technique successfully on two patients12. Gerard van Swieten (1700-1772) 
of Leyden Austria, who had used a percutaneous technique on a large number of live 
animals and human cadavers, considered the procedure to be extremely difficult and 
not without risk7. Subsequent to this, largely because of Trousseau’s  recommendation 
for a large incision and Jackson8 standardising the open surgical tracheostomy, little 
more was heard of the percutaneous procedure until the 1950s. 
Arguably the first step towards the safe performance of a percutaneous tracheostomy 
was not related to airway surgery at all. In 1953 Sven Seldinger (1921-1998), a 
Swedish radiologist, published his technique of catheter insertion over a guidewire34. 
In the 1940s interest in arteriography was increasing although catheter insertion to 
facilitate this was problematic – usually requiring surgical exposure of the relevant 
artery. With the advent of flexible guide-wires and polyethylene catheters Seldinger 
was able to demonstrate the use of percutaneous puncture of a vessel followed by 
guide-wire and then catheter insertion over the wire. He described this technique in 
forty procedures all performed under local anaesthetic. In thirty-seven out of the forty 
procedures arterial puncture and catheter insertion were achieved at the first attempt 
with no significant haemorrhagic complications. 
The first modern description of a percutaneous tracheostomy was described by 
Shelden in 195535. Despite this being after  Seldinger’s  description  of  his  guide-wire 
technique Shelden did not employ it. Shelden described the use of a slotted needle and 
a cutting blade with a ball like tip (figure 1.3). The needle was inserted into the 
trachea below the cricoid cartilage. The ball like tip of the cutting blade was inserted 
into the spherical slot on the needle and the ball passed down the needle lumen in to 
the trachea. With the cutting blade in-situ the needle is removed, the cutting blades 
and attached tracheostomy tube are then advanced in to the trachea. Once in place the 
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cutting blades were removed and the tracheostomy tube left in situ. Shelden had used 
this device for four years at the time of a later publication and claimed use by many 
other neurosurgeons throughout the world33. Despite this it is unclear how many 
patients underwent this procedure. Even though the device was commercially 
available and used extensively by Shelden it appears not be have been widely adopted 
perhaps in part due to reported posterior tracheal wall and oesophageal 
perforation36,37. 
Figure 1.3.  Shelden’s  percutaneous  tracheostomy 
 
 
1. With  the  patient’s  head  extended,  puncture  site  is  palpated  either  above  or  below  
first tracheal ring. 2. Needle is angulated through skin and subcutaneous tissue and 
into lumen of trachea. 3. Ball like tip of cutting blade is placed within lumen of needle 
through the spherical opening. 4. Cutting action of horizontal blade. 5. Horizontal 
blade slides along slot in needle. 6. Tracheostomy tube being inserted into trachea 
after needle has been removed 
Reproduced with permission from Shelden CH et al. Percutaneous tracheotomy. J Am 
Med Assoc. 1957;165(16):2068-2070. Copyright© (1957) American Medical 
Association. All rights reserved.33 
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The first description of a bedside surgical tracheostomy was provided by Roe in 1962 
and suggested to be of use predominantly in the emergency setting37. In a series of 
forty patients with post-operative respiratory compromise he described what might 
now be referred to as a minimally invasive tracheostomy. Using a small incision, that 
admitted the tip of the finger, followed by blunt dissection of the subcutaneous tissues 
the cricoid and tracheal cartilages were initially palpated. Complete exposure of the 
tracheal cartilage was felt to be unnecessary. The procedure had to be abandoned in 
only one patient. 
In 1969 Toy and Weinstein described the first guide assisted percutaneous 
tracheostomy using a modified Seldinger technique38. They described the insertion of 
a five-millimetre tracheostomy tube over a guiding bougie that had been placed via a 
needle inserted in to the trachea. Using a handled bougie (figure 1.4) with recessed 
blade the entire device was thrust in to the trachea. Of the six patients they described, 
five had successful tracheostomy tube insertion and one had a para-tracheal 
placement. Despite the potential for use within a critical care setting the authors did 
not envisage this and suggested its principal uses would be in the emergency setting 
and elective cases where a bleeding diathesis may be present or a concern for the 
cosmetic results was present. 
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Figure 1.4. Toy  and  Weinstein’s  percutaneous  tracheostomy  device.  Illustrated are 
the guiding catheter (left), percutaneous needle, tracheostomy tube and handled 
bougie with recessed blade. 
 
From: Toy FJ, Weinstein JD.38 
Concerns regarding the risk of later tracheal stenosis following damage to the cricoid 
cartilage  persisted  following  Jackson’s  early  papers  until  Brantigan  and  Grow  
published a series detailing 655 crico-thyroidostomies some of which were performed 
First published in: A percutaneous 
tracheostomy device. Toy FJ, 
Weinstein JD. Surgery. 
1969;65(2):384-389.38  
Copyright (1969) with permission 
from Elsevier. 
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at the bedside39. Of these patients eight developed sub-glottic stenosis and seven had 
sub-glottic granulomas. Pre-existing laryngeal injury was felt to be present in thirteen 
of these fifteen patients due to prolonged trans-laryngeal intubation. The authors 
therefore concluded that there was little risk of tracheal stenosis following 
cricothyroidostomy if the larynx was normal but that it should not be performed after 
prolonged trans-laryngeal intubation. 
The first description of a dilatational percutaneous tracheostomy was provided by the 
thoracic surgeon Pascquale Ciaglia (1912-2000) working in St. Elizabeth Hospital and 
St. Luke’s Memorial Hospital Center, Utica, New York40. Following on from 
Brantigan’s  work39 and the minimally invasive bedside surgical tracheostomy 
described by Roe37 Ciaglia set about reforming the critical care tracheostomy 
procedure. Initially he undertook twenty-six fingertip sub-cricoid tracheostomies 
during which a small incision was made to allow the index finger to palpate the 
cricoid cartilage. A small incision was made through the crico-tracheal membrane and 
the withdrawal of the tracheal tube was also palpated. As the trans-laryngeal tube was 
withdrawn the tracheostomy tube was inserted. After twenty-six procedures Ciaglia 
concluded the whole process could be accomplished percutaneously. Using a 
modified percutaneous nephrostomy set he then performed a further twenty-six 
tracheostomies (one cricothyroidostomy, one through the second to third tracheal 
rings and twenty four sub-cricoid) with no significant intra-operative complications 
other than one difficult dilatation in a patient who had previously had a surgical 
tracheostomy. There were no instances of para-tracheal placement, pneumothorax, 
subcutaneous emphysema or oesophageal injury. There was one case of sub-glottic 
stenosis that was felt to be related to prolonged trans-laryngeal intubation. Ciaglia 
subsequently reported the outcome of fifty two decannulated patients who had 
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undergone his dilatational tracheostomy in 199241. There were mild voice changes in 
one patient, one patient had a stomal infection and there no recorded cases of tracheal 
stenosis or cosmetic problems. Despite this apparent lack of tracheal stenosis reported 
at this point Ciaglia suggested in this paper that a lower insertion point might be 
preferable if feasible. In 1994, McFarlane reported on a series of 121 Ciaglia 
tracheostomies in which there were four cases of sub-glottic stenosis10. This was 
postulated to be due to the high placement of the tracheostomy tube and subsequent 
damage to the cricoid cartilage with its resultant peri-chondritis and necrosis, a 
finding in keeping  with  Jackson’s  earlier  assertions9. From this time onwards, most 
operators have attempted to avoid crico-tracheal placement aiming for a lower 
insertion point. 
Subsequent  to  Ciaglia’s  report, further modifications of the percutaneous dilatational 
technique were proposed and a number of varying approaches have been developed 
over the ensuing years. In 1990 William  “Bill”  Griggs (Adelaide, Australia) described 
the use of guide-wire dilating forceps42, Antonio Fantoni (Milan, Italy) described the 
trans-laryngeal tracheostomy in adults in 199643 and the single tapered dilator 
modification  of  Ciaglia’s  original  procedure  was  reported  in  200044. At the present 
time, the single tapered dilator appears to be the most frequently used percutaneous 
technique45,46.  Subsequently lesser-used techniques have also been described47,48. 
1.7 Modifications to the percutaneous tracheostomy technique 
In 1989 Andreas Paul (Montreal, Canada) described the first percutaneous endoscopic 
dilatational tracheostomy49. After initial testing in five anaesthetised dogs (including 
post mortem examination of tracheal damage) a technique using the fibre-optic 
bronchoscope to visualise the tracheal lumen during the procedure was described in 
four human subjects. In one patient they identified a guide-wire misplacement thus 
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preventing para-tracheal placement. They also postulated that bronchoscopic 
deployment would reduce posterior tracheal wall and oesophageal injuries whilst 
allowing precise tracheostomy tube placement. He also hinted at a possible future use 
of ultra-sound scanning for percutaneous tracheostomy to reduce bleeding 
complications. 
This latter idea was later taken up by Hatfield and Bodenham (Leeds, UK) who 
undertook a study of thirty patients undergoing percutaneous tracheostomy50. In all 
patients, the thyroid cartilage, carotid arteries and internal jugular veins were easily 
identified, as was the mid-line and approximate level of puncture. They identified 
eight patients in whom an anterior jugular vein was considered vulnerable (at or near 
the mid-line). Two patients had vessels ligated and two had minor bleeding episodes. 
Additionally, four patients had vulnerable arterial structures (two carotid and two 
brachio-cephalic arteries). The authors concluded use of ultra-sound scanning may 
reduce bleeding complications especially in patients with difficult to identify surface 
anatomy. 
1.8 Tracheostomy outcomes 
Despite widespread adoption of percutaneous techniques from the late 1980s onwards 
the outcomes, particularly long term ones, when compared to surgical tracheostomy 
and amongst the percutaneous techniques themselves were the subject of some 
discussion and debate. 
1.8.1 Percutaneous tracheostomy versus surgical tracheostomy 
The outcomes of percutaneous techniques compared to surgical tracheostomy have 
been the subject of three systematic reviews dating from 2006 – 2007. In the first such 
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review, Delaney evaluated randomised controlled trials comparing surgical 
tracheostomies with any percutaneous technique in the critical care setting51. He 
identified seventeen trials, including 1212 patients, the commonest percutaneous 
procedure evaluated being the original Ciaglia technique40. The principal findings 
were equivalence for bleeding, major short and long-term complications with a 
significant reduction in stomal infections for the percutaneous procedures. Oliver later 
identified fourteen prospective trials (of which eight were randomised controlled 
trials) comparing surgical tracheostomy with a percutaneous technique performed in 
the critical care unit or the operating theatre52. They found no difference in major 
complications but a greater incidence of minor complications with percutaneous 
techniques along with a greater incidence of early complications for percutaneous 
techniques when compared to surgical tracheostomy performed at the bedside. 
Higgins53 assessed fifteen randomised controlled trials (incorporating 973 patients) all 
but two of which  were  incorporated  in  Delaney’s  review51. They found percutaneous 
techniques resulted in fewer wound infections and cosmetic problems with no 
difference in major complications. When pooled complications were analysed they 
found in favour of the percutaneous procedures. 
1.8.2 Percutaneous versus percutaneous procedures 
For many years there appears to be an assumption of equivalence across the 
percutaneous techniques described. In an attempt to address this Cabrini undertook a 
systematic review of randomised controlled trials comparing two or more 
percutaneous techniques54. They identified thirteen trials, incorporating 1030 patients, 
the most studied techniques being the original Ciaglia multiple dilator method, guide-
wire dilating forceps and the single tapered dilator. They found that the Ciaglia and 
single tapered dilator techniques appeared to have the fewest complications. There 
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appeared to be an increase in minor complications with the guide-wire dilating 
forceps along with higher failure rates for both trans-laryngeal and rotational dilator 
techniques (PercuTwist®). They expressed some surprise at the paucity of randomised 
controlled trials when considering how widespread the use of percutaneous 
tracheostomy has become. Overall it was felt that the most reliable technique for 
safety and success was the single tapered dilator. In a later review Cabrini also 
assessed the complication rates of the two most commonly used percutaneous 
techniques, the single tapered dilator and guide wire dilating forceps55. Having 
identified five eligible randomised controlled trials comprising 363 patients they 
concluded that the guide wire dilating forceps technique is associated with a higher 
incidence of intra-procedural bleeding and technical difficulties when compared with 
the single tapered dilator. There were no differences in mid and long-term outcomes. 
After many centuries of evolving surgical approaches along with advances in our 
knowledge of physiology and anatomy, percutaneous procedures have become 
established as the predominant tracheostomy techniques within the critical care 
setting. Complication rates across the various techniques appear to be at least as low 
as those achieved with surgical tracheostomies. It is possible that the single tapered 
dilator method is now the most frequently used procedure with the lowest associated 
complication rate. However, the paucity of data when comparing percutaneous 
procedures, particularly when considering long-term outcomes, is somewhat 
surprising. It is clear, at present, that equivalence between procedures in this respect 
has not been fully established. 
The meta-analyses described above have included only randomised controlled trials 
(RCTs)51,53. The only exception to this was the analysis by Oliver which also included 
non-randomised prospective studies52. The largest single study incorporated into the 
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previous analyses comprised 346 patients56. It is perhaps unsurprising, therefore, that 
none of the previous meta-analyses have reported differences in late complication 
rates. The exact incidence of long term complications following tracheostomy 
procedures in the critically ill is difficult to quantify due to the associated mortality of 
critical illness, the sub-clinical nature of many tracheal stenoses and the difficulty 
maintaining follow up of these cohorts. Given this associated morbidity and the cost 
associated with the management of TS a clearer picture of the risk associated with 
each tracheostomy technique performed within the critical care setting is required. 
1.9 Aims 
 To determine the utility of adjunctive techniques (bronchoscopy & ultrasound 
scanning) in reducing complications of percutaneous tracheostomies 
percutaneous tracheostomy technique and hence determine the safest 
percutaneous technique 
 To determine the incidence of common early and late complications and 
outcomes of PDT techniques in relation to surgical tracheostomy. 
 To determine the relative indices of early and late complications in relation to 
percutaneous tracheostomy technique and hence determine the safest 
percutaneous technique 
 To determine the role of early complications that may be postulated to play a 
part in the genesis of the late complications of tracheal stenosis, tracheo-
innominate artery fistula and tracheo-oesophageal fistula 
 To determine long term survival following percutaneous tracheostomy 
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Chapter 2 
 
Major late complications following tracheostomy 
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Both surgical and percutaneous tracheostomies are associated with a number of well-
defined early complications that may occur intra-operatively or over a variable length 
of time in to the post-operative period57-59. The most common of these early 
complications are haemorrhage, malpositioning of the tracheal cannula, displacement 
of the tracheal tube, pneumothoraces and subcutaneous emphysema. Assessing the 
relative frequency for each of these outcomes following surgical and percutaneous 
techniques has been relatively well defined and the subject of a number of meta-
analyses51-55. 
Late complications leading to significant morbidity and potentially mortality (tracheo-
innominate artery fistulae, tracheomalacia and tracheal stenosis) may occur after the 
tracheal cannula has been removed. Given the severity of illness occurring in many of 
these patients with its associated mortality, the relative incidences of each of these 
complications remains difficult to define. Additionally, confounding factors present in 
survivors of critical illness may present additional difficulties in diagnosis. Many 
survivors will have significant residual muscle weakness, associated with underlying 
parenchymal lung diseases either predating their critical care stay or as a result of it. 
Consequently, a reduction in exercise capacity and shortness of breath are commonly 
found in this population. Such complaints can often be attributed to the after effects of 
critical illness and underlying tracheal pathology may go undiagnosed. 
2.1 The normal trachea 
2.1.1 Tracheal anatomy 
The trachea lies in the midline of the neck and upper mediastinum. It begins at the 
lower border of the cricoid cartilage at the level of the sixth cervical vertebra and 
extends to its bifurcation in to right and left main bronchi at the carina. It is composed 
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of C shaped rings of cartilage that form the anterior and lateral walls and a musculo-
membranous posterior wall. The smooth muscle in the musculo-membranous portion 
of the tracheal wall contains both transverse and longitudinal fibres. The transverse 
fibres make up the trachealis muscle connecting the ends of the tracheal cartilages. 
Tracheal size is related to the size of the individual but in the adult male there are 
approximately 18-22 tracheal rings extending inferiorly from the cricoid to carina for 
11-12 cm. The lateral diameter is approximately 2.3 cm coronally and 1.8 cm 
sagitally60,61. 
The shape of the tracheal lumen varies with age and in the presence or absence of 
disease states. The lumen in the child is almost circular reaching its usual adult D 
shape at adolescence (figure 2.1). Luminal shape also alters dynamically in response 
to changes in intra-luminal pressure during respiration, coughing and mechanical 
ventilation. During forced expiration the trachealis muscle approximates the ends of 
the tracheal cartilages creating an elongated antero-posterior tracheal diameter. In the 
presence of ageing or significant chronic obstructive pulmonary disease, this 
reduction in lateral diameter may result in a sabre sheath or scabbard trachea. Chronic 
obstructive airways disease may also result in a softening of the tracheal cartilage and 
a widening of the lateral diameter and an antero-posterior narrowing (figure 2.1). This 
conformational change may ultimately lead to luminal obstruction during coughing 
and active expiration. 
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Figure 2.1. Cross sectional tracheal morphology – normal and common variants.  
 
            
A; Juvenile circular trachea. B; Adult D-shaped trachea. C; Sabre sheath or 
scabbard trachea. D; Tracheal changes seen in chronic obstructive pulmonary 
disease. 
Image reprinted with permission from Medscape Drugs & Diseases 
(http://emedicine.medscape.com), 2015, available at 
http://emedicine.medscape.com/article/1949391-overview#a3 
 
The tracheal wall is lined by a ciliated pseudo-stratified columnar epithelium that also 
contains Goblet cells and mucous glands. Also present within the epithelium are 
“brush  cells”  with  surface  microvilli and neuroendocrine cells, the function of both 
cell types is not entirely clear. Mucosal irritation may result in cilia damage and 
squamous metaplasia resulting in an increased dependence upon coughing to clear 
secretions. As a result of such injury the tracheal mucosa must be able to regenerate. 
This occurs from a sub-population of basal stem cells in the columnar epithelium 
which are able to develop in to ciliated surface cell and Goblet cells62. 
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The trachea receives its blood supply segmentally via the lateral walls. The cervical 
trachea is supplied predominantly from the inferior thyroid artery most frequently via 
three tracheo-oesophageal vessels. The mid to lower trachea receives its arterial 
supply from the superior, middle and inferior bronchial arteries. At the segmental 
level each artery to the trachea will branch superiorly and inferiorly over several 
tracheal rings forming a series of longitudinal anastomoses. Additionally anterior and 
posterior braches will run in the inter-cartilaginous space to eventually anastomose 
with contralateral vessels. The posterior vessels also anastomose with oesophageal 
arteries60,61. 
2.1.1.1 Anatomical relations 
The anatomical relations of the trachea explain many of the early and late 
complications seen following tracheostomy (figure 2.2). The oesophagus lies 
posteriorly and slightly to the left of the trachea from the level of the cricoid cartilage 
with the pre-vertebral fascia and vertebral bodies lying posteriorly to the right. The 
isthmus of the thyroid gland is anterior to the second to fourth tracheal rings with the 
inferior thyroid artery supplying the proximal trachea as well as the thyroid gland 
itself. Lateral to the cervical part of the trachea lie the lobes of the thyroid gland, 
carotid artery, internal jugular vein, vagus nerve and cervical lymph nodes within the 
carotid sheath.  
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Figure 2.2. Anatomical relations of the trachea including major vessels, thyroid and 
nerves. Modified from: Deslauriers.61 
 
Reprinted from Thoracic Surgery Clinics 2007;17(4):529-547. Deslauriers J. Anatomy of 
the neck and cervicothoracic junction. Copyright (2007), with permission from Elsevier. 
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As the trachea descends in to the superior mediastinum anteriorly lies the thymus, the 
brachio-cephalic (innominate) artery and vein and the aortic arch. The tracheo-
innominate artery arises as the first branch of the aortic arch. It ascends obliquely and 
posteriorly to cross the trachea at the level of the ninth tracheal cartilage (range from 
sixth to thirteenth). There is however, a degree of variability in the course of the 
tracheo-innominate artery with passage across the trachea being possible as high as 
the second – third tracheal ring63. Posteriorly lie the oesophagus, pre-vertebral fascia 
and recurrent laryngeal nerves in the tracheo-oesophageal grooves. Laterally lie the 
vagus and phrenic nerves, the superior vena cava on the right, left common carotid 
and left subclavian vessels with the thoracic duct on the left and azygous vein on the 
right. 
2.1.2 Tracheal physiology 
 The trachea is designed to: 
 Conduct air from the larynx to the main bronchi 
 Exchange heat and moisture with cold, dry inhaled air 
 Remove particulate debris and secretions from the tracheo-bronchial tract. 
2.1.2.1 Movement of air 
Under normal circumstances for gas to flow through the trachea a pressure gradient 
has to exist to overcome the resistance of the respiratory system. Conventionally, 
laminar flow through tubes is represented by the Hagen-Poiseuille Law where flow is 
inversely proportional to the fourth power of the radius of the tube: 
ΔP  =  Q8Lμ/πr4 
Where: 
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ΔP  = pressure change across tube 
Q = flow rate 
L = length of the tube 
μ  =  gas  viscosity 
r = radius of the tube. 
 
However, when considering the Reynolds number (ratio of inertial forces to viscous 
forces) for flow through a given tube: 
Re = QL/ μ  
Where: 
Q = flow rate 
L= length of tube 
 = density 
μ  =  viscosity 
The transition to turbulent flow occurs at a Reynolds number of around 2300. 
Thereafter, flow becomes completely turbulent when the Reynolds number exceeds 
4000 – conditions found within the trachea. In this situation resistance across the 
trachea becomes directly proportional to the gas flow rate squared and inversely 
proportional to the fifth power of the radius64. 
ΔP = Q2fL/rπ2r5 
Where: 
 = density of gas 
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f = frictional factor 
Consequently, a reduction in airway calibre produced by mucosal swelling, 
endoluminal tumours, tracheal stenosis and tracheal tubes will all considerably 
increase resistance to airflow. 
2.1.2.2 Heat and moisture exchange 
During inspiration the upper airways warm and humidify the inspired gas. During 
quiet breathing, air is completely warmed to 370 centigrade and fully humidified at 
around the level of the tracheal bifurcation – the isothermal saturation point62. The 
drier and colder the inspired air the more distal this point becomes thus increasing 
heat and moisture losses. This situation is further exacerbated when the upper airway 
is bypassed with a tracheal or tracheostomy tube where, in addition to heat and 
moisture loss, mucosal injury may result unless inspired gases are heated and 
humidified. 
2.1.2.3 Removal of particulate debris 
Tracheo-bronchial Goblet cells produce a mucin rich secretion that protects the 
underlying epithelium. The rate and volume of secretions produced is controlled by 
the autonomic nervous system and inflammatory mediators. The resultant mucous 
collects debris and micro-organisms and is transported in a cephalad direction by 
cilial action and exhaled air with expiratory airflow becoming more prominent in the 
larger central airways. 
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2.2 Tracheal pathology 
2.2.1 Tracheal stenosis 
Benign tracheal stenosis (TS) is a progressive narrowing of the tracheal lumen most 
commonly seen after tracheal intubation and tracheostomy insertion. Pooled data from 
a number of studies has shown reported incidences of TS of 0.6 – 2.8% (See Chapter 
4). Such data, should however, be interpreted with caution. The reported rates are 
invariably expressed as percentages of tracheostomies performed and not of survivors 
who have presented for follow up58,59. 
2.2.1.1 Histopathology 
Despite a plethora of studies investigating the management of TS the actual 
mechanisms involved in its initiation remain unclear. It is postulated that hyper-
granulation, cuff induced ischaemic mucosal injury, direct tracheal wall injury, 
infection, gastro-oesophageal reflux and a genetic predisposition may all play a role65-
69. Why this reaction presents in only a small subset of patients undergoing intubation 
and tracheostomy remains unknown. 
Of the above factors, tracheal mucosal pressure induced necrosis seems to be of prime 
importance. If the pressure within the cuff of the tracheal tube is above that of the 
mucosal capillary perfusion pressure the potential result is ischaemic ulceration. As 
the blood supply of the trachea is segmental with vessels perforating the tracheal wall 
through the inter-ring spaces pressure on the mucosa can lead to cartilaginous 
ischaemia and necrosis. Additional hypoperfusion associated with systemic 
hypotensive states is not uncommon in the critically ill. 
Normal wound healing progresses through three phases70: 
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c) Inflammatory phase 
Tissue trauma leads to bleeding and clot formation with the release of 
inflammatory mediators (prostaglandins, interleukin-1 (IL-1), interleukin-6 
(IL-6), tumour necrosis factor α  and  transforming  growth  factor  β  (TGF-β)) 
that increase vessel permeability enabling the migration and accumulation of 
inflammatory macrophages.  
d) Proliferative phase 
This phase is characterised by re-epithelialisation and new vessel formation 
along with fibroblast migration. These processes are largely under the control 
of platelet-derived growth factor, endothelial derived growth factor, IL-1, IL-
6, TGF-β and fibroblast growth factor. Along with fibroblasts there is also 
proliferation of macrophages, keratinocytes and endothelial cells. New 
connective tissue is laid down (granulation tissue) 
e) Maturation phase 
This phase is predominantly controlled by epidermal growth factor and TGF-
β.  As  the  new  connective  tissue  matures, collagen becomes the main 
component. 
A number of authors66,69,71 have postulated the role of infection in generating the 
abnormal tissue reaction to trauma. Bacterial contamination leads to an infected peri-
chondritis and ultimately enhanced fibroblast activity. Whilst the incidence of stomal 
infection following surgical tracheostomy has been shown to be higher than that 
associated with percutaneous tracheostomy51 there is no definitive proof that the 
incidence of TS differs between the two techniques. Furthermore, there are no studies 
that demonstrate a protective effect of antimicrobials in the prevention of TS. 
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The host inflammatory reaction to this mucosal ulceration leads to healing by 
secondary intention. An inflammatory cascade is initiated that results in the up-
regulation of TGF-β which promotes the growth of fibroblasts70. It is also possible 
that fibroblasts may be activated as a result of tissue hypoxia leading to expression of 
hypoxia inducible factor with a resultant proliferation of fibroblasts and 
myofibroblasts within the tracheal mucosa72. The end result is a proliferation of 
granulation tissue and subsequent fibrous scar tissue. In some patients the 
proliferation of granulation tissue may lead to difficulties with decannulation although 
progression to tracheal stenosis is not always seen73. The abnormal healing process 
responsible for tracheal stenosis results in an imbalance of cell types leading to an 
excess of scarring and granulation tissue. The fibroblasts present release collagen and 
an extra-cellular matrix forms, containing types 1 and 3 collagen fibres, fibronectin 
and a significantly reduced number of elastic fibres, obstructing the normal patent 
airway70,72. The increase of collagen over elastic tissue makes the scarred segment 
rigid and relatively avascular.  The mature tracheal stenosis eventually forms within 
three to six weeks of decannulation. The later accumulation of submucosal fibrous 
tissue can lead to contraction, reduction and distortion of the tracheal lumen. The 
abnormal inflammatory process is not usually confined to the tracheal mucosa but 
also involves the deeper tracheal structures such as the peri-chondrium and 
cartilage69. Tracheal patency in the presence of weakened or fractured tracheal 
cartilages becomes compromised, particularly during forceful respiration and 
coughing, leading to a dynamic central airway collapse. 
There may be a number of additional co-factors associated with this abnormal 
inflammatory cascade. A number of authors have noted a preponderance of female 
patients with benign tracheal stenosis74,75 but this is by no means uniform, with other 
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studies reporting a higher incidence in males69,71. Idiopathic tracheal stenosis is also 
more frequently seen in female patients76. It has been postulated that oestrogen has an 
effect whereby it increases levels of TGF-β increasing collagen production and extra-
cellular matrix formation. Additionally, diabetes mellitus77, obesity and cardio-
vascular disease have been noted in up to 30% of TS patients75. It is possible that 
small vessel disease present in such patients may worsen the effects of regional 
ischaemia induced by the cuff of the tracheal tube. There may also be an effect of 
tracheo-oesophageal reflux in promoting abnormal healing both in idiopathic and 
post-intubation stenoses78.  
2.2.1.2 Types of tracheal stenosis 
A number of variants of normal tracheal morphology occur that must be excluded 
when the diagnosis of TS is being considered. In addition to the usual adult D shaped 
lumen a juvenile circular appearance may persist into adult life. A sabre sheath or 
scabbard trachea may be seen in the elderly with lateral narrowing and anterior-
posterior widening and can be defined as a transverse / sagittal diameter <0.6. In 
patients with chronic obstructive pulmonary disease a number of states of dynamic 
tracheal collapse may occur without overt stenosis (figure 2.1). 
TS can be simply defined as an abnormal narrowing of the tracheal cross sectional 
lumen. A degree of stenosis is common after all tracheostomies but intervention for 
symptomatic disease is only required in a minority. A number of studies investigating 
the incidence of sub-clinical tracheal stenosis after percutaneous tracheostomy have 
used a reduction in tracheal cross sectional area (TCSA) of 10 per cent narrowing as 
a definition and found incidences in the region of 10-30%79,80. Symptomatic TS is 
unlikely with reductions in TCSA of 50% with severe symptoms being present with 
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reductions in excess of 75%81. 
Tracheal stenosis may be grouped according to a number of defining characteristics 
related to the underlying disease process. 
a) Benign / Malignant 
Benign TS may present following a number of tracheal injuries and diseases. 
The most frequent cause being post-intubation or post-tracheostomy discussed 
herein. It may also follow from direct tracheal trauma, chemical irritation, 
granulomatosis  with  polyangiitis  (Wegener’s)  and  rarely  be  idiopathic. 
Malignant stenoses result from direct infiltration of the trachea from tumours 
of the oesophagus, thyroid and lung or by malignant lymph node compression. 
Primary tracheal malignancies are unusual. 
b) Functional behaviour 
A stenosis can be further defined by its functional behaviour82. Most 
commonly seen is a fixed stenotic, scarring stricture in relation to the original 
trauma. Less commonly a malacic segment may follow on from the initial 
injury and result in a functional stenosis with dynamic airway collapse during 
the  respiratory  cycle.  Such  “dynamic  stenoses”  are  perhaps  most  commonly  
seen in the patient with chronic obstructive pulmonary disease. 
c) Anatomical features of stenosis 
Further definition of a stenotic segment is given via an anatomical description 
of its nature. Lesions may be long or short, stomal or cuff related or subglottic 
(see below)82. 
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d) Sites of tracheal stenosis 
Mature tracheal stenoses may occur at a number of sites in relation to the 
tracheostomy tube (figure 2.3).  
Figure 2.3. Site of post-intubation tracheal stenosis lesions 
 
A: Cuff related stenosis 
B: Cuff related stenosis with associated stomal stenosis 
C: Laryngo-tracheal (sub-glottic stenosis) related to cricoid cartilage damage 
Reprinted from Seminars in Thoracic and Cardiovascular Surgery 2009;21(3):284-
289. Wain JC. Post-intubation tracheal stenosis. Copyright (2009), with permission 
from Elsevier.65 
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a) Stomal stenosis 
Most commonly TS develops at the site of the tracheal stoma. Epstein73 
considered that secondary bacterial infection develops in the traumatised 
trachea to weaken the anterior and lateral walls.  
b) Cuff related stenosis 
Stenosis can develop in the region of the tracheostomy tube cuff in response to 
ischaemic necrosis of the tracheal wall when the pressure within the cuff 
exceeds the mucosal capillary perfusion pressure. A number of animal67,68 and 
human studies83 have detailed the effects of cuff pressure on capillary mucosal 
perfusion. At around 22mmHg, there is impairment of mucosal blood flow. 
Above 37mmHg, there is total obstruction of blood flow to the mucosa 
overlying the tracheal rings and the stretched posterior muscular wall. 
Pressures over 50 mmHg for 15 minutes can cause epithelial destruction 
which can lead to tracheitis, ulceration, persistent inflammation, chondritis, 
fibrosis and stenosis83.  
Cuff related problems associated with TS were first identified following the 
poliomyelitis epidemics in the late 1940s and 50s. Between 1947 and 1959 
there was a fifteen fold increase in tracheostomies performed at the 
Massachusetts General Hospital84. In 462 reported cases there were two 
tracheal stenoses. Reports of TS rates in the late 1960s were in the region of 
20% in some studies 85,86 although up to 50% of these patients were 
asymptomatic. At this time the importance of the tracheostomy tube cuff and 
associated circuitry were being appreciated in the aetiology of stenosis. 
Andrews demonstrated a reduction in stenosis from 17.5% to 6.9% with the 
introduction of a lightweight ventilator circuit85. They attributed the reduction 
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to diminished pressure on the lateral walls of the trachea thus preventing 
stomal pressure necrosis.  
The first report of a high volume low pressure cuff of the tracheostomy tube 
was presented by Grillo87. In a randomised trial they detailed the management 
of 45 patients who had undergone a tracheostomy in the critical care setting 
comparing those with the new cuff versus with a standard rubber one. Follow 
up of the patients was by fibre-optic bronchoscopy of survivors or post 
mortem examination of the trachea in non-survivors. Rating tracheal damage 
on an objective scale from 0-4 (increasing score indicating increasing mucosal 
damage) they found significantly less tracheal wall damage with the new cuff. 
Average intra-cuff pressures reported were 33mmHg for the low pressure and 
270 mmHg for the standard rubber cuffs. Following Grillo’s work and the use 
of high volume, low-pressure cuffs along with improvements in tracheostomy 
care, ventilator circuitry and tube manufacture the incidence of TS following 
tracheostomy has continued to decrease. 
c) Subglottic stenosis 
The first recognition that stenoses after percutaneous procedures may be 
different to those following surgical tracheostomy was highlighted by 
McFarlane10. They described four cases of supra-stomal subglottic stenosis 
following the original Ciaglia multiple dilator technique. They postulated that 
damage to the cricoid cartilage was the important aetiological factor. Despite 
work by Jackson9 illustrating the dangers of damage to the cricoid cartilage 
early attempts to develop minimally invasive approaches to tracheostomy 
predominantly used the space between the cricoid cartilage and first tracheal 
ring39,40. When initial reports of TS were made in relation to these procedures 
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it was felt that the problems were related to prolonged trans-laryngeal 
intubation rather than the tracheostomy. Only when reviewing long term 
outcomes did Ciaglia later suggest that damage to the cricoid cartilage should 
be avoided41. 
2.2.1.3 Stenosis related to trans-laryngeal intubation versus tracheostomy 
There is little published in the literature to define the relative risks of TS as a result of 
trans-laryngeal intubation or tracheostomy alone. This is confounded by the fact that 
the majority of patients undergoing tracheostomy within the critical care setting have 
previously been intubated trans-laryngeally prior to tracheostomy. Even those who 
undergo early tracheostomy are likely to have had their tracheas intubated for a 
minimum of four to five days, which may be long enough to institute a stenotic 
process. 
In an early report addressing the relative risks of both interventions, Stauffer reviewed 
150 adult critical care patients undergoing tracheal intubation and surgical 
tracheostomy74. They recorded high complication rates in relation to tracheostomy for 
stomal infection (36%), haemorrhage (36%) and subcutaneous emphysema or 
mediastinal air (13%). Follow up of survivors revealed a prevalence of TS of 65% in 
relation to tracheostomy and 19% following tracheal intubation alone. Non-survivors 
who underwent post mortem examination revealed a high incidence of laryngo-
tracheal injury (91-95%). Those patients who had undergone prolonged tracheal 
intubation prior to tracheostomy were more likely to develop TS. In a more recent 
report, Zias describes thirty one patients with TS after tracheal intubation or 
tracheostomy treated at the Lahey clinic in Massachusetts75. Of the thirty-one patients, 
eleven had undergone tracheal intubation alone; the remaining twenty had both 
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tracheal intubation and tracheostomy (mean of 5.5 days tracheal intubation prior to 
tracheostomy). Of the twenty stenoses associated with tracheostomy, seventeen were 
stomal in origin, whilst the predominant feature of post-intubation lesions was a web 
like stenosis at the level of the cuff. In contrast, Herrak reported a retrospective series 
of 174 patients in whom 55% had undergone tracheal intubation alone with only 45% 
having an additional tracheostomy88. 
2.2.1.4 Grading of tracheal stenosis 
A number of grading systems for assessment of TS have been developed. Perhaps the 
first attempt to stratify the degree of obstruction associated with a TS was described 
by Cotton in relation to paediatric laryngo-tracheal stenosis following prolonged 
trans-laryngeal intubation81. In his original paper Cotton described four grades of 
luminal obstruction ranging from < 70% (grade 1) to complete obstruction (grade 4) 
(table 2.1). In an era prior to the widespread use of computed tomography, no 
reference was made as to how assess such reductions in tracheal diameter. In a later 
modification of the Cotton scale, Myer described the use of an endotracheal tube 
(ETT) to better define this89. The percentage reduction in airway calibre was 
calculated by measuring the external diameter of the largest tracheal tube a given 
stenosis could accommodate and comparing this with the age appropriate tracheal 
tube size. Despite widespread use of the Cotton scale it makes no reference to the site 
of the tracheal narrowing, its length or cause. In an attempt to address these issues 
subsequent authors have addressed these perceived deficiencies. In a retrospective 
report of paediatric TS, in addition to describing the airway diameter, Grundfast 
added a description of the length of the stenosis as well as a subjective assessment of 
its consistency90.  
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Table 2.1. Degrees of tracheal stenosis according to Cotton classification81 
 Degree of tracheal narrowing 
Grade 1 < 70% 
Grade 2 70-90% 
Grade 3 > 90% 
Grade 4 Complete obstruction 
 
Further development related to grading of stenosis was described more recently by 
Freitag et al82. They first described the stenosis as either structural or functional. 
Structural lesions may be further defined as intra-luminal, extrinsic compression, 
stricture or distortion. They describe functional or dynamic stenoses as those that vary 
during the respiratory cycle and are frequently due to malacic disease. Within this 
category are the sabre-sheath or scabbard trachea and the commoner inward bulging 
of the posterior musculo-membranous portion of the tracheal wall. Thereafter the 
reduction in cross sectional area is defined and graded from no appreciable 
obstruction (0) to complete obstruction (5). The location of the stenotic segment is 
then described extending from the upper third of the trachea to the right and left main 
bronchi. Finally the abruptness of transition from a normal calibre airway to the 
stenotic segment is described (figure 2.4). In a pilot study to validate this scoring 
system, Freitag found a strong precision and agreement between observers. The most 
recent scoring system was described by Ghorbani et al, in relation to post intubation 
TS91. They described a four point scale for tracheal calibre, type of stenosis and 
clinical symptoms giving a possible score of 0-12 – the more severe the stenosis the 
higher the score. Tracheal measurements and description of stenosis were undertaken 
during rigid bronchoscopy. When assessing the performance of the grading system in 
pre-operative assessment for patients presenting for tracheal resection there was a 
significant association between a score  8.5 and the need for surgery. Additionally, 
when assessed against a surgeon blinded to the score obtained there was a 78% 
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agreement  between  the  score  and  the  surgeon’s  opinion  regarding  the  need  for  
surgery.
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Figure 2.4. Classification of tracheal stenosis. From Freitag et al82. 
 
aIntraluminal tumour or granulation tissue     eScabbard trachea (in cross section) 
bExternal distortion or buckling        fFloppy membrane (in cross section) 
cExtrinsic compression        gAbrupt transition 
dScarred stricture         hTapered transition 
Reproduced with permission of the European Respiratory Society ©. European Respiratory Journal Jul 2007, 30 (1) 7-12; DOI: 
10.1183/09031936.00132804 
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2.2.1.5 Diagnosis of tracheal stenosis 
2.2.1.5.i Clinical assessment 
As long as a high index of suspicion is maintained, the diagnosis of TS can 
largely be made from a history suggestive of airflow obstruction following on 
from a period of prolonged intubation or tracheostomy. In the earlier phases of 
presentation the patient may report an increase in cough associated with 
difficulty expectorating secretions. With more severe stenosis, the most 
frequent symptoms reported will be increasing shortness of breath associated 
with inspiratory stridor. With severe stenosis, dyspnoea at rest is present. At 
this point the airway diameter is likely to be <5mm. It is not uncommon that, 
the presence of stridor may be mistaken for lower airway wheeze and thereby 
treated as asthma92,93. In survivors of critical illness, in whom function may be 
limited due to critical illness associated neuromuscular disease or ongoing 
respiratory pathology, a typical presentation with stridor and shortness of 
breath may not be seen. Such patients may merely report a reduction in 
exercise tolerance the causes for which may be multiple and complex.  
Clinical examination may note findings of tachypnoea, use of accessory 
respiratory muscles, inspiratory stridor a persistently patent stoma and an 
abnormal voice. 
The time course for presentation after intubation may be variable. Most 
patients will present within two months although a small cohort may present 
very late. It is in this group of patients where misdiagnosis as lower 
respiratory tract pathology may be problematic. 
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2.2.1.5.ii Investigation 
a) Radiological imaging 
Most patients will undergo radiological imaging either via computed 
tomography (CT) or magnetic resonance imaging (MRI) prior to formal 
evaluation of the stenotic segment under general anaesthesia. 
Computed tomography with reformatted sagittal and coronal images can 
produce an accurate representation of the underlying stenosis allowing 
definition of site, length, reduction in cross sectional area and character of the 
lesion. Recent advances utilising multi-detector CT imaging to produce three 
dimensional images of both internal and external segments of the distorted 
airway allowing a virtual endoscopy have been described94. A number of 
authors have demonstrated a high degree of correlation between such images 
and the findings at rigid bronchoscopy94-96. Such findings suggest that these 
techniques may have an important role in defining the lesion and planning 
treatment options. 
b) Spirometry 
Although spirometry is one of the simpler techniques used to identify upper 
airway obstruction the typical changes seen occur relatively late in the disease 
progression. Typically a reduction of TCSA of more than 50% must be present 
for changes to be evident. With fixed TS there is a characteristic limitation of 
inspiratory and expiratory flow producing the typical rhomboid curve (figure 
2.5). For those lesions that are malacic and show dynamic flow limitation the 
curve may be more variable with either inspiratory or expiratory abnormalities 
depending upon the site of the lesion. They are of limited use in assessment 
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and planning of therapeutic intervention. A lack of correlation between 
spirometry findings and both clinical symptoms and radiological findings has 
been noted. In an attempt to address some of the limitations of spirometry, 
Verbanck and colleagues described a forced oscillation test that was able to 
define a level of critical TS that was not confounded by the presence of co-
existing peripheral airway obstruction97. 
c). Diagnostic bronchoscopy 
The principal role for bronchoscopy in the setting of TS is for assessment for 
further surgical intervention, as it is able to define the site, length and 
character of the lesion and allow planning for operative repair. It may also be 
utilised with balloon dilatation to temporarily relieve symptoms prior to more 
definitive treatment. However, recent National Institute for Health and 
Clinical Excellence (NICE) guidance documented instances of tracheo-
bronchial rupture, tracheal laceration, laryngeal injury and bleeding as 
possible cause for concern. Consequently, balloon dilatation for TS is not 
recommended by NICE98.  
 64 
Figure 2.5: Normal flow-volume loop: 
 
 
 
The normal Flow-Volume loop begins on the X-axis (Volume axis): at the start of the test both flow and volume are equal to zero. After the 
starting point the curve rapidly mounts to a peak: Peak (Expiratory) Flow. After the PEF the curve descends (=the flow decreases) as more air 
is expired. A normal, non-pathological F/V loop will descend in a straight or a convex line from top (PEF) to bottom (FVC). The forced 
inspiration that follows the forced expiration has roughly the same morphology, but the PIF (Peak Inspiratory Flow) is not as distinct as PEF. 
Copyright spirometry.guru (http://www.spiromtery.guru/fvc.html) 
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Figure 2.6. Spirometry in upper airway obstruction 
A      B     C 
   
A; Fixed large airway obstruction 
Can be both intrathoracic and extrathoracic. The flow-volume loop is typically flattened during inspiration and expiration. 
B; Variable Extrathoracic Obstruction  
The expiratory part of the flow volume loop is normal: the obstruction is pushed outwards by the force of the expiration. During inspiration the 
obstruction is sucked into the trachea with obstruction and flattening of the inspiratory limb.  
C; Variable Intrathoracic Obstruction  
An obstruction near the intrathoracic part of the trachea is sucked outwards during inspiration with a normal inspiratory part of the flow 
volume loop. During expiration the lesion is pushed into the trachea with partial obstruction and flattening of the expiratory part of the flow 
volume loop.  
Copyright spirometry.guru (http://www.spiromtery.guru/fvc.html)
 66 
2.2.1.6 Management of tracheal stenosis 
i. Interventional bronchoscopy and laser therapy 
A number of authors have reported successful outcomes following 
combination therapy of balloon dilatation in association with laser 
resection75,99,100. Such interventions frequently require multiple procedures for 
a successful outcome. Early work suggested that this therapy was less 
effective for complex and longer stenoses and those affecting the cricoid 
cartilage. Gallucio, in a study of 209 patients (mean number of interventions 
per patient of 1.56-3.27) with two year follow up, reported successful 
outcomes, with a combination of balloon dilatation, laser resection and 
stenting, in 96% of simple stenoses and 69% of complex lesions99. Similarly 
Zias, in a report of 31 cases of TS undergoing an average of 2.4 procedures 
per patient, described the need for operative intervention in only one patient75. 
It is possible that dynamic stenoses, particularly those involving a degree of 
tracheomalacia, may be more problematic. In a series of sixty patients 
undergoing combination therapy of laser resection and stenting, Plojoux 
described a fifty one per cent success rate with a stent migration rate of 
31%101. 
It would appear, from the literature, that the lesions most suitable for endo-
luminal therapy are simple web like stenoses. There may also be a role in 
more complex lesions for symptom relief prior to definitive surgery. 
ii. Stenting 
Traditional use of tracheal stenting has been for patients with malignant 
strictures where there is a limited life expectancy102. When used for benign 
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disease with associated longer survival stent related complications become 
more problematic. Whilst early results achieve relief of obstruction in up to 
95% of patients long-term complications can be debilitating103,104. Long term 
problems associated with tracheal stents include formation of granulation 
tissue, re-stenosis, bleeding, migration, fracture and erosion. The formation of 
granulation tissue and re-stenosis are two of the more problematic issues 
related to stent use for benign airway strictures particularly when used in the 
proximal (sub-glottic) airway. Metallic stents appear to cause more significant 
problems in this region105. Additionally, the sub-cricoid area is not distensible 
like the proximal trachea. Consequently, a rigid metallic stent placed here is 
prone to significant shear forces generating formation of significant amounts 
of granulation tissue, a propensity toward stent fracture and re-stenosis. The 
resultant granulation tissue makes stent removal more difficult which may be 
particularly problematic for airway management if these patients present with 
upper airway obstruction with a stent in-situ.  
Whilst a number of small case series published in the literature frequently 
report satisfactory early symptom relief, the long term complications are 
frequently excessive, with some authors suggesting that the incidence of late 
complications is more related to the length of time the stent is deployed rather 
than the material it is made from103. Consequently, the Food and Drug 
Administration in the United States issued a series of recommendations related 
to metallic stenting in benign airways disease in 2005 suggesting their use 
should be avoided106. 
The principal role for tracheal stenting in benign TS appears to be as a bridge 
to more definitive therapies107. It should, therefore, be largely confined to 
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patients with significant co-morbidities in whom the risk of operative repair is 
deemed unacceptable, those with a limited life expectancy, those who refuse 
surgery, those with long complex stenoses that are deemed inoperable and to 
provide symptom relief prior to definitive surgery. 
Potential for an enhanced role for stenting in the future has been suggested 
with the use of drug eluting stents aimed at reducing the tissue reaction and 
production of granulation tissue108. Stents eluting drugs targeting the 
mammalian target of rapamycin (mTOR) pathway (sirolimus, everolimus, 
zotarolimus and paclitaxel) may have local immuno-modulatory effects 
reducing new vessel formation and production of granulation tissue. 
iii. Surgical management 
Despite reports detailing the use of tracheostomy in pre-biblical times and 
intermittent use through the ages tracheal surgery per se was hampered by the 
belief that cartilaginous tissue heals poorly5. This opinion was stated by, 
amongst others, Hippocrates and Aretaeus and persisted well in to the 
twentieth century. The first description of a healing tracheal anastomosis in 
dogs was reported by Gluck and Zeller who felt the technique may have a role 
in humans109. The first reported human tracheal resection for post-traumatic 
TS was described by Kuster in 1886110. Despite these early advances the full 
utility of tracheal resection for stenotic lesions was not realised until the late 
1960s and 70s with the pioneering work of Grillo111 and Pearson112. Currently 
the treatment of choice for most tracheal stenoses is segmental tracheal 
resection with primary anastomosis. Pre-operative assessment includes multi-
planar CT evaluation with three-dimensional reconstruction, virtual and rigid 
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bronchoscopy as detailed above. Surgical dissection is limited to preserve the 
lateral segmental blood supply but segments in excess of six centimetres may 
be resected in the case of complex lesions113.  
Surgical outcomes have been superior to alternative non-operative procedures 
with good to satisfactory results reported in excess of 90% of patients114-116. 
Mortality is in the region of 0-2% with the most frequent late complications being 
anastomotic failure, formation of granulation tissue and laryngeal dysfunction114. 
For long complex and sub-glottic lesions the success rate appears to be around 80-
90%65. The highest failure rate is seen in patients requiring more than one 
procedure to correct the defect117. Success rates may also be compromised in 
patients who have previously undergone laser resection and stenting which may 
damage the cricoid or lead to extension of the length of the stenotic segment118. 
Where the stenosed segment extends beyond a length that is primarily resectable 
surgical management becomes decidedly more complex requiring reconstruction 
of the trachea itself. A reconstructed trachea requires lateral rigidity with 
longitudinal flexibility. Anastomoses need to be airtight and any prosthetic 
material should ideally not provoke an antigenic tissue reaction. Simple tracheal 
transplantation is not possible due to the segmental nature of its blood supply. 
Additionally, prolonged use of immuno-suppressants poses risks of graft infection 
and breakdown. Currently approaches used have involved tracheal allografts, 
aortic allografts and tracheal allografts with tissue engineered host stem cells119. 
Cryopreserved and decellularised grafts appear to reduce their antigenicity and 
potentially improve long-term outcome. Despite this, reports of such cases are few 
in number predominantly being small cases series and isolated case reports119,120. 
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iv. Adjuvant therapy 
Adjuvant treatments have been targeted at the three phases of wound healing 
detailed above in an attempt to diminish the abnormal healing process responsible 
for TS. Examples of strategies used include: 
Inflammatory phase 
Corticosteroids, antibiotics, hyperbaric oxygen. 
Proliferative phase 
Antibiotics, corticosteroids, mitomycin-C, 5 fluorouracil / triamcinolone, 
hyperbaric oxygen. 
Maturation phase 
Colchicine, penicillamine, N-acetyl cysteine. 
All phases 
Anti-reflux therapy 
 Many of the potential agents have limited evidence particularly in humans with the 
most studied being corticosteroids (topical, inhaled and systemic), mitomycin-C 
(topical) and anti-reflux medication (proton pump inhibitors) 
Corticosteroids 
Theoretically corticosteroids could be expected to affect both inflammatory and 
proliferative phases of wound healing. 
In relation to airway injury, a number of studies have assessed the role of 
dexamethasone in reducing laryngeal oedema and reducing the need for re-intubation. 
A Cochrane review, of six studies in adults totalling 1953 patients, found that 
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prophylactic use of corticosteroids reduced the risk of post-extubation stridor in those 
patients at high risk but did not reduce the re-intubation rate121. Although a number of 
studies have shown some beneficial effects in paediatric patients there is limited 
evidence for the role corticosteroids in the setting of adult post-intubation TS – 
studies being confined case reports or small case series. 
Mitomycin-C 
Mitomycin-C is an antimicrobial agent as well as having anti-metabolite and anti-
proliferative properties. It inhibits de-oxyribonucleic acid (DNA) synthesis and in 
higher concentrations suppresses ribonucleic acid (RNA) and protein synthesis. 
Consequently it has been used as a chemotherapeutic agent for solid tumours. When 
administered topically it has been shown to inhibit fibroblast proliferation possibly by 
inducing apoptosis. Whilst mitomycin is amongst the most frequently studied 
adjuvant agents for the management of TS data relating to human use is largely 
confined to retrospective studies and case reports122-124.  
Two randomised studies have, however, attempted to evaluate the role of mitomycin-
C in the treatment and prevention of TS. Hartnick reported a paediatric study of 24 
patients undergoing a single mitomycin application after laryngotracheal 
reconstruction125. Thereafter development of granulation tissue was graded on a scale 
of 0-4. After recruitment of 13 patients to the intervention group and 11 to the control 
group the study was stopped early, as the outcome in both groups was almost identical 
(Granulation grade 3-4: placebo treated 1 patient, mitomycin treated 3 patients. 
Granulation grade 0-2: placebo treated 10 patients, mitomycin treated 11 patients). 
More recently Smith and Elstad reported the findings of a randomised controlled trial 
comparing a one or two applications of mitomycin-C in association with endoscopic 
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laser treatment126. Twenty-six patients were recruited with idiopathic, post-intubation 
and  polyangiitis  (Wegener’s)  stenosis.  All  patients  received  mitomycin-C at the first 
procedure. One month later a second endoscopic intervention was undertaken at 
which patients were randomised to receive either a second application of mitomycin-
C or a saline placebo. Follow up for five years revealed an increase in the median 
interval to relapse from 2.4 years in the single application group to 3.8 years in the 
two application group. Relapse rates at five years, however, were identical in both 
groups. Leading the authors to conclude mitomycin-C delays rather than prevents re-
stenosis. 
In a review of adjuvant therapies for upper airway stenosis Hirshoren identified 11 
human studies (181 patients) assessing the effects of mitomycin-C70. Only one was 
randomised125, eight had no control group and six were retrospective. Of these trials, 
nine claimed a positive outcome.  
Mitomycin-C clearly has an effect on wound healing however optimal timing for 
application remains unclear. Its efficacy for treating established stenoses is 
questionable.  
Treatment for gastro-oesophageal reflux disease 
Initial data suggesting gastro-oesophageal reflux may play a role in the development 
of TS came from case reports by Little and Bain127,128. Further work suggested that 
those with reflux disease were over-represented in sub-glottic stenosis populations 
particularly those with idiopathic disease129,130. A number of studies have described 
less successful outcomes for surgical reconstruction in patients with uncontrolled 
reflux disease131-133. However, this was not supported by the findings of a large single 
blind observational study134. In an prospective, single blind observational study of 74 
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paediatric patients Zalzal failed to find any effect of gastro-oesophageal reflux disease 
on the outcome of undergoing laryngotracheal reconstruction. Thus concluding that 
evaluation for and treatment of reflux disease had no role in this patient population. 
2.2.2 Tracheo-innominate artery fistula 
The first report of a tracheo-innominate artery fistula (TIF) was in 1879 when Korte 
described a fatal fistula in a five year old child with diptheria135. In a case report and 
clinical review from 1976 Jones et al documented a total of 127 cases from the world 
literature to that point136. The first survivor of a TIF was not reported until 1965137. In 
a series of six patients, Silen reported on the management of a young female patient 
who had undergone a tracheostomy for respiratory failure due to Guillain-Barre 
Syndrome. Five days after tracheostomy insertion she developed a TIF. This was 
managed with surgical excision of the necrotic portion of the innominate artery 
followed by over-sewing of the arterial stumps. She survived for 15 days before dying 
from an aspiration pneumonitis. The first long term survivor was reported by Reich in 
1968 in a young female patient who again underwent resection of the necrotic arterial 
segment138. Despite multiple reports in the intervening years the mortality still 
remains high. A recent review139 of the surgical management of TIF in Beijing, 
covering 32 years and 14 cases, reported one survivor without neurological 
impairment at 11 months. 
Tracheo-innominate artery fistula is an uncommon and life threatening complication 
occurring after tracheostomy that is universally fatal without surgical intervention. 
The true incidence of this rare complication is difficult to assess as it is most 
frequently reported in small case series or isolated case reports. The incidence seems 
to have reduced following the widespread introduction of high volume low pressure 
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cuffs for tracheal and tracheostomy tubes. The overall incidence of late haemorrhage 
after tracheostomy has been reported at around 3%. Approximately 10% of late 
bleeding is thought to be related to a TIF, however, in our own series all significant 
late bleeding was due to TIF (0.35%59). Massive haemorrhage may also originate 
from the aortic arch, common carotid and thyroid arteries and the innominate vein140. 
Pooled data of 5530 tracheostomies recorded the incidence of delayed massive 
haemorrhage as 0.3%141. In our own series of 1000 percutaneous procedures 
performed using the single tapered dilator, the rate is around 0.4% (see Chapter 5). 
Elsewhere, reported rates are 0.1–1% after surgical and 0.3% after percutaneous 
tracheostomy, with peak incidence 7–14 days post procedure142,143. 
2.2.2.1 Pathophysiology 
The tracheo-innominate artery is the first branch of the aortic arch (figure 2.2). It 
divides into the right common carotid and right subclavian artery 3–4 cm lateral to the 
trachea, behind the right sternoclavicular joint. In its inferior proximal portion, its 
relations include: 
a) Anterior: left tracheo-innominate vein and thymus; 
b) Posterior: trachea (6–10th ring); 
c) Posterior and left: left common carotid artery; 
d) Right: right tracheo-innominate vein, superior vena cava and pleura. 
The tracheo-innominate artery supplies blood to the right arm and the right side of the 
head and neck. Its absence on the left is explained by the direct branching of the left 
common carotid and subclavian arteries from the aortic arch. A high lying innominate 
artery, particularly in the thin and young, may act as a risk factor in TIF formation 
following tracheostomy63. 
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Pressure necrosis from high cuff pressure, mucosal trauma from a malpositioned 
cannula tip, low tracheal incision, excessive neck movement, radiotherapy or 
prolonged intubation have all been implicated in TIF formation144. The relationship of 
the tracheostomy tube to the tracheo-innominate artery can be seen in figure 2.7. 
Figure 2.7. Relationship of the cuff of the tracheostomy tube to the tracheo-
innominate artery – anterior and lateral representations. 
 
Reproduced with permission from Kapural L et al. Tracheo-innominate artery fistula 
after tracheostomy. Anesthesia & Analgesia. 1999;88(4):777-780145 
Two principal mechanisms are capable of producing sufficient pressures to generate 
the erosive processes that lead to fistula formation (figure 2.8): 
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Figure 2.8. Mechanisms of tracheo-innominate fistula formation 
A       B      C 
 
 (A): Pressure generated beneath the angulated neck of a tracheostomy tube can produce anterior tracheal wall ischaemia 
 (B): Pressure generated by the tracheostomy tube cuff can cause anterior tracheal wall erosion 
 (C): Pressure produced by the tip of the tracheostomy tube causes erosion through the anterior tracheal wall 
Amended from: Wolfe WG. Complications of Thoracic Surgery: Reproduced with due acknowledgement to WG Wolfe and publisher 
 77 
 The first mechanism involves pressure generated beneath the angulated neck 
of a tracheostomy tube (figure 2.8A). This could produce ischaemia anteriorly 
on the tracheal mucosa and into the innominate artery. 
 A fistula may also occur between the anterior tracheal wall and artery. This is 
secondary to the mechanical force generated by either the tracheostomy tube 
cuff or tube tip depending on the relative positioning of the tube within the 
trachea (figure 2.8B & 2.8C). 
Some authors suggest that a low lying tracheostomy tube is an obvious cause of 
fistula formation73. However, even when the tracheotomy incision is placed between 
the second and third tracheal rings as recommended, these complications can still 
occur. In a post-mortem study, Oshinsky found that ten standard vertical incisions 
placed in the second and third rings resulted in all subsequently placed tracheostomy 
tubes having either cuff or tip anatomically adjacent to the innominate artery, 
suggesting the potential presence of this complication in all patients with 
tracheostomies146. 
2.2.2.2 Diagnosis 
Any peri-stomal bleed or haemoptysis should lead to a full clinical investigation to 
ascertain the underlying cause. A differential diagnosis is based on the lag time 
between the tracheostomy and subsequent haemorrhage. Haemorrhage within 48 h is 
typically associated with local factors such as traumatic puncture of anterior jugular 
or inferior thyroid veins, systemic coagulopathy, erosions secondary to tracheal 
suction or bronchopneumonia. 
Vascular erosion from a tracheostomy tube, resulting in a TIF, requires at least 48 
hours to develop even in the most friable mucosa. Haemorrhage occurring 3 days to 6 
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weeks after tracheostomy should be thought of as a result of TIF until proven 
otherwise147. Other causes of catastrophic pulmonary haemorrhage include pulmonary 
artery flotation catheter induced arterial rupture, thoracic aneurysm rupture and less 
common vascular fistula (carotid artery, inferior thyroid). It is likely that the majority 
of TIF will occur in the Critical Care Unit, as 70% of all delayed haemorrhage occurs 
during the first 3 weeks148. A sentinel bleed is reported in more than 50% of patients 
who then develop massive delayed haemorrhage136,149. Haemorrhage occurring after 
more than 6 weeks is rarely related to TIF and more likely to be secondary to 
granulation tissue, tracheo-bronchitis or malignancy. 
2.2.2.3 Clinical management 
Adequate oxygenation is the mainstay of immediate management with simultaneous 
identification and termination of bleeding. In most TIF related deaths the cause of 
death is hypoxia due to bleeding into the airway rather than exsanguination from 
massive haemorrhage144. 
Management of a suspected TIF will depend upon whether there is active bleeding 
into the airway hindering adequate ventilation (Figure 2.9). The use of immediate 
bronchoscopy to confirm the extent and source of bleeding has been advocated144. 
Although bronchoscopy is unlikely to identify the fistula opening per se, it may 
exclude other pathology and allows direct monitoring of attempts to obtain a blood-
free airway. Rigid bronchoscopy to clear the tracheobronchial tree of aspirated blood 
and to terminate blood flow is ideal, but this may not be possible.  
If bronchoscopy confirms that the main bronchi are blood-free then immediate 
intervention is not required but further investigation to confirm the cause of bleeding 
is vital. Other causes of haemorrhage must be excluded before a sentinel bleed 
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associated with TIF can be confirmed. If no other cause is evident then a provisional 
diagnosis of TIF should be made; urgent surgical advice and consideration of stoma 
exploration should follow. If, in the presence of active bleeding, bronchoscopy 
indicates that the airway is clear of blood but there is ongoing external haemorrhage, 
the potential for catastrophic airway contamination is real. Overinflating the cuff 
provides additional airway protection and may control the bleeding temporarily. If, 
however, bleeding continues then pressure dressings should be applied to the stoma 
site. These manoeuvres temporarily control bleeding by a direct tamponade effect in 
more than 80% of patients150. As long as the airway remains free of blood, no attempt 
should be made to manipulate the tracheostomy tube. Immediate surgical exploration 
should follow. 
Where bronchoscopy confirms that there is active bleeding into the airway, the major 
threat is respiratory compromise rather than hypovolaemia151. Airway protection is 
the primary management aim. Movement of the tracheostomy tube may precipitate 
disastrous airway occlusion143. The aims must be to gain temporary control of the 
bleeding, get adequate oxygenation and proceed to immediate stomal exploration and 
definitive treatment.  
i Haemorrhage control measures 
 Over-inflation of the tracheostomy cuff is first line management. 
If this measure fails to reduce bleeding in to the trachea then proceed 
immediately to trans-laryngeal intubation with digital compression. 
 Trans-laryngeal intubation and digital compression of the innominate artery 
against the posterior surface of the manubrium. A cuffed oral tracheal tube is 
advanced so that the balloon lies distal to the tracheostomy stoma. The 
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tracheostomy tube should only be withdrawn to facilitate simultaneous trans-
laryngeal tracheal intubation. This procedure should terminate bleeding in > 
90% patients and if maintained, allows transfer to the operating theatres. 
 If digital compression fails to stem bleed, slow withdrawal of the tracheal tube 
and cuff over-inflation should follow. Manipulating the ETT tube, and its cuff 
to produce tamponade is the only other manoeuvre available in this situation 
and attempts should persist.  
If the bleeding stops, and ventilation is acceptable, then immediate surgical 
intervention should follow. There is no evidence to support any imaging prior to 
immediate surgical exploration.  
ii Surgical management 
It is clear from the literature that the mortality for TIF without surgery is close to 
100%. There remains a degree of controversy around the optimal surgical 
management. 
Most surgical approaches utilise a median sternotomy or upper sternotomy extended 
to the second right intercostal space to access the fistula. 
Thereafter the controversy revolves around the two basic strategies for fistula 
management and concerns relating to post-operative neurological deficit. 
 Maintenance of flow within the innominate artery 
Direct repair of the fistula 
Graft interposition 
 Interruption of flow within the artery 
Simple ligation of the innominate artery 
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Bypass grafting – aorto-axillary 
The principal concern relating to maintenance of flow within the vessel is related to 
the risk of re-bleeding. The area surrounding the fistula is highly like to have active 
underlying infection and ongoing inflammation. Repair of the fistula or interposition 
of a foreign body to bypass the defect are therefore highly likely to fail. In a review of 
37 cases published between 1975 and 1988 Yang described the outcomes of patients 
surviving to undergo operative intervention152. Fourteen patients underwent resection 
or ligation of the innominate artery with a re-bleeding rate of 7% and 64% long-term 
survival. Ten patients underwent procedures maintaining flow within the innominate 
artery and had a re-bleeding rate of 60% and a long-term survival of 10%. Similarly 
Gelman reported on the outcomes of 71 TIF survivors in 1994151. With maintenance 
of flow within the vessel re-bleeding rates were 60% versus 7% when there was 
disruption of flow. With maintenance of flow mortality was 86% versus 29% with 
disruption. Even with ligation of the innominate artery, reported neurological 
sequelae were minimal. Despite these data, continued reports of stent 
interposition153,154, vascular grafting155 and endovascular embolisation156,157 continue 
to appear. Reported neurological sequelae are unusual with arm weakness occurring 
in around 4% of patients and more significant neurological deficit in less than 5% of 
patients158 .
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Figure 2.9. Algorithm for management of delayed (> 48 hours) tracheal haemorrhage.    From: Grant144  
Manipulation of ETT 
with Cuff over inflation 
Surgical Exploration 
Surgical Exploration 
Trans-laryngeal Intubation 
Overinflate Tracheostomy Cuff 
Bleeding Controlled 
Non-Contaminated Trachea 
Overinflate Tracheostomy Cuff 
Surgical Exploration Pressure Packs 
Surgical Exploration 
Bleeding Continues 
Bleeding Continues Bleeding Controlled 
Contaminated Trachea 
Digital Compression via Stoma 
Bleeding Continues Bleeding Controlled 
 Bleeding Continues Bleeding Controlled 
From Grant C et al144. Tracheo-innominate artery fistula after 
percutaneous tracheostomy. Br J Anaesth. 2006;96(1):127-131. 
With permission from Oxford University Press 
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2.2.3 Tracheo-oesophageal fistula 
Tracheo-oesophageal fistulae related to tracheostomy insertion may occur as both an 
early and late complication. Trauma to the posterior tracheal wall during 
tracheostomy insertion may lead to direct fistula formation although a simple 
posterior tracheal wall tear with entry only into the mediastinum is perhaps more 
likely. Such fistulae will usually be evident immediately post-operatively although 
diagnosis may be delayed159,160. Features suggestive of an immediate problem include 
a persistent cuff leak with the formation of subcutaneous and mediastinal emphysema 
as well as pneumothoraces. 
Although tracheo-oesophageal fistulae (TOF) may result from several different 
aetiologies, including trauma and post-surgically, those originating after prolonged 
tracheal intubation and tracheostomy remain the commonest. TOF due to 
tracheostomy cuff erosion was first reported in the 1960s161-163, with Flege being the 
first to postulate ischaemic necrosis, due to the cuff of the tube impairing tracheal 
wall capillary perfusion, as the underlying cause162. The reported incidence is similar 
to that of TIF164 formation although the presentation maybe somewhat later with 
median times to diagnosis around 30 – 35 days from onset of mechanical 
ventilation165,166. Similarly to TIF and TS, with the introduction of high volume low 
pressure tracheostomy tube cuffs, the incidence of TOF appears to have 
diminished167. Muniappan recently reviewed cases of TOF presenting over a 35 year 
period extending from 1975 to 2010 and reported a falling incidence of post 
intubation lesions from 71 to 47%168. 
2.2.3.1 Pathophysiology of late TOF 
The aetiology of late TOF is essentially the same as that described above for both TIF 
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and TS. Over inflation of the tracheostomy tube cuff will lead to pressure necrosis, 
additionally malpositioning of the tube may also lead to erosions of the posterior 
tracheal wall by the tip of the tracheostomy tube. After short periods of intubation, 
epithelial disruption, basement membrane loss, and / or an appearance of ischemic 
non-inflammatory necrosis can occur. More prolonged intubation results in broader, 
deeper ulcers, disruption of basement membranes and ischemic necrosis. Similar to 
the aetiology of tracheal stenosis, cuff pressures of greater than 20-30 cm of water 
contribute to mucosal ischemia67,68,83. The effects of cuff related mucosal injury may 
be exacerbated by repeated tracheal tube manipulations, intubations, or excessive 
movements of the tracheostomy tube and ventilator circuitry. Additional factors 
important in the aetiology may be the presence of a naso-gastric tube, advanced age, 
diabetes mellitus, steroid therapy, prolonged hypotension, oesophageal infections and 
prolonged cannulation169. However, pressure related necrosis may be more likely to 
be associated with the rigid cartilaginous anterior tracheal wall than the soft tissue of 
the musculo-membranous posterior wall. This may account for the more frequent 
descriptions of TS and TIFs170. 
As most TOF related to prolonged intubation and tracheostomy insertion are related 
to mucosal ischaemia produced by the cuff of the tube their site is usually in the 
proximal trachea. Muniappan in a report of 74 cases of TOF, of which 59% were post 
intubation / tracheostomy, described the site of the fistula in the upper trachea in 36%, 
the mid-trachea in 61% and the lower trachea in 3%168. Additionally, 35% of lesions 
were < 1cm, 58% were 1 – 3cm and 8% were in excess of 3cm (figure 2.10). 
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Figure 2.10 Location (2.10 A) and size (2.10 B) of tracheo-oesophageal fistulae. Fistulae are found predominantly in the proximal and mid-
trachea and are usually less than 3cm in length. 
 
Reprinted from Muniappan A et al. Surgical treatment of non-malignant tracheo-oesophageal fistula: a thirty five year experience. Annals of 
Thoracic Surgery 2013;95(4):1141-1146. Copyright (2013) with permission from Elsevier.168 
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2.2.3.2 Diagnosis 
Hallmarks of TOF include persistent choking or coughing in relation to swallowing 
leading to aspiration pneumonitis. An ongoing air leak around the cuff of the 
tracheostomy tube, gastric distention and abdominal air movement synchronous with 
respiration may be seen. Further signs may include subcutaneous and mediastinal 
emphysema and pneumothorax171. As the underlying pathology is similar to that 
responsible for both TS and TIF the timing of presentation of late TOF is likely to be 
several days to weeks following the tracheostomy. 
Whilst the diagnosis is largely made on clinical grounds, with associated plain 
radiology showing evidence of mediastinal or pleural air, CT scanning will confirm 
the diagnosis. The fistula may be visualised directly by fibre-optic bronchoscopy 
although if due to erosion from the cuff it may be obscured by the tracheostomy tube 
itself. Definitive visualisation, prior to operative intervention, will be achieved by 
rigid bronchoscopy and oesophagoscopy. 
2.2.3.3 Clinical management 
When the diagnosis of TOF is confirmed the initial management involves avoiding 
further aspiration of gastric secretions into the tracheo-bronchial tree. The cuff of the 
tracheostomy or trans-laryngeal tube should be advanced beyond the fistula and the 
nasogastric tube should be removed. Gastric reflux should be reduced by the insertion 
of a gastrostomy tube and enteral feeding continued via jejunostomy. Antibiotic 
treatment of associated aspiration pneumonitis may also be required. These measures 
should prevent further aspiration pneumonitis and allow weaning from mechanical 
ventilation before more invasive therapies are contemplated. 
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i Conservative management 
Whilst spontaneous healing of a TOF, over many months, with conservative 
management of gastrostomy, jejunal feeding and re-positioning of the tracheostomy 
tube has been reported this is far from usual172 . Surgical treatment remains the 
mainstay of treatment but a number of less invasive therapies have been described in 
recent years. In a series of 25 patients with oesophageal leaks or fistulae Blackmon 
reported the use of metallic stents in their management173. Only four patients had TOF 
and in only two of whom was this due to prolonged intubation. The authors reported 
that in two of these four patients their fistulae sealed, whether further surgery was 
required or not was not reported. In another report of stenting for TOF Eleftheriadis 
described the management of twelve mechanically ventilated patients166. Whilst the 
authors stated that stent insertion was successful in all cases with sealing of the fistula 
and no migration only three of the twelve patients survived to surgery. Whether the 
stent placement resulted in a delay in referral for surgical intervention or, due to 
reduced  gastric  aspiration,  allowed  an  improvement  in  the  patients’  general  condition  
to enable consideration of surgery is unclear168. The use of fibrin glue to close a TOF 
in a mechanically ventilated patient has also been reported174. 
ii Surgical management 
Repair of TOF is a major undertaking in the critically ill patient. Consequently most 
authors advocate waiting until the patient has been weaned from mechanical 
ventilation and largely recovered from the after effects of their critical illness 
including any critical illness related neuro-muscular weakness164. This will allow 
improvement in nutritional status and reduce the risk of further post-operative 
prolonged mechanical ventilation. In a recent report of 13 patients undergoing TOF 
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repair Foroulis described the use of a pre-sternocleidomastoid incision with 
interposition of a vascularised sternocleidomastoid pedicle165. Five of the thirteen 
patients were still mechanically ventilated at the time of operation, of whom three 
died in the post-operative period (60% mortality). In the eight patients in whom 
surgery was performed after weaning from mechanical ventilation there were no 
deaths. 
The surgical approach to repair is largely dependent upon the site of the fistula and 
whether there is associated tracheal involvement. For those fistulae that are small (< 
3cm) without tracheal involvement then a direct repair via a pre-sternocleidomastoid 
approach, with or without extension in to the superior mediastinum may be the most 
appropriate option. When there is associated tracheal disease (stenosis or 
tracheomalacia) a combined tracheal resection and oesophageal repair, as popularised 
by Grillo, is the most frequently used technique175. For more distal and complex 
lesions the use of a median sternotomy or thoracotomy may be required along with 
oesophageal reconstruction using gastric or colonic interposition. In addition to 
repairing the defect most authors recommend the interposition of vascularised 
pedicled muscle flaps (sternocleidomastoid, strap or pectoralis major muscles) to 
separate the tracheal and oesophageal anastomoses168,176 although the need for these 
has recently been questioned177. In their series of 25 patients Marulli reported the use 
of a cervical approach in 56%, a combined cervical & sternotomy incision in 24% and 
a thoracotomy in 16% of cases176. In the same patients they undertook a direct fistula 
repair in 60% and a combined tracheo-oesophageal resection in 32%.  
Although early reports for mortality after TOF repair were as high as 28%178,179 most 
case series published after 2000 have reported mortalities of less than 
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10%168,176,177,180. Complication rates, however, remain high (32-56%)168,176 with 
anastomotic breakdown and pulmonary infection being the most common. 
2.3 Summary 
The first reports of long-term complications of tracheostomy in significant numbers 
followed the poliomyelitis epidemics in the 1940s and 50s with the first widespread 
use of tracheal intubation and cuffed tracheostomy tubes for the purposes of 
mechanical ventilation. Whilst the absolute incidence of each complication has fallen 
with the introduction of high volume low-pressure cuffs, improved monitoring of cuff 
pressures and ventilator circuitry the underlying prevalence continues to increase as 
increasing numbers of patients receive these treatments.  
Treatment of each complication is dependent upon the complexity of the lesion 
present, the symptoms produced and co-existing co-morbidities for any given patient. 
In a population of critically ill patients all long-term complications of tracheostomy 
will pose significant problems with considerable morbidity and mortality.  
For TS tracheal resection provides the best chance of a lasting cure with success rates 
in the region of 90% for simple lesions and 80-85% for more complex ones. 
Endoscopic treatments are largely reserved for symptom relief pending definitive 
surgery or for those deemed unfit for tracheal resection.  
For TIF outcomes are directly related to rapid diagnosis and surgical intervention. 
With techniques involving ligation or resection of the innominate artery long-term 
survival of 70% of patients surviving to the operating theatre is possible.  
Tracheo-oesophageal fistulae require an approach to minimise ongoing gastric 
aspiration to facilitate weaning from mechanical ventilation and allowing 
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improvement in general health and nutritional status prior to attempting surgical 
repair. With this cautious approach mortality rates of less than 10% can be 
achieved168,176,177,180, however, operating on patients who remain ventilator dependent 
still results in much higher death rates165. 
Whilst the incidence of TS following percutaneous tracheostomy is evident from a 
number of long term cohort studies57-59 the issue of missed or sub-clinical stenoses has 
not been fully addressed. Non-specific symptoms are common following critical care 
admission and PDT, with frequent reports of voice changes, swallowing difficulties, 
cough and shortness of breath181,182. We hypothesised that, in this cohort of patients, 
there are a number of patients with undetected TS.  
2.4 Aims 
 To identify aetiological factors in initiation of tracheal stenosis with particular 
reference to peri-operative events 
 To determine the role of early complications that may be postulated to play a 
part in the genesis of the late complications of tracheal stenosis, tracheo-
innominate artery fistula and tracheo-oesophageal fistula 
 To determine the prevalence of sub-clinical tracheal stenosis following 
percutaneous tracheostomy using the single tapered dilator technique. 
 To determine possible aetiological factors for such sub-clinical stenoses 
namely tracheal ring fracture and duration of cannulation 
 To determine whether sub-clinical tracheal stenosis may be presenting 
atypically in the post-critical care population 
 To determine the utility of simple spirometry and a symptom based 
questionnaire in identifying sub-clinical tracheal stenosis 
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Rationale for thesis 
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3.1 Systematic Review 
Percutaneous dilatational tracheostomy (PDT) has become widely adopted in critical 
care units following Ciaglia’s first description of the dilatational technique40. Since 
then multiple percutaneous techniques have been described, introduced and widely 
evaluated in comparison to both each other and surgical tracheostomy (ST). Whilst 
the short-term complications of these techniques are well described, the prevalence 
and impact of longer-term outcomes, particularly TS, is unclear. Previous meta-
analyses have attempted to address this problem but have been confounded by the low 
incidence of TS and, in particular, the limited number of studies reporting long-term 
outcomes 51-55.  
On examination of current evidence, the meta-analysis published by Delaney et al, 
found a significantly decreased rate of wound infection after all commonly performed 
percutaneous techniques compared to surgical tracheostomy51. Additionally, there 
were reductions in mortality and bleeding in patients undergoing percutaneous 
tracheostomy in the critical care unit as opposed to ST in the operating theatre. 
Higgins et al, also reported a tendency towards a reduction in overall complications 
for percutaneous procedures53. In contrast, Oliver et al, found an increased incidence 
of minor early complications associated with percutaneous techniques but insufficient 
evidence to suggest a difference in late complications of poor cosmetic results and 
tracheo-cutaneous fistulae52. Cabrini et al, found that the six percutaneous techniques 
analysed (Ciaglia multiple dilator method (CPDT), guide wire dilating forceps 
(GWDF), single tapered dilator (STD), trans-laryngeal tracheostomy (TLT), balloon 
dilator (BD), single step rotational dilator (SSRD)) were largely comparable with the 
exception of the TLT, which was associated with an increased conversion rate to ST 
or other percutaneous technique and more severe early complications54. They also 
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found the STD was associated with fewer complications and failures. In a later 
analysis the same authors reported less operative bleeding and fewer technical 
difficulties associated with the STD technique compared to the GWDF technique 
using a composite endpoint55. 
The meta-analyses described above have included only randomised controlled trials 
(RCTs). The only exception to this was the analysis by Oliver which also included 
non-randomised prospective studies52. The largest single study incorporated into the 
previous analyses comprised 346 patients56. It is perhaps unsurprising, therefore, that 
none of the previous meta-analyses have reported differences in late complication 
rates. The exact incidence of long term complications following tracheostomy 
procedures in the critically ill is difficult to quantify due to the associated mortality of 
critical illness, the sub-clinical nature of many tracheal stenoses and the difficulty 
maintaining follow up of these cohorts. From a number of prospective cohort series it 
would appear that sub-clinical TS is found in around 10% of survivors79 with 
clinically evident lesions presenting in 0 - 0.35%57-59.  
Despite its low incidence, TS causes significant ongoing morbidity and healthcare 
costs associated with its management. The management of choice for TS has been 
segmental tracheal resection since Grillo183 and Pearson112 demonstrated good 
outcomes. However, in some patients stenoses may not be amenable to surgery. 
Management of such patients presents a challenge; alternative treatments include 
endoscopic dilatation, laser ablation, tracheal stenting and cryosurgery107. These 
interventions may temporarily alleviate the symptoms of TS but as re-stenosis is a 
frequent occurrence repeated procedures are often necessary. Given this associated 
morbidity and the cost associated with the management of TS a clearer picture of the 
risk associated with each tracheostomy technique performed within the critical care 
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setting is required. 
There is little direct evidence for the association of any peri-operative complications 
with the aetiology of TS. In a study, pre-dating the widespread introduction of PDT, 
assessing the impact of prolonged tracheal intubation and tracheostomy Stauffer 
identified a high incidence of complications associated with ST (36% for stomal 
bleeding, 36% for stomal infection) and a 65 % tracheal stenosis incidence74. Despite 
a number of moderate sized case series from tertiary centres reporting of the 
management of tracheal stenosis none have specifically looked at the role of peri-
operative events in the initiation of TS71,75,88,184. The only peri-operative event that has 
been postulated to have a role in the genesis of TS is tracheal ring fracture. Whilst a 
number of authors184-186 have suggested that tracheal ring fracture may be of 
significance this is not necessarily borne out within large cohort studies59. Further 
studies have considered a role for infection in the initiation of TS. In an animal model 
of tracheal stenosis Squire inoculated the tracheas of rabbits with Staphylococcus 
aureus66. When compared to those without bacterial inoculation the incidence of 
tracheal stenosis was higher and the resultant lesions narrower. Additionally, 
Welkoborsky examined operative specimens removed from 18 patients undergoing 
surgical resection for TS and felt infection at the stenotic segment played a part in its 
initiation in 4 patients69. Despite this work and evidence to suggest a greater incidence 
of stomal infections for ST compared to PDT51 there is no evidence to that the 
incidence of TS differs between the two techniques or that antimicrobial treatment 
reduces the incidence of TS.  
Despite this lack of direct evidence for the association of peri-operative events with 
the development of TS we postulated that some complications maybe surrogate 
markers for a more severe tracheal injury at the time of tracheostomy and thus affect 
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the healing process. When considering such problems it is possible that many of the 
events listed in Appendix 1 may lead the operator to settle for sub-optimal 
tracheostomy tube positioning which may have an impact on later healing or 
predispose to infection. We, therefore, felt that the role such factors may play in the 
initiation of tracheal stenosis was worthy of further study. 
Therefore, we performed a systematic review of all prospective studies that reported 
long-term outcomes and assessed potential predisposing factors. Our aim was to 
determine if longer-term complication rates, with particular reference to TS, differed 
between percutaneous and surgical tracheostomy techniques in the critical care 
setting. 
3.2 Single tapered dilator percutaneous tracheostomy: An 11-year review 
Despite the popularisation of the percutaneous dilatational approach by Ciaglia40,41 
and the proliferation of a number of similar techniques42-44,47,187 the long term 
outcomes and survival following percutaneous tracheostomy remain unclear. A 
number of large cohort studies have described late complications and short term 
survival following PDT57-59,188 but survival beyond 12 months has not been previously 
been reported. 
Percutaneous dilatational tracheostomy has now largely replaced conventional 
surgical tracheostomy in critical care patients, with benefits in terms of cost, ease of 
performance, and reduced complications51. In 2000, the first description of a 
modification of the original CPDT technique described by Ciaglia40 was reported 
using a single tapered dilator44. The STD method has now largely supplanted the 
sequential dilatational procedure and appears to be the single most common technique 
for performing a PDT in the critical care setting45,46,189. 
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Several authors have published large PDT case series. Kearney, in perhaps the largest 
single centre evaluation to date, reported the outcome of an eight year review of the 
CPDT technique188. Diaz-Reganon reported an evaluation of both CPDT (51 patients) 
and GWDF (749 patients) in a single centre study58 whilst Kost reported outcomes of 
both CPDT and STD techniques across multiple units in Montreal57. Here, we update 
our earlier single centre evaluation of the STD technique59 reporting long term 
outcomes over an 11 year study period. 
3.3 Tracheal stenosis following percutaneous tracheostomy: A MRI study 
Whilst the incidence of TS following percutaneous tracheostomy is evident from a 
number of long term cohort studies57-59 the issue of missed or sub-clinical stenoses has 
not been fully addressed. Non-specific symptoms are common following critical care 
admission and PDT, with frequent reports of voice changes, swallowing difficulties, 
cough and shortness of breath181,182. We hypothesised that, in this cohort of patients, 
there are a number of patients with undetected TS.  
Earlier studies have attempted to identify the prevalence of TS following PDT using 
CT181,190, MRI80, plain linear tomography191, spirometry with fibre-optic 
laryngoscopy192, or fibre-optic laryngoscopy alone193. Norwood’s  study181 using CT 
evaluation of tracheal anatomy after sequential dilatation PDT and correlation with 
symptoms found an incidence of TS of 31%, 20% of whom were symptomatic, but 
could not determine whether voice changes or respiratory problems were a result of 
critical illness or PDT itself. Spirometry has been variably described as 
straightforward but with unproven utility in detecting stenosis194 and as unhelpful in 
detection of TS in patients after critical illness, with poor correlation between 
spirometry findings and endoscopic features192. The forced expiratory volume in 1 
second (FEV1) to peak expiratory flow rate (PEFR) ratio (FEV1: PEFR) ratio was 
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demonstrated by Empey to be useful in distinguishing upper airway obstruction from 
lower airways disease but has not been widely adopted195.  
Despite the above attempts to delineate tracheal post-PDT changes there are limited 
data pertaining to STD PDT. Although Fikkers used MRI to evaluate long-term 
outcome only 14 STD patients were evaluated80. We therefore undertook a 
prospective study to radiographically evaluate tracheal changes following STD PDT 
in an attempt to better define the prevalence of sub-clinical TS. 
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3.4 Statement of Aims 
Systematic review 
 To identify aetiological factors in initiation of tracheal stenosis with particular 
reference to peri-operative events 
 To determine the utility of adjunctive techniques (bronchoscopy & ultrasound 
scanning) in reducing complications of percutaneous tracheostomies 
percutaneous tracheostomy technique and hence determine the safest 
percutaneous technique 
 To determine the incidence of common early and late complications and 
outcomes of PDT techniques in relation to surgical tracheostomy. 
 To determine the role of early complications that may be postulated to play a 
part in the genesis of the late complications of tracheal stenosis, tracheo-
innominate artery fistula and tracheo-oesophageal fistula 
 To determine the relative indices of early and late complications in relation to 
percutaneous tracheostomy technique and hence determine the safest 
percutaneous technique 
Cohort study 
 To determine the role of early complications that may be postulated to play a 
part in the genesis of the late complications of tracheal stenosis, tracheo-
innominate artery fistula and tracheo-oesophageal fistula 
 To determine long term survival following percutaneous tracheostomy 
MRI study 
 To determine the prevalence of sub-clinical tracheal stenosis following 
percutaneous tracheostomy using the single tapered dilator technique. 
 To determine possible aetiological factors for such sub-clinical stenoses 
namely tracheal ring fracture and duration of cannulation 
 To determine whether sub-clinical tracheal stenosis may be presenting 
atypically in the post-critical care population 
 To determine the utility of simple spirometry and a symptom based 
questionnaire in identifying sub-clinical tracheal stenosis  
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Chapter 4 
 
Long-term outcome following tracheostomy in critical 
care: A systematic review 
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4.1 Search strategy 
We searched Embase, PubMed-Medline and the Cochrane Central Register of 
Clinical Trials for prospective studies involving humans in the critical care setting that 
reported tracheostomy outcome data and included patients that had received at least 
one PDT either alone or in comparison with ST or another percutaneous technique. To 
reflect contemporary practice we limited the search to studies published from the year 
2000 onwards. The search was restricted to full text reports of papers published in 
English in peer-reviewed journals. In addition, reference lists of those studies returned 
in the above search were scrutinised for additional relevant papers. 
 
4.1.1 Study selection 
Titles and abstracts of the references obtained were reviewed by three independent 
reviewers (G Dempsey, B Morton & C Hammell). Studies were categorised as - for 
inclusion, possible inclusion and exclusion. In the absence of a decision by two 
investigators to exclude a paper, data extraction of full text articles was undertaken by 
two of the three reviewers independently. Discrepancies between reviewers prompted 
a re-evaluation of the paper. Ongoing disagreement was resolved by the third 
reviewer. If the outcome data in the original article was unclear the corresponding 
author was contacted for clarification. Our protocol relating to study selection and 
data extraction is published on: 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014008830 
 
4.1.2 Data extraction and outcomes 
A database was constructed to incorporate outcomes common to previous systematic 
reviews of percutaneous tracheostomy (additional parameters not presented in the 
main text of this chapter can be found in appendix 1). Outcomes were defined a 
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priori. The primary outcome was TS. Secondary outcomes were wound infection 
requiring treatment and bleeding (major and minor).  
 
4.1.3 Internal validity and risk of bias assessment 
The internal validity and risk of bias for RCTs was assessed using the Oxford Quality 
Scoring System (Jadad Score)196. The score is based on randomization (0-2 points), 
blinding (0-2 points), and withdrawals / dropouts (0-1 point). Studies scoring < 3 are 
considered to be of low quality197. Non-randomised cohort studies were assessed 
using the Newcastle-Ottawa score for cohort studies198. The scale assesses patient 
selection (0-4 stars), comparability of patient cohorts (0-2 stars) and outcomes (0-3 
stars). Responses indicating high quality earn a star resulting in a maximum possible 
quality summary score of nine. Assessments were undertaken and confirmed by two 
independent reviewers. There is a lack of formal assessment tools for observational 
studies therefore no assessments were performed on the single arm observational 
studies. 
 
4.1.4 Data analysis  
For each complication, we calculated the risk difference (RD) and 95% confidence 
interval (CI) in each study that had compared two or more techniques. Studies that 
specifically reported that no events of a particular type had occurred were included in 
analyses as zero events. The RD was used as the measure of effect as the data were 
sparse in many studies and we wanted to ensure that studies with zero events in both 
arms contributed to meta-analyses. We used a random effects meta-analysis to pool 
the RD across multiple studies199. Analyses were performed in STATA version 9.2 
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(StataCorp, 2005 Stata Statistical Software: Release 9. College Station, TX: 
StataCorp LP).  
As we were interested in estimating the complication risks associated with each 
technique we calculated the proportion of total patients with a complication and 95% 
CI in each study that provided data for a particular technique. Proportions were first 
transformed via the Freeman-Tukey double arcsine method200 which were then pooled 
using random effects meta-analysis199. Analyses were performed in StatsDirect 
statistical software version 2.7.9 (StatsDirect Ltd, 2013 England). 
We assessed statistical heterogeneity through visual inspection of the forest plot and 
interpretation of the I2 statistic (percentage of variation across studies that is due to 
heterogeneity rather than chance)201 and the Cochrane Q test. Where a sufficient 
number  of  studies  were  included  in  analyses,  funnel  plots  were  examined  and  Egger’s  
test applied to assess potential bias in meta-analyses202. 
A sensitivity analysis was performed to compare results when restricted to RCTs 
only.  
4.2 Results 
4.2.1 Search results 
Database search results yielded 463 studies that were subsequently assessed for 
eligibility (figure 4.1). One hundred and twenty four studies were subjected to full 
text review with 95 failing to meet inclusion criteria47,48,56,181,184,185,190,203-290. One 
study was excluded due to possible duplication of results and a lack of response to a 
clarifying e-mail query (figure 4.1)216. A total of 29 papers reporting on 5473 patients 
were included in the analysis (table 4.1).57-59,80,187,188,291-313 
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4.2.2 Study characteristics 
Of the 29 studies included, nine (n=1023 patients) were RCTs that evaluated two or 
more percutaneous techniques.80,187,292,295,297,298,303,305,310 Of the remaining 20 studies, 
one was a prospective cohort study comparing three techniques (ST, TLT and CPDT 
n=100 patients)300 , two compared prospective PDT techniques with historical 
surgical control groups (n= 421; the retrospective ST patients were not included in our 
analysis)294,309, three were prospective observational studies reviewing more than one 
technique (n=1513)57,58,311 and 14 were single arm prospective studies 
(n=2416)59,188,291,293,296,299,301,302,304,306-308,312,313. Further details of study characteristics 
including risk of bias assessments can be seen in table 4.1. The mean Jadad score for 
RCTs was 2.4 and mean Newcastle Ottawa score for the cohort studies was 6.25. 
In all studies evaluating the CPDT, the Ciaglia Percutaneous Tracheostomy Multiple 
Dilator set (Cook Critical Care, Bloomington, IN) was used. All studies assessing the 
GWDF technique used the Portex kit (SIMS Portex Ltd, Hythe, Kent, UK). For 
studies evaluating STD the Ciaglia Blue Rhino Percutaneous Tracheostomy 
Introducer set (Cook Critical Care, Bloomington, IN, USA) was used in six 
57,59,187,293,295,309 and the Portex Ultraperc (Smith Medical, Hythe, Kent, UK) was used 
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Figure 4.1. Study selection flow chart 
 
 Literature search 
Assessed  for  eligibility  (n=463) 
Title  /  abstract 
Full  paper  review  (n=124) 
Inclusion  for  analysis  (n=29) 
• 121  published  pre  2000 
• 85  retrospective  studies 
• 48  does  not  meet  inclusion  criteria 
• 21  abstract  not  obtainable 
• 13  assessed  tracheostomy  timing  only 
• 12  case  reports 
• 10  editorials 
• 10  letters  to  editor  (not  original  data) 
• 5  review  articles 
• 4  case  series 
• 4  articles  not  in  English 
• 2  post  mortem  studies 
• 2  animal  studies 
• 2  retracted  articles 
• 35  short  term  complications  only 
• 18  Tracheostomy  technique  not  stated 
• 12  Denominator  unclear 
• 5  Manuscript  not  obtainable 
• 5  Non-critical  care  patients 
• 4  Article  retracted 
• 4  Letter  to  editor 
• 3  Population  duplication 
• 1  Case  series 
• 1  author  no  reply  to  queries 
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Table 4.1. Characteristics of studies included in analysis 
*Also reviewed 29 ST patients retrospectively – not included in analysis 
** Also reviewed 161 ST patients retrospectively – not included in analysis 
First author (year) Mean age Males (%) Study design Techniques (patients) Bronchoscopic control Stated length of follow up 
Risk of bias 
assessmenta 
Diaz-Reganon (2008) 62*** 570 (71) PO CPDT (51), GWDF (749) 35/800 procedures 6 months 6 
Kost (2005) Not reported 280 (56) PO CPDT (191), STD (309) Yes 3-4 months 7 
Chen (2002) 44 14 (67) PO GWDF (21) No 6 months - 
Yurtseven (2007) 61 83 (64) RCT CPDT (44), GWDF (41), SSRD (45) Yes 6 months 3 
Fikkers (2002)1 57 70 (70) PO STD (100) Yes 12 months - 
Donaldson (2000)* 64 39 (72) PO CPDT (54) Yes 3 months - 
Anon (2004) 63 38 (72) RCT STD (27), GWDF (26) No 282 days**** 2 
Sviri (2003) 56 66 (62) PO GWDF (106) No 30 months*** - 
Lukas (2007) 65 125 (61) RCT GWDF (100), ST (105) No 6 months 2 
Kearney (2000) 56 519 (63) PO CPDT (824) Selected cases 461 days**** - 
Heikkinen (2000) 65 40 (71) RCT GWDF (30), ST (26) No 18 months 2 
Fikkers (2011) 62*** 81 (68) RCT GWDF (60), STD (60) Yes 3 months 3 
Fikkers (2002)2 62*** 99 (58) PO GWDF (171) Yes 2.5 years*** - 
MacCallum (2000) 63 65 (65) PNR ST (50), TLT (37), CPDT (13) Only TLT group 6 months 6 
Cianchi (2010) 61*** 52 (74) RCT STD (35), BD (35) Yes LTOR 2 
Dempsey (2010) 58 340 (59) PO STD (576) Yes 3 months - 
Ben Nun (2005) 62 90 (58) PO GWDF (154) No 6 months - 
Velmahos (2000) 42 72 (72) PO CPDT (100) First 14 cases 10 months**** - 
Silvester (2006) 64*** 137 (69) RCT CPDT (100), ST (100) 80% CPDT 20 months*** 3 
Mittendorf (2002) 54 45 (63) PO CPDT (71) No 3 months - 
Melloni (2002) 57 31 (62) RCT ST (25), CPDT (25) 100% CPDT 6 months 2 
Gatti (2004) 71 18 (55) PO CPDT (33) No 3 months - 
Escarment (2000) 52 117 (72) PO GWDF (162) 13% (selected cases) 3 months - 
Dollner (2002) 65 21 (55) PO GWDF (162) Yes 22 months**** - 
Beltrame (2008)** 65 26 (72) PO STD (367) Yes 10 months**** - 
Antonelli M (2005) 64 83 (60) RCT TLT (67), ST (72) No 1 year 3 
Polderman (2003) 54 N/A PO GWDF (173), ST (40) GWDF 77% 14 months**** 6 
Stochetti (2000) 47 14 (70) PO TLT (20) Yes 3 months - 
Joshi (2006) 35 18 (45) PO CPDT (40) No LTOR - 
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*** Reported as median 
****Reported as mean 
1Fikkers BG et al Anaesthesia 2002;57(11):1094-7 
2Fikkers BG et al Head Neck 2002;24(7):625-31 
a Risk of bias assessments –  RCT -  Jadad score (0-5) 
The score is based on randomisation, blinding, and withdrawals / dropouts. Studies scoring < 3 are considered to be 
of low quality.197. See text for details. 
     Observational studies - Newcastle Ottawa Scale (0-9) 
The scale assesses patient selection, comparability of patient cohorts and outcomes. Responses indicating high 
quality earn a star with a maximum possible score of 9. See text for details. 
     Single arm studies – no assessment 
Note: Scores for RCTs & observational studies are not directly comparable 
 
PO  Prospective Observational 
RCT  Randomised Controlled Trial 
PNR  Prospective Non-Randomised 
CPDT  Ciaglia multiple dilator method 
STD   Single tapered dilator 
GWDF  Guide wire dilating forceps 
TLT  Trans-laryngeal tracheostomy 
BD  Balloon Dilator 
SSRD  Single step rotational dilator 
ST  Surgical tracheostomy 
LTOR  Length of follow up not stated but long term outcomes reported
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in one80. For the TLT technique two studies did not specify the equipment used300,310 
and in the third the Mallinckrodt kit (Mallinckrodt Medical, Mirandola, Italy) was 
used312. The study evaluating the BD technique187 used the Ciaglia Blue Dolphin 
Percutaneous Tracheotomy Introducer Kit (Cook Critical Care Inc., Bloomington, IN, 
USA) whilst the PercuTwist Set (Rüsch GmbH, Kennen, Germany) was used for the 
SSRD study292. For surgical tracheostomy two studies used a modified Bjork flap 
technique297,298, one used a midline vertical incision303, one used an H shaped 
incision305 whilst in three others the technique used was not described300,310,311. 
 
Three studies were conducted in multiple centres57,295,300, four were undertaken within 
multiple units within the same hospital294,302,305,309 and 22 were conducted within a 
single critical care unit (CCU)58,59,80,187,188,291-293,296-299,301,303,304,306-308,310-313. Of the 26 
studies conducted within a single institution 23 were in a university / teaching 
centre58,59,80,187,188,291-294,296,297,299,301-305,307,308,310-313. There were two studies 
respectively reporting findings from neuro291,312 and cardiac surgical306,308 
populations, the remaining studies were of mixed populations. In 12 studies the 
primary operators were CCU physicians / 
anaesthetists59,80,187,292,295,296,303,305,307,309,310,313, in six studies they were surgically 
trained57,291,294,298,302,304, in a further nine studies there was a mixture of both surgical 
and CCU personnel58,188,297,299-301,306,308,311 and two studies failed to specify the 
background of the operator293,312. 
4.3 Data analysis 
 
4.3.1 Comparative analyses 
 
Figures 4.2 - 4.5 summarise meta-analyses of studies that provide comparative data 
(RCT and prospective cohort data) between individual techniques for the 
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complications of TS, total bleeding episodes, major bleeding and wound infections 
respectively. Overall there are few studies, all with small sample sizes, that provide 
data comparing the different techniques, particularly in relation to those described 
more recently (STD, SSRD, BD). We did not identify direct comparisons between 
STD, BD or SSRD versus ST. A statistically significant risk difference was not 
identified for any of the meta-analyses, apart from the comparison between ST and 
CPDT in relation to wound infection (figure 4.5), with a pooled RD (95% CI) of 0.12 
(0.02, 0.23) in favour of CPDT. There was evidence of heterogeneity for several 
comparisons that could not be explored in detail due to the limited number of studies. 
However, heterogeneity was accounted for by using a random-effects meta-analysis. 
A sensitivity analysis restricting meta-analyses to only RCTs suggested that results 
and conclusions were similar although for the bleeding complication results were 
statistically significant for two comparisons when restricted to RCTs only [ST vs 
GWDF: -0.06 (-0.25 to 0.12) RCTs and prospective observational studies, (-0.15 (-
0.23 to -0.08) RCTs only); and ST vs TLT 0.05 (-0.02 to 0.11) RCTs and prospective 
observational studies, (0.08 (0 to 0.16) RCTs only]. 
4.3.2 Single-arm studies 
To supplement the comparative analyses, a crude overall summary of incidence of TS, 
bleeding episodes (total and major) and wound infection, pooled across all studies 
(single-arm studies and the relevant arm data from comparative studies) according to 
the random effects proportion meta-analysis, is given in Tables 4.2 - 4.5. There is a 
high degree of heterogeneity (measured by the I2 statistic) between studies suggesting 
that the complication risk could vary according to setting or patient. Direct 
comparisons between the complication incidences for different techniques should not 
be made based on these pooled estimates due to their observational nature.
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Figure 4.2. Forest plot comparing risk of tracheal stenosis for different percutaneous tracheostomy and surgical tracheostomy techniques. 
 
Forest plot detailing comparisons 
between surgical and percutaneous 
tracheostomies techniques for the 
development of post-operative 
tracheal stenosis. There are no 
significant differences between any 
of the techniques compared. 
Key: 
ST: Surgical tracheostomy 
CPDT: Ciaglia percutaneous 
dilatational tracheostomy 
GWDF: Guide wire dilating forceps 
TLT: Trans-laryngeal tracheostomy 
STD: Single tapered dilator 
SSRD: Single step rotational dilator 
BD: Balloon dilator 
RCT: Randomised controlled trial 
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Figure 4.3. Forest plot comparing risk of all bleeding (major and minor) episodes reported for different percutaneous tracheostomy and 
surgical tracheostomy techniques. 
Forest plot detailing 
comparisons between surgical 
and percutaneous tracheostomy 
techniques for total bleeding 
episodes. There are no 
significant differences between 
any of the techniques compared. 
When observational studies are 
excluded and RCTs considered 
in isolation the comparison for 
ST versus TLT become 
significant (favouring TLT) as 
does the comparison between ST 
and GWDF (favouring ST) 
although the numbers of studies 
and patients for each 
comparison are small (see page 
101). 
Key: as per figure 4.2 
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Figure 4.4. Forest plot comparing risk of major bleeding (requiring blood transfusion or surgical intervention) episodes reported for different 
percutaneous tracheostomy and surgical tracheostomy techniques. 
Forest plot detailing 
comparisons between surgical 
and percutaneous tracheostomy 
techniques for major bleeding 
episodes. There are no 
significant differences between 
any of the techniques compared.  
Key: as per figure 4.2 
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Figure 4.5. Forest plot comparing risk of wound infection for different percutaneous and surgical tracheostomy techniques.
  
Forest plot detailing 
comparisons between surgical 
and percutaneous tracheostomy 
techniques for post-operative 
stomal infections. There is a 
significant difference between 
surgical tracheostomy and the 
Ciaglia Percutaneous 
dilatational tracheostomy 
(favouring the percutaneous 
technique). Further comparisons 
failed to reveal additional 
significant differences. 
Key: as per figure 4.2 
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Table 4.2. Tracheal stenosis according to tracheostomy technique: Random effects proportion meta-analysis 
 
Tracheostomy technique Number of studies 
(patients included) 
Number of stenoses Pooled estimate (%) and 
95% CI* 
I2 % (95% CI) 
Surgical tracheostomy (ST) 7 (418) 11 2.8 (0.8 - 5.9) 57.9 (0 - 79.9) 
Guide Wire Dilating Forceps (GWDF) 13 (1831) 10 0.9 (0.3 – 1.7) 50.3 (0 – 72) 
Ciaglia technique (CPDT) 12 (1546) 15 1.0 (0.4 – 1.9) 33.7 (0 – 66) 
Single Tapered Dilator (STD) 7 (1474) 7 0.6 (0.2 – 1.2) 22.6 (0 – 67) 
Trans-laryngeal tracheostomy (TLT) 3 (124) 1 1.5 (0.1 – 4.3) 0 (0 – 73) 
Single step rotational dilator (SSRD) 1 (45) 0 - - 
Balloon dilator (BD) 1 (35) 0 - - 
*Calculated from random effects model  
CI: Confidence intervals 
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Table 4.3. Total bleeding episodes according to tracheostomy technique: Random effects proportion meta-analysis 
Tracheostomy technique Number of studies 
(patients included) 
Total number of bleeding 
episodes  
Pooled estimate (%) 
and 95% CI* 
I2 % (95% CI) 
Surgical tracheostomy (ST) 7 (418)  29  7.3 (4 to 11.4) 52.1 (0 - 78) 
Guide Wire Dilating Forceps (GWDF) 11 (1687) 100  9.2 (5 to 14.4) 88.8 (82 - 92) 
Ciaglia technique (CPDT) 11 (1355) 64  6.6 (4 to 9.7) 62.9 (12 - 79) 
Single Tapered Dilator (STD) 6 (1165) 80  12.1 (3.3 to 25.3) 96.3 (95 - 97) 
Trans-laryngeal tracheostomy (TLT) 3 (124) 2  2 (0.3 to 5.3) 0 (0- 73) 
Single step rotational dilator (SSRD) 1 (45) 1  - NA 
Balloon dilator (BD) 1 (35) 20  - NA 
* Calculated from random effects model 
Studies not reporting bleeding: 
GWDF – (Dollner, Sviri) 
Bleeding events not attributable to technique: 
Kost (CPDT & STD) 
CI: Confidence Interval 
NA: Not Applicable (only one study) 
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Table 4.4 Major bleeding episodes (need for surgical cautery or blood transfusion) according to tracheostomy technique: Random effects 
proportion meta-analysis 
Tracheostomy technique Number of studies 
(patients included) 
Major bleeding episodes  
 
Pooled estimate (%) and 
95% CI (%)* 
I2 % (95% CI) 
Surgical tracheostomy (ST) 7 (418)  17 4.7 (2.8 – 7.1) 7 (0 – 64) 
Guide Wire Dilating Forceps (GWDF) 11 (1687) 36 3.4 (1.4 – 6.3) 82 (66 - 89) 
Ciaglia technique (CPDT) 11 (1355) 18 1.8 (0.7 – 3.5) 55.7 (0 - 78) 
Single Tapered Dilator (STD) 6 (1165) 10 1.1 (0.2 – 2.7) 65.1 (0 - 85) 
Trans-laryngeal tracheostomy (TLT) 3 (124) 0 0.6 (0.01 – 2.6) 0 (0 – 73)- 
Single step rotational dilator** (SSRD) 1 (45) 0 - - 
Balloon dilator** (BD) 1 (35) 0 - - 
* Calculated from random effects model 
CI: Confidence Interval 
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Table 4.5. Wound infection according to tracheostomy technique: Random effects proportion meta-analysis 
 
Tracheostomy technique Number of studies 
(patients included) 
Number of tracheostomy 
wound infections 
Pooled estimate (%) 
and 95% CI* 
I2 % (95% CI) 
Surgical tracheostomy (ST) 7 (418) 36 8.5 (4.1 – 14.4) 71.5 (18 – 85) 
Guide Wire Dilating Forceps (GWDF) 10 (1666) 16 1.5 (0.6 – 2.8) 61.5 (1.6 – 79) 
Ciaglia technique (CPDT) 11 (1355) 11 1.0 (0.36 – 2.1) 32.5 (0 – 66) 
Single Tapered Dilator (STD) 4 (554) 6 1.7 (0.02 – 5.9) 80.1 (17.4 – 90.6) 
Trans-laryngeal tracheostomy (TLT) 3 (124) 4 3.9 (1.26 – 8) 0 (0 – 73) 
Single step rotational dilator** (SSRD) 1 (45) 0   
Balloon dilator** (BD) 1 (35) 0   
* Calculated from random effects model 
CI: Confidence Interval 
Studies not reporting infection: 
Guide wire dilating forceps (GWDF) – 3 (Sviri, Chen & Dollner) 
Single tapered dilator (STD) – 2 (Cianchi, Dempsey) 
 
Infection episodes not attributable to technique: 
Kost (Ciaglia multiple dilator method & single tapered dilator) 
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4.4  Discussion 
We have investigated the incidence of long-term TS in patients undergoing 
tracheostomy in a critical care setting. Additionally, we have estimated the incidence 
of peri-procedural complications (bleeding and wound infection) that we have 
postulated may have a role in the development of TS. When considering published 
RCTs and comparative observational studies reporting long-term outcomes we have 
found ST and all percutaneous techniques (CPDT, GWDF, STD, TLT, SSRD, BD) 
broadly similar in terms of TS and bleeding. In keeping with earlier meta-analyses we 
have also found a higher incidence of wound infection when comparing ST to 
CPDT51. Despite the frequency with which percutaneous tracheostomies are 
performed within the critical care setting there appear to be relatively few high quality 
studies assessing long term outcomes between techniques.  
When considering our pooled proportions meta-analysis across all studies, the TS rate 
reported varies from 2.8 to 0.6% for ST and STD respectively with all percutaneous 
techniques being broadly comparable (table 4.2). The point estimate of rate for total 
bleeding episodes varies from 12.1% for STD to 2% for TLT (table 4.3) but the 
confidence intervals around some of these estimates are wide with a substantial 
degree of between study heterogeneity. Major bleeding ranges from 4.7% for ST to 
0.6% for TLT, whilst wound infection for ST is 9.9% and 1.1% for CPDT, again with 
wide 95% CIs and substantial between study heterogeneity.  
By incorporating cohort studies as well as RCTs into our analysis we have adopted a 
different methodology to earlier meta-analyses. The majority of studies incorporated 
into previous analyses were RCTs of relatively small samples sizes and as such, given 
the low incidence, were limited in their ability to detect a difference in risk of TS. 
Whilst the incorporation of non-randomised studies may introduce an element of bias, 
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work by Golder et al has suggested this effect may be minimal314. In a meta-analysis 
of meta-analyses they found a high degree of concordance between meta-analyses of 
adverse events comparing data solely from RCTs with those from both RCTs and 
observational studies (with less discrepancy for larger studies) concluding that meta-
analyses of adverse events should not, necessarily, be confined to specific study types. 
In a sensitivity analysis, we excluded the non-randomised studies and compared meta-
analysis results to those that include both RCT and prospective observational studies. 
Overall, results were similar but changed from being non- significant to statistically 
significant for bleeding complication for two comparisons, suggesting that there may 
be important differences between RCTs and observational studies (see below). 
Another potential limitation to accurate determination of the incidence of TS, 
following percutaneous tracheostomy, in the current study is the possibility that 
patients who are perceived to be predisposed to a difficult tracheostomy may be 
assigned to the ST group in non-randomised studies. In support of this concern, of the 
seven studies assessing ST, five were RCTs 297,298,303,305,310 reporting a TS incidence 
of 1.4% (4/328) and two were prospective non-randomised studies with a TS 
incidence of 8.4% (7/90)300,311. In addition, the risk difference estimates for TS from 
the prospective non-randomised studies were each more extreme than corresponding 
estimates from RCTs in those comparisons between ST and percutaneous 
tracheostomy. Of the non-randomised studies, the study by MacCallum (reporting 2 
stenoses) provides no information on group allocation other than stating that 
procedures were performed consecutively300. In contrast, Polderman (5 stenoses) 
reports that 7 patients were allocated to the ST group because of perceived difficult 
anatomy whilst the remainder of patients were allocated randomly.311 No information 
as to whether those patients with difficult anatomy were also the patients who 
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developed TS was provided. The choice between surgical and percutaneous 
tracheostomy in most situations is not a random event with most operators opting for 
the surgical approach when potential difficulties or safety concerns are anticipated. It 
is probable, therefore, that many of the surgical tracheostomies described within the 
studies herein would be more prone to the occurrence of complications. It is possible, 
therefore, that the observed differences in complication rates we have demonstrated in 
our analyses could be due to patient factors rather than the operative technique per se. 
However, as discussed above, other than a potential role for tracheal ring fracture 
there is little evidence for peri-operative complications causing TS. 
Accepting these potential limitations, in the critical care setting, there is a trend 
toward increased risk of TS for surgical tracheostomy patients.  
Our data confirm our view that in the critical care setting, in common with previous 
authors, a percutaneous procedure should be the technique of choice as it is both safe 
and cost effective51.  
It is somewhat surprising (and a common theme across all previous meta-analyses), 
given the frequency with which PDTs are now undertaken, that we have only 
identified 29 studies reporting upon the long term outcomes of 5473 patients over the 
preceding 14 years. We find it concerning that some techniques in relatively 
widespread use (SSRD, BD, TLT) have such sparse long-term outcome data. When 
specifically considering the issue of TS and the possibility of unrecognised sub-
clinical TS in this patient population, very few studies have undertaken 
comprehensive radiological imaging to determine the underlying prevalence of 
stenosis. Considering that the STD technique appears to be currently the most widely 
used approach,45,46,189 until recently there were only 14 patients described in the 
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literature who had undergone radiological imaging after STD tracheostomy to 
determine the underlying prevalence of both clinical and sub-clinical TS80. 
Reporting of complications across studies remains far from standardised and posed 
significant problems during data extraction. We had initially set out to collect data for 
a significant number of secondary outcomes (appendix 1). However, lack of uniform 
reporting made this aim much more difficult and ultimately of little value as many 
complications are reported infrequently with marked differences in incidences across 
studies. Even reporting of our primary and secondary outcomes was inconsistent, with 
some studies failing to quote an incidence for TS, bleeding and wound infection. One 
study appeared to describe an apparent incidence of TS (presence of stridor with 
spirometry findings in keeping with upper airway obstruction) but failed to ascribe 
these findings to a diagnosis of TS.296 A lack of a consistent definition for significant 
versus minor bleeding lead us to analyse total bleeding episodes as well as those 
categorised as major. Additionally, one study reported stomal decay as an outcome, 
interpreted as infection for our analysis.297 Additionally, we were unable to explore 
the possible relationships between bleeding and stomal infection and TS. Whilst most 
of the studies included in the analysis reported TS, bleeding and stomal infection rates 
there was little, if any, supplemental data reported for us to ascertain whether these 
events were associated and occurring within the same patients or not. A number of 
other studies that detailed complications of multiple techniques reported composite 
outcomes where the complication rate for a given technique was impossible to 
ascertain. In this circumstance we wrote to the author for clarification. In some 
instances this resolved the problem either completely or partially. In others, where 
there was no reply from the corresponding author the study was excluded from the 
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analysis. These limitations highlight the vital need to develop and report standardised 
core outcome measures to improve the synthesis of trial data.315 
Whilst RCTs to compare long term outcomes, particularly TS, following individual 
PDT techniques would be desirable it is highly unlikely that they will be performed. 
TS has a low incidence, critical illness mortality is high and long term follow up 
difficult. An adequately powered study would require at least 2000 patients to detect a 
reduction  in  TS  from  2.8%  to  1%  (α  =  0.05  β  =  0.8)  and  this  figure  excludes  drop  out.  
Thus we believe our study, despite the limitations described, is currently best placed 
to inform clinicians in this area. 
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Chapter 5 
 
Single tapered dilator percutaneous tracheostomy in 
the critical care unit: An eleven-year single centre 
review 
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5.1 Methods 
This prospective service evaluation was carried out at Aintree University Hospital 
NHS Foundation Trust (AUH). The critical care unit (CCU) at AUH is a 23-bedded 
mixed medical and surgical unit undertaking between 80 - 100 PDTs per year. The 
regional referral centre for head and neck cancer, the largest such unit in the UK, is 
also situated at AUH. The need for PDT in any individual case was determined by the 
duty consultant intensivist. After the decision to proceed with a tracheostomy, all 
patients were fully evaluated and examined before operation. In all cases, when a 
tracheostomy is deemed appropriate, patients are assessed as to their suitability for a 
PDT. Patients undergoing ST as part of their surgical management for head and neck 
cancer were not included in the study. 
From November 2003 to February 2015, data were prospectively collected on all 
PDTs performed at AUH. All PDTs were performed by critical care physicians at the 
bedside using the Blue Rhino® Percutaneous Tracheotomy Introducer Kit (Cook 
Critical Care, Bloomington, IN). All patients were over the age of 16 and each 
received intravenous general anaesthesia with neuromuscular block. Each procedure 
was undertaken with bronchoscopic guidance to ensure correct placement of the 
guide-wire. 
Before commencement of the procedure, the patient was positioned with the head 
extended and the lungs were ventilated with 100% oxygen. Throughout the procedure, 
heart rate, arterial pressure, and oxygen saturation were monitored continuously. After 
digital palpation of the neck, direct laryngoscopy was performed to position the 
tracheal tube (TT) above the site of the proposed PDT insertion point. Local 
anaesthesia and vasoconstriction were achieved using 2% lidocaine with 1:100,000 
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epinephrine administered subcutaneously to the pre-tracheal tissues. A 1 cm 
horizontal skin incision was made midway between the cricoid cartilage and the 
sternal notch. Pre-tracheal tissues were separated by blunt dissection. Tracheal 
puncture was performed with the standard 15-gauge needle. After bronchoscopic 
confirmation of the position, the guide-wire was passed into the tracheal lumen. A 4.5 
cm 14 Fr gauge dilator was passed over the guide-wire after which the STD was used 
to expand the tract between the skin and the tracheal lumen. The appropriate-sized 
tracheostomy tube was introduced into the tracheal lumen utilising a loading dilator. 
Perioperative data on each patient were recorded prospectively and included age, sex, 
reason for admission, admission APACHE II score, and intraoperative and 
postoperative complications as detailed below. 
A  PDT  was  assigned  as  ‘technically  difficult’  or  complicated  as  described  
previously59,316. Routine post-procedural chest X-rays (CXRs) were performed after 
the first 384 PDTs. Thereafter, CXRs were limited to those PDTs considered 
technically difficult. 
After critical care discharge, further surveillance was provided by the AUH Critical 
Care Outreach Service and after hospital discharge by the critical care follow-up 
clinic allowing identification of late complications. Long-term survival data was 
cross-referenced with the AUH clinical records system (System C Medway Sigma, 
Maidstone, UK). 
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5.2 Results 
During the study period, 1056 CCU patients required a tracheostomy. In 1025 
patients, a PDT was attempted, and in 1019 (99%), the procedure was completed 
successfully at the first attempt (Table 5.1). Two further patients underwent 
successful PDT at the second attempt. In four patients (0.4%), PDT was abandoned 
due to excess bleeding; three of these patients subsequently went on to have an ST. 
Consequently, a total of 31 (3% (n=1056) patients underwent ST. In the remaining 
patient, the procedure was abandoned and ST considered inappropriate due to 
worsening multiple organ failure. All PDTs were undertaken between the hours of 
09:00 and 17:00 and 929 (91%) were performed on a weekday (figure 5.1). Number 
of PDTs performed by year is presented in figure 5.2. Nine hundred and fifty one 
(93%) procedures followed an emergency critical care admission. In 813 (79%) cases, 
the most senior clinician present was a consultant. For the remainder, in 190 (19%) 
and 22 (2%) cases, the most senior clinician present was a senior critical care trainee 
(clinical fellow) and a specialist anaesthetic registrar, respectively.
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Figure 5.1 Tracheostomy insertion by day of the week 
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Table 5.1 Patient characteristics for those undergoing tracheostomy. PDT: Percutaneous dilatational tracheostomy, CCU: Critical care unit, 
IQR: Inter quartile range, sd: Standard deviation 
 Type of tracheostomy 
Percutaneous n= 1025 Surgical n= 31 
Age in years (sd) 59 (15.8) 55 (21.2) 
Male (%) 608 (59%) 17 (55%) 
Mean admission APACHE II Score 18.7 (5.7) 18.4 (5.4) 
Number of emergency admissions (%)  951 (93%) 28 (90%) 
Median day to PDT from CCU admission (IQR) 5 (4, 7) 5 (2,9) 
Median day to PDT from tracheal intubation (IQR) 4 (3, 6) 4 (2, 8) 
Number of medical patients (%) 540 (53%) 12 (39%) 
Number surviving to CCU discharge (%) 757 (74) 25 (81%) 
Median length of CCU stay in days for non-survivors (IQR) 15 (10, 23) 11 (5,18) 
Median length of CCU stay in days for survivors (IQR) 19 (14, 27) 16 (10, 29) 
Number surviving to hospital discharge (%) 687 (67%) 23 (74%) 
Median hospital stay in days for CCU survivors (IQR) 34 (7, 400) 34 (19, 68) 
Number surviving beyond 1 year (%) 555 (54) 18 (58%) 
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Figure 5.2 Number of tracheostomies performed by year 
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Thirty-one surgical tracheostomies were performed during the study period (table 
5.1). Three followed failed percutaneous procedures detailed above, four were 
performed in post-operative oesophagectomy patients, seven in patients who had 
sustained trauma to the neck including spinal injuries, eight patients had head and 
neck infections or tumours and the remaining nine patients had perceived difficult 
anatomy. All STs were completed uneventfully. The most senior operating surgeon 
was a consultant in 18 (58%) procedures and a specialist registrar in 13 (42%). 
According to the definitions described above, technical difficulties were encountered 
in 230 (22%) procedures (Table 5.2). The overall complication rate was 3.5% 
(36/1025). Twenty-six (2.5%) procedures were deemed as having early 
complications. These included ten cases of significant bleeding (including four where 
the PDT was abandoned), four cases resulting in para-tracheal placement of the 
tracheostomy tube, four with significant surgical emphysema, three pneumothoraces 
(one tension), two with significant posterior tracheal wall injury (one of whom also 
had significant surgical emphysema), and two cases where the tracheostomy tube was 
malpositioned. In two instances tracheal ring fracture resulted in the fractured ring 
directly abutting the posterior tracheal wall. In both cases the tracheal ring was 
resected endoscopically. Eleven cases (1%) were associated with significant late 
complications. Of these, two patients developed tracheal granulation tissue delaying 
decannulation. In both cases this was excised endoscopically with no further problem. 
Four patients (0.4%) developed a tracheo-innominate fistula (TIF) and five patients 
(0.5%) developed a tracheal stenosis (TS). In only one of these procedures was the 
initial tracheostomy regarded as being technically difficult (oxygen desaturation and a 
tracheal ring fracture in a patient subsequently developing TS). The four patients who 
developed TIF died as a result of haemorrhage in to the airway whilst still patients on 
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the CCU and represent a mortality directly attributable to PDT of 0.4%. 
Late complications of ST were present in three patients (9.7%). One patient 
developed a tracheal stenosis (3%) and was felt to be unsuitable for tracheal resection. 
One patient developed a stomal infection requiring antimicrobial treatment and one 
had a poor cosmetic result. 
Table 5.2 Adverse events during 230 technically difficult PDT procedures 
Difficulty Number (%) n=1025 
Minor posterior wall injury 12 (1) 
Tracheal ring fracture 112 (11) 
Multiple attempts to cannulate trachea 73 (7) 
Minor bleeding 38 (4) 
Oxygen desaturation 25 (2) 
 
There were no significant differences demonstrated between grade of most senior 
physician present and technical difficulties / complications encountered (Table 5.3).  
Table 5.3 Early complications and technically difficult tracheostomies by grade of 
most senior physician present. 
Grade of most 
senior doctor 
present 
Number of 
uncomplicated 
tracheostomies (%) 
Number of technically 
difficult tracheostomies 
(%) 
Number of major 
complications (%) 
Consultant (813) 615 (76) 175 (22) 23 (2) 
Clinical fellow (190) 138 (72) 50 (26) 2 (2) 
Registrar (22) 16 (73) 5 (23) 1 (4) 
 
Overall survival of the cohort is presented in figure 5.3 demonstrating a median 
survival of 3.3 years (95% CI 2.4 – 5.3). Estimated five year survival is 44% 
(Standard Error (SE) 0.02). Survival by age is shown in figure 5.4 demonstrating 
median survivals of 380 and 69 days for those 60-75 years and over 75 years 
respectively. Estimated five year survival by age is 61% (SE 0.02), 31% (SE 0.03) 
and 24% (SE 0.04) for those aged < 60, 60 – 75 and over 75 years respectively. 
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Survival by APACHE II score is presented in figure 5.5 with median survivals of 9.9 
years, 3.5 years (95% CI 1.9 – 5.1) and 1.6 years (95% CI 0.9 – 2.2) for those with 
APACHE II scores of less than 15, 15 – 20 and greater than 20 respectively. 
Estimated five year survival according to APACHE II score was 56%, 44% and 36% 
respectively. There were no differences in survival by admission category (emergency 
/ elective), diagnostic category (medical / surgical), type of tracheostomy (PDT / 
surgical) and gender. 
Figure 5.3 Kaplan Meier plot of overall survival (all patients undergoing 
tracheostomy – both percutaneous and surgical n = 1056). Median survival is 3.3 
years (95% CI 2.4 – 5.3) with estimated five-year survival of 44% (Standard Error 
(SE) 0.02) 
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Figure 5.4 Kaplan Meier plot of survival of patients undergoing percutaneous 
tracheostomy (n = 1025) by age demonstrating significantly worse survival for older 
age groups. Median survivals are 380 and 69 days for those 60-75 years and over 75 
years respectively. Estimated five year survival by age is 61% (SE 0.02), 31% (SE 
0.03) and 24% (SE 0.04) for those aged < 60, 60 – 75 and over 75 years respectively. 
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Figure 5.5 Kaplan Meier plot of survival for all percutaneous tracheostomies (n = 
1025) by APACHE II Score demonstrating significantly worsening survival with 
increased illness severity. Median survivals are 9.9 years, 3.5 years (95% CI 1.9 – 
5.1) and 1.6 years (95% CI 0.9 – 2.2) for those with APACHE II scores of less than 
15, 15 – 20 and greater than 20 respectively. Estimated five year survival according 
to APACHE II score was 56%, 44% and 36% respectively. 
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Six hundred and eighty seven (67%) PDT patients survived to hospital discharge. At 
follow up 543 had no tracheostomy related issues, seven patients had not been 
decannulated (for reasons other than TS), six had a sub-clinical TS picked up as part 
of an earlier study79 or from incidental imaging. Five patients developed symptomatic 
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TS, one underwent corrective surgery, one died from rapidly progressive malignant 
disease and three had no surgical management. Ninety-seven patients had no 
documented follow up appointment. Of these 63 had been referred from outside our 
catchment area and 34 were AUH patients. Of the remaining 30 patients, 16 died 
before a follow up appointment and 13 had not reached 3 months from hospital 
discharge at the time of writing. 
5.3 Discussion 
When considering these updated results in light of our previous report the most 
reassuring finding is the consistency of the outcomes. The rate of technical 
difficulties, early and late complications have changed little. In our earlier paper we 
described a 26% rate of technically difficult PDTs. This has reduced slightly over 
time to 22% in the current paper. This would indicate a technical difficulty rate of 
18% for the more recent patients (149 / 576 versus 81 / 449). Similarly, the early 
complication rate remains low at 2.5 percent (26 / 1025) in comparison to the 
previously reported three percent (16 / 576). Again, when considering the outcomes 
for more recent patients the rates remain almost identical at 2.2% (10 / 449). The rates 
for later complications have remained constant across both study periods with four 
tracheo-innominate fistulae (2/576, 2/449) and five tracheal stenoses (2/576, 3/449). 
Given the high consultant presence during the PDTs undertaken a reduction in peri-
operative technical difficulties with time may point to a prolonged learning curve 
where continued exposure and practice may subtly diminish complications. Given the 
constancy of our late complications it may also indicate that peri-operative events 
have a relatively small role to play in long term outcomes with patient factors being 
the most important determinant here. 
When comparing our data with previous reports the most direct comparisons come 
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from large, long term observational studies similar to our own. Kearney et al, in 
perhaps the first large observational cohort study of PDT, described their eight year 
experience of the original CPDT reporting an overall complication rate of 15%188. 
The intra-operative complication rate was six percent with the most frequent events 
being premature tracheal extubation, bleeding and para-tracheal placement of the 
tracheostomy tube. They also reported major peri-operative complications of tracheal 
laceration requiring thoracotomy (1 patient) and tracheo-oesophageal fistulae (2 
patients). Their late complications consisted of a 1.6% rate of TS with no reported 
TIF. They reported a procedure related death rate of 0.6% largely related to early 
post-procedural complications. Diaz-Reganon et al reported on the outcomes of 800 
predominantly guide wire dilating forceps (GWDF) PDTs (749 GWDF, 51 CPDT)58. 
They reported an overall complication rate of four percent with 2.1% intra-operative, 
0.75% early post-operative and 1.1% late. The most common procedural complication 
was minor bleeding with one reported TS. Kost reported the outcomes of 500 
procedures (191 CPDT, 309 STD) performed across a number of critical care units in 
Montreal57. The overall complication rate was 9.2% although considering the STD 
group alone this was 6.5% with the most common events being oxygen desaturation 
and bleeding. Kost also reported upon the effects of a learning curve with the CPDT 
technique in that complications were more common for the first 30 patients 
undergoing CPDT. This effect was not apparent for the STD group. No cases of TS 
were reported. 
For the above studies the overall complication rates appear to be around 15% for 
CPDT, 4% for GWDF, 6.5% for STD and 3.5% for the present study. Some of this 
discrepancy can be accounted for on the basis of differing definitions for 
complications used by each paper and some from a degree of reporting bias. There 
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may, however, also be an inherent difference in complication rates between the 
techniques that has not previously been picked up in RCTs comparing the techniques. 
In two recent meta-analyses Cabrini and co-workers have tried to better quantify this 
situation54,55. In their earlier paper, using data from 13 RCTs, they noted that the 
different techniques were largely comparable with the exception of the retrograde 
(trans-laryngeal) tracheostomy which was associated with more severe 
complications54. The STD technique was associated with fewer failures and less 
minor complications leading the authors to conclude that it seemed to be the most 
reliable in terms of safety and success rate. A later paper by the same authors assessed 
five RCTs comparing GWDF to STD PDT using a composite outcome of difficult 
cannula insertion / difficult dilatation / failure55. The incidence of this composite 
outcome was 15.5% for GWDF versus 4.9% for STD. They also noted more frequent 
bleeding with GWDF (19.3 v 7.6%) with no difference in long-term outcomes. A 
recently completed systematic review incorporating data from RCTs and 
observational studies has failed to show a difference in long term outcomes of 
tracheostomy techniques commonly used within the critical care setting (ST, CPDT, 
GWDF, STD, TLT, BD, SSRD) from RCT data. However, when adding data from 
observational studies the pooled proportions meta-analysis seems to indicate a 
difference in reported TS rates from 0.6% for STD to 2.8% for ST, very similar to the 
rates described herein.317 
To our knowledge, long-term outcomes and survival much beyond 12 months have 
not been previously reported for PDT in the CCU setting. Our data represent survival 
data for up to 11 years after PDT. Six hundred and eighty seven PDT patients (67%) 
survived to hospital discharge. The overall median survival for the cohort was 3.3 
years (95% CI 2.4 – 4.3). Unsurprisingly, this is significantly impacted upon by age 
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with median survival reducing to 69 days (95% CI 0, 292) for those patients aged 
over 75 years. Similarly, illness severity significantly reduced survival with those 
with an APACHE II score in excess of 20 having a median survival of 1.6 years (95% 
CI 0.9 – 2.2). Perhaps somewhat unexpectedly, there were no outcome differences 
related to category of admission (elective versus emergency and medical versus 
surgical). To some extent this may be explained by those patients admitted to the 
CCU after an elective surgical admission who subsequently require a PDT have 
invariably had a significant complication during their stay which will adversely affect 
their outcome. The reason for a lack of a difference between medical and surgical 
patients is less clear but may be due to a degree of selection bias on the part of the 
attending intensivist with PDT not being undertaken on those patients felt to be more 
likely to have poorer outcomes. 
The rate of PDT has changed over the course of our study whilst the number of 
admissions per year has remained relatively constant. For the earlier years of the 
study we were undertaking approximately 100 PDTs per year with this number falling 
to around 80 for more recent years (figure 5.2)55. The reasons for this may be several. 
Firstly, whilst the number of CCU admissions has remained relatively constant, the 
case mix appears to have changed with an increase in level II patients. This may be 
accounted for by the introduction of a hospital wide medical emergency team (MET) 
in 2009 resulting in patients being referred to the unit at an earlier stage. Secondly, 
during the course of the study, a number of papers have evaluated the role of 
tracheostomy, particularly in relation to timing of the procedure, in the CCU22,23,24. 
The most recent meta-analysis concluding that early tracheostomy produced no 
mortality benefit, no reduction in ventilator associated pneumonia, length of stay or 
sedative usage25. Given that each of the above studies have demonstrated a delay in 
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performing a tracheostomy invariably results in some patients not needing the 
procedure at all this work may partly explain the reduction seen here. However, the 
timeline does not entirely fit with the data as presented. Our tracheostomy rate fell 
from 2008 onwards, with most of the above publications being dated 2010 or later. 
Additionally, whilst our rate of PDT has fallen there has been little change in the 
timing of the tracheostomy from our earlier study. This is largely due to the fact that 
within our unit the tracheostomy is not utilised in isolation but as part of a package of 
care to facilitate early withdrawal of sedation, mobilisation, enhanced nutrition and 
weaning from mechanical ventilation. 
Whilst the reported complication rates presented herein are in keeping with, if not an 
improvement upon, those published previously this remains a single centre evaluation 
with its attendant limitations. It may, however, add weight to the gathering evidence 
that the STD PDT is one of the safer techniques available. Our rate of early technical 
difficulties appears to be reducing whilst long-term outcomes remain unchanged. 
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Chapter 6 
Tracheal stenosis following percutaneous dilatational 
tracheostomy using the single tapered dilator: a MRI 
study 
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6.1 Methods 
This prospective cohort study was carried out at Aintree University Hospital NHS 
Foundation Trust.  
A database of all patients receiving PDT, including associated outcome data, 
undertaken within the CCU at AUH has been kept since 2003. All PDTs are 
performed by critical care physicians at the bedside using the STD technique with 
bronchoscopic guidance. All patients were over the age of 18 and each received 
intravenous general anaesthesia with neuromuscular blockade during the procedure.  
Following ethical approval (Liverpool (UK) Research Ethics Committee: Reference 
No 08/H1005/121) patients surviving for a minimum of three months from the 
insertion of PDT were identified from the database. Cross-referencing with AUH 
clinical records system (System C Medway Sigma, Maidstone, UK) and following 
contact with the patient’s  general  practitioner,  when  required,  confirmed  whether  
patients were still alive. They were then contacted by telephone, informed of the 
nature of the study and invited to AUH to complete a simple questionnaire, undergo 
spirometry and MRI scanning (figure 6.1). 
Following written informed consent, background data including age, sex, admission 
illness severity (APACHE II), duration of oro-tracheal intubation prior to PDT, 
complications and technical difficulties during PDT59, duration of cannulation, length 
of critical care and hospital stay were collected. A PDT was considered complicated if 
there were one or more technical difficulties (multiple tracheal punctures (≥ 3), 
tracheal ring fracture, minor bleeding - > 3 soaked gauze swabs) or significant 
complications (pneumothorax, subcutaneous emphysema, major bleeding – need for 
surgical intervention or transfusion). A Health Status Screening Questionnaire 
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(Appendix 2) was devised and used to ascertain evidence of pre-existing respiratory 
disease, respiratory symptoms after critical care and current exercise tolerance. 
Simple spirometry was then undertaken using a micro-loop spirometer (CareFusion 
Health UK 232 Ltd, Basingstoke, UK) to obtain values for FEV1, PEFR and forced 
vital capacity (FVC). The best of three readings obtained were used to calculate the 
FEV1/PEFR ratio. This constitutes the Empey Index (EI) (EI= FEV1/PEFR) and 
previous data have reported a ratio > 10 to be clinically significant195. 
MRI scanning was undertaken using a Siemens 1.5 T Avanto scanner (Siemens, 
Munich, Germany). A T2-weighted coronal scan using 5 mm slices was carried out, 
along with a T1 flash sagittal 3D volume scan with 1 mm slices. Multi-planar 
reformats were constructed from the volume scan in the axial and coronal planes. All 
sequences included the trachea from the inferior border of the cricoid cartilage to the 
carina. All images were reviewed by a single consultant radiologist, unaware of the 
clinical details of the patient pertaining to the PDT. Coronal and sagittal 
measurements were reported at the narrowest section of the trachea at or above the 
level of the tracheostomy and compared to normal tracheal dimensions above or 
below the abnormality. TCSA at each level was calculated using the Picture 
Archiving and Communications System (PACS – Carestream Vue PACS, Carestream 
Health, Hertfordshire, UK). A significant stenosis amounting to a reduction in the 
TCSA of 10% or more when compared to normal trachea above or below the 
abnormal segment was defined as TS for the purpose of this study in common with 
previous similar studies181,191,192. All patients with identified TS on MRI were then 
referred to a consultant head and neck surgeon for further evaluation. In these cases, 
each patient was initially investigated with fibre-optic laryngo-tracheoscopy, 
continuing to rigid tracheo-bronchoscopy under general anaesthesia if this was 
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considered necessary. 
6.2 Statistical analysis 
Data were analysed initially using Microsoft® (Redmond,  WA,  USA)  Excel™  
software. GraphPad (GraphPad Software Inc, La Jolla, CA, USA) was used to carry 
out  Fisher’s  exact  test  for  categorical  data  and  Mann-Whitney U tests for continuous 
data. A p value of less than 0.05 was considered statistically significant.   
6.3 Results 
At the time of the study the database contained 745 patients who had undergone STD 
PDT more than three months previously. Four hundred and eighty-three of these 
patients survived to hospital discharge. A further 178 died within six months of 
hospital discharge, leaving 305 eligible for inclusion. One hundred and twenty 
patients were contacted by telephone. Seventy patients declined the invitation or were 
unable to attend for MRI scanning, including 11 who failed to present for pre-
arranged appointments. The remaining 50 patients underwent MRI (Figure 6.1). Of 
these, 49 also attended for interview, during which a standardised questionnaire was 
completed (Appendix 2). 
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Figure 6.1: Recruitment to study 
 
50 attended for MRI 
49 attended for interview & spirometry 
745 patients in tracheostomy database 
178 died within six months of hospital discharge 
120 patients contacted by telephone 
70 refused or unable to attend 
483 survived to hospital discharge 
305 patients eligible for inclusion 
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Table 6.1. Characteristics of patients with tracheal stenosis compared to those 
without and patients declining the invitation to attend for MRI scanning 
IQR Inter-quartile range    *p=0.002  Fisher’s  exact  test 
 
Of the 50 patients undergoing MRI scanning, 5 patients (10%, 95% CI 3-22%) were 
diagnosed with TS as per the study criteria. Patient characteristics of those with and 
without TS (non-TS: nTS) and non-attenders are presented in table 6.1. Median 
reduction in TCSA for those with TS was 30% with individual stenoses documented 
as 16, 24, 30, 38 and 46% respectively (table 6.2). There were no differences between 
the groups with respect to age, sex, illness severity and number of days of oro-
tracheal intubation prior to PDT insertion and time from PDT to MRI scan. The 
 Stenosis 
(n = 5) 
No stenosis 
(n = 45) 
Non-Attenders 
(n= 70) 
Age median (IQR) 51 (39-59) 58 (48-72) 58 (42-67) 
Male n (%) 2 (40) 26 (58) 45 (64) 
Admission APACHE II score, 
median (IQR) 
14 (14-15) 16 (14-19) 16 (13-21) 
Oro tracheal intubation prior to 
PDT days, median (IQR) 
4 (4-5) 4 (2-5) 4 (3-5) 
Duration of cannulation days, 
median (IQR) 
15 (12-21) 9 (6-15) 15 (11-23) 
Time from decannulation to MRI 
months, median (IQR) 
22 (12-58) 24 (10-45) __ 
Peri-operative complications, n (%) 
Bleeding 
Multiple tracheal punctures 
Tracheal ring fracture 
4 (80)* 
1 (20) 
2 (40) 
1 (20) 
2 (4)* 
0 (0) 
1 (2) 
1 (2) 
22 (31) 
4 (6) 
9 (13) 
9 (13) 
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difference in median duration of cannulation of 15 days in the TS group and 9 days in 
nTS group was not statistically significant (p=0.17). 
Table 6.2. Tracheal stenosis, spirometric and questionnaire data 
````*P=0.022  Fisher’s  exact  test  
FEV1 Forced expiratory volume in one second 
PEFR Peak expiratory flow rate 
FVC Forced vital capacity 
CCU Critical care unit 
 
Overall, six of the 50 PDTs were complicated as defined above. Four of the five 
patients diagnosed with TS in comparison with two of 45 without, underwent 
complicated STD PDT (table 6.1). When complications were considered individually, 
patients with TS may be more likely to have multiple attempts at tracheal puncture 
 Tracheal stenosis 
(n=5) 
No tracheal stenosis 
(n=45) 
Tracheal measurements median 
Reduction in tracheal cross sectional area (%) 
(range) 
 
30 (16-46) 
 
- 
Pulmonary function tests (median, IQR) 
FEV1 (ml) 
PEFR (L/min) 
FVC (L) 
Empey index  
 
2.06 (1.69-2.52) 
235 (219-249) 
2.42(1.89-3.27) 
7.96 (7.19-9.4) 
 
2.3 (1.77-2.84) 
337 (222-427) 
3.06 (2.52-3.49) 
6.89 (6.08-8.28) 
Empey index >10, n (%) 1 (20%) 3 (7%) 
Pre-CCU exercise tolerance 100m or less, n (%) 1 (20%) (n=5) 4 (10%) (n=39) 
Post-CCU exercise tolerance 100m, n (%) 4 (80%)* (n=5) 9 (23%)* (n=39) 
Voice change, n (%) 2 (40%) 16 (38%) 
Shortness of breath reported, n (%) 4 (80%) 17 (40%)  
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(2/5 versus 1/45) but there was no apparent difference between the groups in relation 
to tracheal ring fracture (1/5 versus 1/45) or minor bleeding (1/5 versus 0/45) rates. 
Results from the questionnaire revealed no differences in the presence of voice 
changes (2/5 versus 16/45) and shortness of breath (4/5 versus 17/45) between those 
with TS and those without. Two patients reported the presence of inspiratory noise – 
neither were found to be stridulous or have TS on MRI scan. Data pertaining to 
exercise tolerance was provided by 44 patients (5 TS and 39 nTS). Four of the five 
patients with TS reported an exercise tolerance of 100 metres (m) or less, two of 
whom reported unlimited exercise tolerance prior to critical care admission. In 
contrast, 9 of 39 nTS patients (23%) reported an exercise tolerance of 100m or less.  
Mean values for FEV1, PEFR and EI are shown in table 6.2. Neither FEV1, PEFR nor 
EI were predictive of TS.  
The five patients found to have TS on MRI scanning were referred to a consultant 
head and neck surgeon for further evaluation and to assess the need for additional 
intervention. At initial fibreoptic laryngo-tracheoscopy three of the five were deemed 
to have an adequate airway and further intervention was deemed unnecessary. The 
remaining two underwent rigid tracheo-bronchoscopic examination under general 
anaesthesia and were again found to have an adequate airway. It was felt that further 
surgical intervention would not significantly improve the airway, in a clinically 
meaningful way, in any of the 5 patients with TS. 
6.4 Discussion 
We have found a sub-clinical TS rate of 10% in fifty patients investigated ranging 
from a 16 – 46% reduction in TCSA. All patients with TS had fibre-optic laryngo-
tracheoscopic evaluation and two of the five had rigid tracheo-bronchoscopy. No 
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patient required any therapeutic intervention and all were felt to have an adequate 
airway and were discharged from further follow-up. The low incidence and the sub-
clinical nature of the stenoses is reassuring, indicating the underlying prevalence of 
undiagnosed TS in patients following STD PDT is of doubtful clinical significance.  
There are limited studies in the literature reporting long term follow up of PDT 
patients using radiological imaging (CT/MRI) with very few studying tracheal calibre 
in patients who have had STD PDTs even though this is now probably the most 
frequently used technique45,46,189. The 10% rate of TS described herein was less than 
that found in another MRI study80. Fikkers compared long term outcome of patients 
randomly allocated to either GWDF or STD PDTs. Sixty patients were assigned to 
each group, 31 patients underwent MRI scanning (14 patients in the STD group), with 
12 (39%) showing tracheal narrowing. Whilst the absolute number of patients with 
tracheal narrowing demonstrated by Fikkers is larger than our own, the degree of 
stenosis is similar in that all cases were felt to be of limited clinical consequence. 
Two further studies utilised CT assessment. Norwood4 studied 100 patients who had 
undergone PDT using the sequential dilators of the original Ciaglia technique 
(CPDT)40. Forty-eight of these patients underwent CT scanning. Fifteen (31%) 
patients were found to have more than 10% TS on CT with 10 (21%) of these being 
mild (tracheal narrowing of 11-25%), 4 (8%) moderate (26-50% narrowing) and 1 
(2%)  severe  (>50%  narrowing).  In  Karvandian’s  study,  20  patients  were  assessed  
using CT and fibre-optic laryngotracheosopy after CPDT190. Only three of the 20 
patients had cannulation times of less than three weeks (none of whom had TS) and 
85% had significant sub-glottic stenosis (53% with < 50% narrowing). The study 
group appeared different from our own with a mean duration of cannulation of 9 
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weeks. Additionally, 54 of 86 patients surviving four months after discharge from 
hospital required permanent or long-term mechanical ventilation.  
van Heurn described a TS prevalence of 26% in a study of 54 patients undergoing 
plain linear tomography following CPDT191. Law used spirometry and fibre-optic 
laryngo-tracheoscopy without any radiological assessment in 41 patients after 
CPDT192. Three patients were found to have tracheal narrowing of between 10-30% 
and one with a 40% stenosis. After a median cannulation time of 20 days, a 10% rate 
of TS was reported.  
The 10% rate of TS we describe is at the lower end of incidences reported above (10 – 
85%). Part of this difference may be accounted for by differing definitions of TS. 
However, the definition of TS as tracheal narrowing of >10% is common to most of 
the studies cited above with only Fikkers80 and Karvandian190 not specifically stating 
their definition of TS. The difference might also partly be attributed to shorter 
tracheal cannulation times. In each of the studies described above the duration of 
tracheal cannulation was longer than that described in our study (15 days in the TS 
group and 9 days in the nTS group). Cannulation times ranged from 18 days in 
Fikkers GWDF group80 to  9  weeks  in  Karvandian’s  paper190. Those studies reporting 
a lower prevalence of TS or only minor tracheal changes appear to have shorter 
cannulation times80,192. A further consideration to take into account is the duration of 
tracheal intubation prior to the insertion of PDT. PDT was carried out early in our 
patients (median 4 days), whereas previous studies have reported durations from 7 – 
18 days80,181,191,192. Another factor to be considered is PDT insertion technique used. 
Most of the studies described above have used CPDT with only Fikkers80 evaluating 
GWDF and STD techniques radiologically and then in only 15 and 14 patients 
respectively. It is possible, given the paucity of data available, that the incidence of 
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post PDT TS may differ significantly between commonly used techniques. 
Considering the widespread use of these techniques the lack of long-term radiological 
outcome data would appear somewhat surprising. 
The TS patients appear more likely to have undergone a complicated or technically 
difficult PDT compared to the nTS group (table 6.1). The most frequent difficulty 
encountered was the need for multiple tracheal punctures to site the cannula required 
for guide-wire insertion. Whilst the significance of this finding is unclear, the 
association between multiple tracheal punctures and later tracheal narrowing has not 
been made previously. It is possible that several attempts to position the cannula may 
ultimately lead the operator to settle for a suboptimal position for the tracheostomy 
tube potentially causing tracheal injury and later narrowing.  
As all cases of TS detected were clinically asymptomatic, with none requiring 
surgical correction, it is difficult to explain the significance and relevance of the 
reduced exercise tolerance found in these patients (four out of five reporting 
significantly limited exercise tolerance, two of whom had previously been unlimited). 
Conventionally TS is expected to become evident clinically when the tracheal 
narrowing reaches 50 – 75%. However, many critical care survivors are likely to have 
significant impairment of cardio-respiratory and neuro-muscular function. It is 
possible, in the setting of such limited physiological reserve, that post critical care 
patients may be symptomatic at lesser degrees of tracheal narrowing than would 
usually be the case. Under normal circumstances for gas to flow through the trachea a 
pressure gradient exists to overcome the resistance of the respiratory system. Flow 
within the trachea is usually turbulent and in such conditions the resistance is 
inversely related to r5 64. Therefore, the TS patient has to generate a greater pressure 
gradient to overcome this added resistance. Consequently, for the post critical care 
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patient, the symptoms of the TS may be more in keeping with significant fatigue than 
those usually associated with upper airway obstruction. 
The principal limitations of this study are sample size and patient selection. The study 
population may have self-selected to some extent, being limited to those who were fit 
enough to travel to hospital to take part in the study. Rates or severity of TS might be 
different in those patients unable to come to hospital. Conversely, those who were 
well enough to have returned to full-time employment may not have been contactable 
by telephone at home during office hours so may have been missed. We were, 
however, unable to demonstrate any differences in patient characteristics between 
those attending for scans and those unable to do so (Table 6.1). Additionally, we are 
unaware of the cause of death in those patients surviving their critical care stay but 
dying prior to an invitation to attend for scan. It is possible some of these patients may 
have had some degree of upper airway obstruction. Given that our institution houses 
the regional head & neck surgery service, and such patients would have been referred 
back should they develop airway obstruction, this seems less likely.  
Our initial intention was to assess 60 patients following STD PDT, specifically 
recruiting 20 after uncomplicated procedures, 20 after PDT complicated by tracheal 
ring fracture and a further 20 after more than 14 days cannulation. The incidences of 
ring fracture and of cannulation for more than 14 days were too low for the original 
aim to be achievable. Consequently, we recruited fifty eligible patients from the 
database. Whilst we were unable to study these factors as initially intended, analysis 
of the limited data obtained would appear to suggest that tracheal ring fracture is not 
obviously implicated in TS. Data pertaining to the length of tracheal cannulation may 
indicate a possible relationship between prolonged cannulation and TS (nTS 9 days 
versus 15 days TS) but this was not statistically significant. Whilst we could not 
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demonstrate a statistically significant association between duration of cannulation and 
TS further studies with larger numbers may be able to do so. Such studies are likely to 
be confounded by differences in timing of PDT between institutions. The long follow-
up required to detect post tracheostomy TS would be another limiting factor, as would 
cost – particularly if only 10% cases prove positive for TS which then may be 
regarded to have limited clinical significance. 
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Chapter 7 
 
Discussion 
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In the preceding chapters we have demonstrated the safety of percutaneous 
tracheostomy and more specifically the STD technique in relation to ST. We have 
shown, from the prospective studies published reporting long term outcomes, that 
percutaneous techniques in common use have complication rates similar to, if not 
better than ST. We have also illustrated, within our own unit59, that the complication 
rate of the STD technique is amongst the lowest published when compared to similar 
studies57,58,188 . Additionally, concerns relating to undiagnosed sub-clinical tracheal 
stenosis seem to be unfounded79. 
From the limited published data we have not found a significant difference in the 
incidence of TS between a range of percutaneous techniques and surgical 
tracheostomies. When considering all published data reporting long-term outcomes, 
our pooled proportions meta-analysis may indicate a tendency toward a higher rate of 
TS for ST but this finding is likely to be prone to selection bias. Similarly, in relation 
to major bleeding, we have not found a difference between the techniques commonly 
used. Again the pooled proportions meta-analysis may indicate a tendency toward 
more major bleeding for ST. In relation to wound infection we have found a 
significant reduction associated with CPDT compared to ST in keeping with earlier 
work51. Across all percutaneous techniques for the primary and secondary outcomes 
studied complication rates appear to be broadly similar but confidence intervals for 
pooled risk differences are wide and include clinically important differences in both 
directions. Due to limited data reporting, we were unable to identify peri-operative 
events that may be of significance in the generation of TS. Neither were we able to 
quantify the utility of adjuvant techniques (bronchoscopy and ultrasound scanning) in 
reducing peri-operative complications. 
Whilst the reported complication rates presented within our cohort study are in 
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keeping with, if not an improvement upon, those published previously57,58,188, this 
remains a single centre evaluation with its attendant limitations. It may, however, add 
weight to the gathering evidence55 that the STD PDT is one of the safer techniques 
available. Our rate of early technical difficulties appears to be reducing whilst long-
term outcomes remain unchanged. 
We have demonstrated a lower rate of sub-clinical stenosis in patients following STD 
PDT than has previously been reported79. Whilst we considered that some degree of 
functional limitation, in such patients, following critical care discharge might be in 
part due to an underlying prevalence of TS this would appear not to be the case. 
Those stenoses found were felt to be of doubtful significance with no patients 
requiring corrective surgery and all, ultimately, discharged from further follow up. 
Routine radiological imaging and spirometry following STD PDT would appear to be 
unwarranted in asymptomatic patients. 
When considering the data generated by each of the studies in the previous chapters a 
number of issues arise that have not been discussed previously. 
7.1 Gender Bias 
In both our own prospective series (608/1025) and in all but one of the papers 
reviewed for the systematic review313 there is a significant gender bias toward males. 
The 29 papers reviewed incorporated a total of 5473 patients, only one paper failed to 
report a male: female ratio311 (Polderman: 213 patients). Therefore, of 5260 patients 
within these trials 3153 (60%) were males. A similar position is described within 
Delaney’s  meta-analysis51. Of the 17 papers reviewed all but two235,281 consisting of 
123 out of 1212 patients describe a preponderance of males. This is not a 
phenomenon that is exclusive to trials of tracheostomy insertion or indeed to critical 
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care. When reviewing a selection of landmark papers published within the New 
England Journal of Medicine from 1999 onwards26,318-324 we can see a similar trend, 
with only one paper achieving a male : female ratio in excess of one in favour of 
females (table 7.1)318 . These eight papers describe the management of 16,843 patients 
of whom only 6,242 (37%) are female.  
Table 7.1 A selection of landmark critical care papers published in the New England 
Journal of Medicine illustrating the gender bias present within such studies. All but 
one have a significantly higher proportion of male study entrants. 
Study Number of patients Number of males (%) Number of females (%) 
ARDSNet26 861 512 (59.5) 349 (40.5) 
Kress318 128 60 (47) 68 (53) 
Hebert319 838 524 (63) 314 (37) 
Finfer320 6997 4197 (60) 2800 (40) 
Sprung321 499 332 (67) 167 (33) 
NICE-Sugar322 6104 3897 (64) 2207 (36) 
Guerin323 466 318 (68) 148 (32) 
Nielsen324 950 761 (80) 189 (20) 
  
However, when we review admission data for our unit from 2009 onwards we see that 
a similar sex distribution to that described for our tracheostomies is maintained 
(figure 7.1). It would, therefore, appear that any gender bias present within the critical 
care department is not related to the tracheostomy procedure per se but toward the 
decision to admit in the first place.
 156 
Figure 7.1 Graphical representation of gender bias for admissions to Aintree University Hospital Critical Care Unit from 2009 – 2014. The 
proportion of males admitted is approximately equal to the proportion undergoing tracheostomy within the study period. 
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It is generally believed that access to critical care is determined by need and severity 
of illness with differences in admission rates between genders being accounted for by 
the different disease spectra between the sexes. For example, it is generally accepted 
that ischaemic heart disease and trauma are commoner in males. However, a number 
of studies have demonstrated some concerns in relation to gender bias within critical 
care. A Canadian study analysing over 466,000 hospital admissions found that women 
over 50 years of age were less likely to be admitted to a critical care unit and more 
likely to die than men after a critical illness325. In contrast, in a cohort of 26,000 
patients in Austria Valentin found that whilst there was a higher illness severity in 
women men received an increased level of care and more invasive procedures but this 
did not translate in to improved outcomes326. 
A study emanating from the UK Intensive Care National Audit and Research Centre 
(ICNARC) examined the influence of gender on admission to critical care327. They 
examined admissions for a number of diagnostic categories for evidence of vertical 
and horizontal inequity. Reviewing over 46,000 admissions from 91 critical care units 
they were unable to find evidence of gender bias in admission or mortality in relation 
to cardiac arrhythmias, chronic obstructive pulmonary disease, asthma, self-poisoning 
and seizures. There was some evidence of vertical and horizontal inequity for females 
with myocardial infarction and central nervous system bleeding. There was also 
evidence suggestive of vertical inequity for male pneumonia and ventricular failure 
patients. 
When considering our own data we can see that the mean admission APACHE II 
score for males admitted to the unit who undergo a tracheostomy is 18.3 whilst that 
for females is 19.3 (p=0.005 unpaired t test). This would indicate females admitted to 
our critical care unit who undergo a tracheostomy are sicker than their male 
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counterparts at critical care admission, possibly indicating an admission gender bias 
within our unit. When considering survival of these cohorts the median survival for 
males is 2.9 years (95% CI 1.8 – 3.9) with an estimated five-year survival of 43% (SE 
0.02). For females the equivalent figures are a median survival of 3.7 years (95% CI 
2.3 – 5.1) with an estimated five-year survival of 45% (SE 0.03) (figure 7.2). 
Therefore, whilst the illness severity for female patients is increased this is not 
seemingly translated in to worse survival figures as would be expected. The crude 
APACHE II mortality prediction for the scores described above would be 29% for 
males and 32% for females. Samples sizes to reliably detect such a difference should 
be 511 in each group (α  0.05,  power  0.8). 
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Figure 7.2 Kaplan Meier survival curve illustrating survival according to gender for 
male (n = 608) and female (n = 417) patients respectively undergoing tracheostomy 
in Aintree University Hospital Critical Care Unit. Despite a higher illness severity for 
female patients, as evidenced by their admission APACHE II Scores, there is no 
difference in overall survival. The median survival for males is 2.9 years (95% CI 1.8 
– 3.9) with an estimated five-year survival of 43% (SE 0.02). For females the 
equivalent figures are a median survival of 3.7 years (95% CI 2.3 – 5.1) with an 
estimated five-year survival of 45% (SE 0.03). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p=0.28 
 
7.2 Timing of tracheostomy insertion 
The median time to tracheostomy within our own series is five days from critical care 
admission and four days from tracheal intubation. When reviewing the literature 
related to tracheostomy timing insertion is broadly divided into early (< 10 days) and 
late (> 10 days) groups. There remains much controversy as to the optimal timing for 
tracheostomy insertion within a critical care population. Initial interest in early 
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tracheostomy was fuelled by a number of randomised controlled trials reporting 
improvements in ventilator associated pneumonia, ventilator free days and length of 
critical care stay for patients undergoing early tracheostomy275,328,329. 
An early meta-analysis by Griffiths, incorporating five trials totalling 406 patients, 
failed to show a mortality benefit or a reduction in ventilator associated pneumonia 
but did demonstrate a reduction in both duration of mechanical ventilation and critical 
care length of stay330. However, an updated review by Wang from 2011 failed to 
show any of the outcome benefits reported previously331.  
From 2010 – 13 a number of larger studies assessing patient outcomes related to 
tracheostomy timing have been published. In a study performed in 12 Italian centres 
Terragni randomised 419 patients to undergo tracheostomy between days 6 – 8 versus 
days 13- 15332. The primary outcome was 28-day incidence of ventilator-associated 
pneumonia with the study being powered to demonstrate a 35% reduction therein. 
Whilst there was no reduction in ventilator associated pneumonia (early 30 versus late 
44 pneumonias p= 0.07) there were reductions in duration of mechanical ventilation, 
critical care length of stay and duration of weaning from mechanical ventilation for 
the early tracheostomy group. There were no differences in mortality or hospital 
length of stay. In a study of tracheostomy timing in the cardiac surgical setting 
Trouillet studied 216 patients and failed to demonstrate outcome benefits in relation 
to nosocomial infection, length of stay or mortality333. They did, however, 
demonstrate significantly less sedative usage, less agitation and delirium, improved 
oral nutrition and earlier mobilisation for the early group. The Tracman study, 
performed within the UK, is the only study to date with 30 day mortality as the 
primary outcome334. The targeted recruitment to achieve this aim was 1208 patients to 
detect a 7.5% reduction in critical care mortality. The study failed to recruit to target, 
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being halted at 909 patients, the principal reasons being recruitment fatigue and 
exhaustion of funding. There was no difference in any of the outcome measures 
reported above other than a reduction in sedative usage in the early tracheostomy 
group. 
The most recent Cochrane review of tracheostomy timing has been published in 
2015335. In a review of eight studies incorporating 1977 patients, including each of the 
larger studies alluded to above332-334, the authors reported a lower risk of mortality at 
the longest follow up time available (28 days – two years) in the early group (Relative 
Risk (RR) 0.83, 95% CI 0.70 to 0.98; P = 0.03) stating that 11 patients would need to 
be treated with an early tracheostomy instead of a late one to prevent one death. The 
probability of discharge from the critical care unit was also higher at 28 days for the 
early tracheostomy group day (RR 1.29, 95% CI 1.08 to 1.55; P = 0.006). When 
reviewing the quality of the evidence available the authors concluded that for 
mortality it was of moderate quality and for discharge at day 28 was high quality. 
7.3 Reasons for tracheostomy insertion 
The reasons for tracheostomy insertion in the critical care setting are frequently 
subjective and complex (table 7.2). In our own unit time of insertion may differ quite 
markedly for different patient groups (figure 7.3). Potential outcome benefits in 
relation to mortality, critical care length of stay and reductions in nosocomial 
respiratory infections have been suggested as reasons but, as can be seen from the 
above, the evidence in this regard can be contradictory. Further potential reasons put 
forward for tracheostomy insertion include improvements in patient comfort, safety, 
oral nutrition and hygiene and reduced work of breathing336. When considering the 
evidence supporting these assertions it is frequently confined to uncontrolled reports, 
clinical opinion and theoretical analysis. 
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Figure 7.3 Tracheostomy insertion algorithm 
Patient requiring invasive mechanical ventilation 
Condition leading to intubation resolved? 
Consider sedation break and trial extubation 
Need for ongoing: 
Mechanical ventilation 
Airway protection 
Relief of upper airway obstruction 
Pulmonary toilet 
Daily assessment for weaning including sedation breaks 
Consideration for extubation to non-invasive ventilation 
Consider early tracheostomy day 3 - 7 
Presence of: 
Severe cardio-respiratory dysfunction 
Significant traumatic brain injury (when 
intra-cranial hypertension resolved) 
Significant hypoxic brain injury 
Neuro-muscular disease 
Cautions: 
Significant coagulopathy 
Significant ongoing oxygenation problems 
Soft tissue infections at proposed insertion site 
Perceived difficult anatomy 
Following tracheostomy aim to: 
Stop sedation 
Progress to spontaneous ventilation 
Mobilise early 
If no resolution 
No 
Yes 
Failed extubation 
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Table 7.2 Reputed benefits of changing from a trans-laryngeal endotracheal tube to a 
tracheostomy tube, and level of evidence supporting such a decision, in a patient who 
requires prolonged intubation.
Republished with permission of Daedalus Enterprises Inc, from Tracheostomy: why, 
when, and how? Durbin CG. Respir Care. 2010;55(8):1056-1068336 Copyright 2010; 
permission conveyed through Copyright Clearance Center, Inc. 
 
When strategies for tracheostomy insertion within the critical care setting are 
considered it is frequently noted that many of those patients allocated to late insertion 
do not necessarily undergo the procedure334. An argument is then proposed that the 
risk of the tracheostomy is difficult to justify in this patient group. This viewpoint 
assumes that prolonged trans-laryngeal intubation is a risk free management plan. 
This is quite clearly not the case, with at least one series of patients with tracheal 
stenosis reporting a higher rate associated with trans-laryngeal intubation alone as 
opposed to tracheostomy following trans-laryngeal intubation88. Additional risk 
factors associated with prolonged trans-laryngeal intubation include vocal cord 
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oedema, mucosal erosions, laryngeal scarring and stenosis and recurrent laryngeal 
nerve damage. These changes may be seen within several days with the likelihood of 
recovery directly related to the duration of intubation336.  
7.3.1 Complex intervention 
On initial reflection the decision to insert a tracheostomy may be viewed as a simple 
intervention with a number of limited and predictable consequences. However, when 
we begin to consider our ability to transfer our findings and experience to other 
settings and centres we need to take in to account several factors surrounding the 
decision to perform a tracheostomy, the package of care delivered after its insertion 
along with staff, patient and family attitudes (see section 7.9). Complex interventions 
have previously been defined as those that comprise multiple interacting components 
337. In this context, therefore, it is clear that inserting a tracheostomy in to a critical 
care patient is part of a highly complex intervention package rather than a simple 
isolated procedure. Traditionally randomised controlled trials have been regarded as 
the gold standard for establishing the effectiveness of an intervention but they may 
not provide information pertaining to how the intervention will be delivered outside 
of the clinical trial setting or if the suspected outcomes will be delivered338. 
The key steps in evaluating a complex intervention are illustrated in figure 7.4. 
When considering our intervention of tracheostomy insertion with a view to 
replicating our findings beyond Aintree University Hospital there are several barriers 
that would currently prevent this process. 
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Figure 7.4 Key functions of process evaluation and relations among them for complex interventions. Implementation, mechanisms of impact and 
context are felt to be the key components of a process evaluation 
 
Reproduced from Process evaluation of complex interventions: Medical Research Council guidance. Moore GF et al BMJ. 2015;350:h1258338. 
Copyright 2015 with permission from BMJ Publishing Group Ltd 
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7.3.1.1 Defining the intervention 
Whilst it is a simple task to identify all critical care patients in whom a tracheostomy 
has been inserted it is more difficult to quantify the change in care that results from it. 
Within our unit the intervention is not simply tracheostomy insertion but the package 
of care delivered thereafter. Although it is easy to observe this change, as yet, we have 
not documented the process. This would require, as a minimum, assessments 
addressing sedative usage, time spent out of bed and mobilising, changes in ventilator 
management and additional time spent by allied health professionals with the patient. 
Additionally, patient factors further complicate our ability to define the intervention 
with some patients receiving a tracheostomy earlier (severe end organ dysfunction) 
whilst in others this may be delayed (figure 7.3). 
7.3.1.2 Implementation 
The first barrier to acceptance of a process of early tracheostomy and its associated 
package of care within other centres may lie in its acceptance. There is limited data 
showing a mortality benefit in relation to early tracheostomy insertion with most 
recent large randomised controlled trials failing to demonstrate a difference in 
outcome332-334. The most recent systematic review does, however, seem to indicate 
both a mortality benefit and a reduction in critical care length of stay335. 
Further process evaluation to assess how the intervention would be delivered would 
be required. This would need to include elements of resource allocation, assessment 
of training needs (both for those undertaking the tracheostomy and for those 
delivering care after insertion), staff and organisational communication issues, 
measurement of delivery as well as adapting the intervention to different settings338. 
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7.3.1.3 Impact and outcomes 
Any potential positive benefits related to the package of care delivered around early 
tracheostomy insertion may be difficult to identify given the negative outcomes 
associated with previous studies332-334. If this were to be the case this may be related 
to poor initial study design with a failure to fully define the intervention or poor 
implementation339. Surrogate endpoints designed to assess patient non-mortality 
related outcomes are likely to be required and may include duration of mechanical 
ventilation, length of critical care and hospital stay, incidence of delirium, 
assessments of neuromuscular function and psychological well-being. Further 
assessments of patient and family acceptance would also be required (see section 7.9). 
It is also possible that the positive effects of tracheostomy insertion may be seen even 
when the intervention package is not fully delivered. Whilst there may be no mortality 
benefit for early tracheostomy insertion the cessation of sedation may provide 
unexpected benefits that are more difficult to measure. From our own data 26% of 
patients undergoing tracheostomy do not survive to critical care discharge (table 5.1). 
It is possible, that in such patients, after sedation has been stopped an enhanced ability 
to communicate with family and friends may contribute to a more favourable end of 
life experience. 
7.4 Aetiological factors associated with tracheal stenosis 
In both our prospective cohort and within the systematic review we have attempted to 
identify factors present at tracheostomy insertion that may be associated with the 
aetiology of tracheal stenosis. To this end we have largely been unsuccessful. Within 
our own series, the reason for this was largely due to the low incidence of tracheal 
stenosis preventing meaningful interpretation of our data. Of the five stenoses 
observed one patient had a peri-operative tracheal ring fracture and oxygen 
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desaturation, another had marked laryngeal mucosal injury from trans-laryngeal 
intubation at tracheostomy insertion. The remaining three patients had uneventful 
tracheostomy insertions. 
The only peri-operative event described within the literature and postulated to be 
associated with the development of tracheal stenosis is tracheal ring fracture at 
tracheostomy insertion184-186. Within our own series we reported a rate of tracheal ring 
fracture of 11% and a TS rate of 0.5%. Only one of those patients was noted to have a 
tracheal ring fracture at tracheostomy insertion. Additionally, a number of authors 
have noted differing rates of tracheal ring fracture with the various percutaneous 
techniques with reported rates being higher with the STD technique54. However, the 
pooled proportions meta-analysis from our systematic review suggested, that of the 
percutaneous techniques, the rate of TS for the STD was lowest – seemingly 
indicating a lack of correlation between ring fracture and TS. A further consideration 
to factor in is that tracheal ring fracture is almost certainly underreported following 
PDT and is largely dependent upon the bronchoscopist actively seeking this 
complication. This assertion is supported by work from cadaveric studies340. Walz 
undertook a clinico-pathological study of tracheal specimens following PDT from 
critical care patients who had died from causes unrelated to their tracheostomy. In 
twelve out of forty two specimens there was an inter-cartilaginous rupture of the 
tracheal wall associated with a tracheal ring fracture and in 10 of 42 there was a 
cartilage defect at the stomal site. Each of these specimens revealed denuded cartilage 
with necrotic lesions that were related to duration of cannulation. 
From the data presented it would seem the most important aetiological factors 
associated with the genesis of TS are stomal and cuff related ischaemic damage, 
duration of cannulation and inherent patient factors. 
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7.5 Critical care survival 
The survival data presented within Chapter 5 demonstrates significantly worsening 
outcomes with both increased illness severity and advancing age. This is in keeping 
with previously published data341 and our own, as yet, unpublished observations (see 
below).  
7.5.1 Survival to hospital discharge 
We have studied a cohort of 505 elderly patients over the age of 80 years undergoing 
non-elective admissions to our critical care unit from January 2010 to December 
2014. We have found the predominant predictors of survival to hospital discharge on 
univariate analysis are related to category of admission (medical versus surgical) and 
acute physiological derangement (APACHE II score, SOFA score & modified SOFA 
score) (table 7.3). Survival to hospital discharge appears to be unrelated to indices of 
chronic health and co-morbidities (Functional co-morbidity score, chronic health 
evaluation of APACHE II score).  
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Table 7.3 Univariate analysis of factors predicting survival to hospital discharge of 
elderly patients admitted to Aintree University Hospital Critical Care Unit (n= 458). 
The most significant predictors are all related to the degree of acute physiological 
derangement present at critical care admission. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APACHE II: Acute Physiology Age & Chronic Health Evaluation 
SOFA: Sequential Organ failure Assessment score 
AMSS: Aintree Modified SOFA Score 
FCS – Functional co-morbidity score 
The functional co-morbidity score assesses a range of 13 co-morbid states. 
For the presence of each co-morbid state the patient scores 1 if there is no co-
morbidity the patient scores 0. The total score is that generated across all 13 
disease states. 
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When considering multivariable analyses we find the only independent predictors of 
survival to hospital discharge is the modified SOFA score (table 7.4 & figure 7.3). 
Table 7.4 Multivariable analysis of factors predicting survival to hospital discharge 
of elderly patients admitted Aintree University Hospital Critical Care Unit (n= 458).  
The only significant association with survival to hospital discharge is the modified 
SOFA Score 
 
 
 
 
 
 
 
 
 
 
APACHE II: Acute Physiology Age & Chronic Health Evaluation 
SOFA score – Sequential Organ Failure Assessment 
AMSS – Aintree Modified SOFA Score 
The modified SOFA score is amended to include scores for worsening pH and 
serum lactate measurements. 
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Figure 7.5 Survival amongst elderly emergency admissions to Aintree University 
Hospital Critical Care Unit (n = 458) according to the ranked modified SOFA score 
shows worsening survival with increasing score (increasing physiological 
derangement). Score ≤ 1 n=117 (26%), score 2 - 4 n =186 (41%), score ≥  5  n=  155  
(34%). 
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7.5.2 Survival to one year from critical care admission 
In the same cohort of elderly non-elective critical care patients when considering 
univariate analyses the predominant factors predicting survival to one year remain the 
degree of acute physiological derangement present at admission (higher APACHE, 
SOFA and modified SOFA scores predicting worse outcomes) (table 7.5). However, 
when subjected to multi-variable analyses the independent predictors of 12-month 
survival are age, APACHE II score and a cardio-respiratory functional co-morbidity 
score of 2 (table 7.6 and figure 7.4). With each year increase in age one-year 
survival decreases by 8% and each unit increase in the APACHE II score reduces one-
year survival by 6%. Median survival for those patients with Modified SOFA scores 
5 are 7 days (95% CI 3 – 11) and for a cardio-respiratory functional co-morbidity 
score 2 are 43 days (95% CI 0 – 110) 
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Table 7.5 Univariate analysis of factors predicting one-year survival for elderly 
patients admitted to Aintree University Hospital Critical Care Unit (n = 458). Even at 
twelve months after critical care admission the most significant predictors of long-
term outcome continue to be those related to the degree of acute physiological 
derangement at critical care admission. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APACHE: Acute Physiology Age & Chronic Health Evaluation 
SOFA: Sequential Organ failure Assessment score 
AMSS: Aintree Modified SOFA Score 
CR-FCS: Cardio-respiratory functional co-morbidity score 
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Table 7.6 Multivariable analysis of factors predicting one-year survival for elderly 
patients admitted to Aintree University Hospital Critical Care Unit (n = 458). Only 
when we subject our data to multi-variable analysis does an element of chronic health 
appear to be significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APACHE: Acute Physiology Age & Chronic Health Evaluation 
AMSS: Aintree Modified Sequential Organ failure Assessment (SOFA) Score 
CR-FCS: Cardio-respiratory functional co-morbidity score 
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Figure 7.6 Survival of a cohort of elderly non-elective patients admitted to Aintree 
University Hospital Critical Care Unit (n = 458) according to their functional co-
morbidity score. Score 0 n =232 (51%), Score 1 n =173(38%), Score  ≥  2  n  =53 
(12%). 
 
 
When we attempt to make a more direct comparison between our tracheostomy data 
and our elderly survival data the similarities remain. For those over 80 years of age 
with an APACHE II score in excess of 20 the median survival is eight days. When we 
look solely at those tracheostomy patients over 75 years of age with an APACHE 
Score  of  ≥  20  the  median  survival  is  76  days  compared  to  3.7  years  for  those  <  75  and  
/ or with an APACHE II Score < 20 (figure 7.5). Whilst this survival is better than the 
elderly population alone it remains a very poor prognostic group. The discrepancy 
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between the two groups is probably accounted for by the fact that the elderly cohort is 
slightly older and an unselected group of patients reviewed from the date of 
admission. For the tracheostomy group, patients must survive a median of five days 
prior to tracheostomy insertion. Therefore, those patients with the worst prognoses 
will not undergo the procedure. 
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Figure 7.7 Survival of patients undergoing percutaneous tracheostomy (n = 1025) 
comparing those over 75 years with and APACHE II Score ≥  20 (n = 69) to the 
remainder of patients (n = 956). 
 
 
7.6 Critical care length of stay 
Whilst the durations of critical care and hospital length of stays are somewhat less 
than previously published tracheostomy studies58,80 it is probable that this is related to 
timing issues surrounding tracheostomy insertion. Most if not all of our 
tracheostomies are inserted prior to day ten of mechanical ventilation (median 5 days 
to PDT from critical care admission). Despite this apparently favourable comparison 
there is little doubt we would be able to reduce this length of stay with a more intense 
multi-disciplinary team involvement in patient assessment and rehabilitation342. To 
this end increased physical and occupational therapy services may improve functional 
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well-being, speech and language therapy input may improve swallowing (and thus 
reduce episodes of aspiration pneumonitis), nutrition and communication, 
psychological therapy may improve mental well-being and reduce the incidence of 
post-traumatic stress disorder. After critical care discharge the maintenance of the 
above services with enhanced input from the critical care outreach team may further 
reduce length of stay and allow earlier identification of patient deterioration.  
Despite this well recognised need for enhanced observation and rehabilitation 
amongst the critical care patient population easily achieved interventions are not 
frequently undertaken. In a recent study performed across 12 critical care units in 
Australia and New Zealand incorporating 192 patients 52% of patients were found to 
have critical care associated weakness which was associated with an increased risk of 
death following critical care discharge343. Despite this 84% of patients did not receive 
any attempts at early mobilisation (defined as any active exercise where the patient 
could assist the activity using their own muscle strength). 
 
There remains, however, a degree of uncertainty relating to the implementation and 
timing of critical care rehabilitation programmes. In part this is due to a lack of 
funding for resource intense interventions where the outcome is not immediately 
demonstrable and in part from a lack of experience in delivering such interventions. 
The evidence is further clouded by the differing levels of physiotherapy support 
currently provided as the norm across units in North America, Europe and Australasia 
with much higher levels provided in Europe and Australasia 342. A number of studies 
have demonstrated the benefits of early initiation of a rehabilitation 
programme182,342,344,345 but this has not been universal346. The benefit of rehabilitation 
programmes instituted following critical care discharge have been more disappointing 
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with several trials failing to achieve a positive outcome347-349 perhaps indicating that 
intervention at this point is too late.  
 
7.6.1 Future work 
Our own intention in relation to improving outcomes for patients discharged from our 
unit was to attempt a targeted intervention based on our use of the Sabadell Score. We 
have shown that the in hospital mortality of patients discharged from our unit who are 
assigned a Sabadell 2 score is 16% (figure 7.6). We postulated that by targeting an 
intense rehabilitation programme, involving increased senior medical, physiotherapy 
and critical care outreach nursing input, toward a group of patients at high risk of in-
hospital mortality we may be able to improve on earlier studies where the intervention 
has been delivered to all patients discharged. We have, so far, been unable to secure 
funding for this project. 
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Figure 7.8 Survival from the point of critical care discharge according to the 
Sabadell Score – data from Aintree University Hospital 2011 -2013 (n = 1916). The 
Sabadell score is a subjective scoring system applied at critical care discharge based 
on  the  patient’s  expected  long-term prognosis. Sabadell 0 patients (n = 652 (34%)) 
would be expected to have a good long-term prognosis and survive beyond 12 
months. Sabadell 1 patients (n = 954 (50%)) would be expected to have a good short-
term prognosis but with survival beyond 12 months less clear. Sabadell 2 patients (n 
= 249 (13%)) would be expected to have a poor short-term prognosis but survival to 
hospital discharge would be expected. Sabadell 3 patients (n = 61 (3%)) would be 
expected to die within the same hospital admission. 
 
 
 
7.7 Percutaneous tracheostomy use outside the critical care unit 
 
7.7.1 Emergent airway access 
Despite several of the early developments in relation to percutaneous tracheostomy 
being suggested as suitable interventions for gaining emergent airway access37,38 
current guidelines preclude its use,350 frequently suggesting it as a contraindication351. 
Despite this, however, there are a number of reports of the successful use of PDT in 
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the emergency setting.352-356 It seems likely, that those expert in the insertion of a PDT 
would be able to achieve emergent airway access within the time frame consistent 
with a satisfactory neurological outcome. It also seems likely that such individuals 
would be much more comfortable gaining airway access in this setting via a PDT 
rather than using those techniques set out within difficult airway guidelines.  
 
7.7.2 Future work 
We would like to further investigate the hypothesis that PDT insertion in the 
emergency airway setting is contra-indicated. We would postulate that for those 
expert in its insertion it may be a credible alternative to crico-thyroidotomy. We 
would assess this using a bench test of timed airway access using either an airway 
mannequin or pig larynx. We would assess two groups of individuals trained in 
airway management but with one group also being expert in PDT insertion (intensivist 
group). We will assess time to securing the airway via surgical means according to the 
Difficult Airway Society surgical crico-thyroidotomy approach and also via a 
standard STD PDT approach. We could potentially expect a rapid securing of the 
airway with the STD PDT in the intensivist group but assessment of the speed of 
airway access in the non-expert group would also be an interesting addition to the 
literature. 
 
7.8 Percutaneous versus surgical tracheostomy in the elective setting 
Despite our unit housing the largest Head and Neck unit within the UK we have 
limited experience in the use of PDT in the setting of elective head and neck cancer 
surgery. We have used PDT in a small number of such patients but this was 
abandoned for reasons other than those related to PDT insertion. Use of PDT within 
an elective head and neck cancer population have formed part of some studies 
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assessing PDT outcomes357 but the majority of patients within this study were 
critically ill. There are no reports detailing the use of PDT solely within a head and 
neck cancer population. In addition to the low morbidity we have described herein 
there are other benefits that may be realised in the head and neck oncology patient. It 
has been clearly shown, both within our own meta-analysis and others, that the 
incidence of stomal infection is reduced with PDT. Siting of the PDT in a surgical 
patient allows the tracheostomy wound to be clearly separated from any neck wound. 
This, in association with the reduced rate of stomal sepsis, may lead to a reduction in 
post-operative neck wound infection in elective cancer patients if routine PDT use 
were considered. Significant safety related concerns would, however, remain should 
the tracheostomy become displaced in the early post-operative period. The use of 
PDT within our unit stopped following a case of accidental decannulation (non-PDT 
patient) on the first post-operative night in a patient undergoing tumour resection and 
free tissue transfer. In this patient it proved impossible to rapidly re-secure the airway 
leading to a hypoxic brain injury. Our current practice, therefore, is to use Bjork flap 
surgical tracheostomies in these patients. Despite these concerns, within the critical 
care unit (where these patients are routinely nursed), we have not had a significant 
problem with accidental decannulation for either surgical or percutaneous 
tracheostomies. 
 
7.8.1 Future work 
Whilst we have no current plans to explore the role and efficacy of percutaneous 
tracheostomy in the elective surgical setting this would be a relatively simple 
undertaking. A small randomised pilot study may help to evaluate a potential place for 
PDT in this setting. We would assess not only the safety concerns relating to 
inadvertent post-operative decannulation that have previously been raised within our 
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unit but also its effect on post-operative infection and the impact on the patient 
experience. Given the general dislike of tracheostomies amongst the surgical 
population further work may explore the role of smaller tracheostomy tubes, uncuffed 
tubes and guidelines toward earlier decannulation for these patients. 
Widespread adoption of percutaneous tracheostomy within the elective surgical 
setting would, however generate its own concerns. Currently head and neck surgeons 
in training gain experience required for securing the emergency surgical airway in the 
elective setting. If percutaneous tracheostomy were to be widely adopted in favour of 
surgical this could potentially raise significant training issues and a deskilling of the 
surgical team.    
 
7.9 Perceptions of tracheostomy in critical illness survivors 
As can be seen above (table 7.2) the reasons for tracheostomy insertion within critical 
care are frequently subjective with sometimes questionable evidence to support the 
decision making process. It is often assumed by critical care staff that tracheostomy 
insertion leads to a more settled and comfortable patient. This is in stark contrast to 
the experience of our head and neck unit where the presence of the tracheostomy is 
often the most complained about aspect of surgical head and neck cancer care 
(personal communication). The assumption that patients are more comfortable has, 
however, been relatively untested. In a review of qualitative studies of patient 
experiences related to weaning from mechanical ventilation Cook described 
uncertainty, stress, discomfort and a lack of control of surroundings and events as 
common themes358. Whilst not all of the patients assessed within this analysis will 
have had tracheostomies inserted it is easily appreciated that many of these symptoms 
could be ascribed to such patients. In a small qualitative study of eight patients (not 
exclusively critical care patients) Sherlock undertook a semi-structured interview to 
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identify common factors relating to their tracheostomy experience359. All but two of 
the patients included had been decannulated at the time of interview. They divided 
their interviews and responses into four themes namely; physical sensations, 
understanding, information and feelings after tracheostomy removal. They found that 
whilst most patients understood the reason for the tracheostomy and understood the 
reasons for its presence there were less positive experiences reported in relation to the 
physical presence of the tube, eating and drinking, tracheal suctioning and 
communication. Additionally, three of the six patients who had been decannulated 
reported panic attacks following removal of the tube despite happily anticipating this 
event.  Whilst  Sherlock’s  study  offers  some  insights  in  to  the  experiences  of  
tracheostomised patients it does not exclusively study critical care patients. 
Additionally, only patients capable of participating in 45-minute interview with a 
recordable voice were included and all had previously undergone at least one 
tracheostomy change. The evolving contemporaneous experiences of these patients as 
they progress through their critical care stay are yet to be documented although some 
insight in to this has been provided by Flinterud360. In a study of eleven patients from 
a university hospital in Norway they documented similar emotions to those described 
by Sherlock namely frustration, panic and anger, powerlessness, despair and loss of 
control. However, they also noted a time related improvement associated with 
development of coping strategies to enable easier communication. 
7.9.1 Future work 
It is our intention to explore the patient experience in relation to tracheostomy 
insertion in more detail over the coming months and years. We initially envisage a 
study conducted solely within the critical care unit undertaken with patients who have 
their tracheostomy in situ at the time of interview. We would also like to capture the 
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experience of the small group of patients who tolerate oro-tracheal intubation without 
sedation prior to either extubation or tracheostomy and compare their experiences 
with those of patients with tracheostomies. We would then intend to follow up all 
surviving patients to compare their memories and experiences following 
decannulation or extubation. Additionally, we would like to compare the experiences 
of these patients with those of their carers and families. To this end, we would hope to 
either confirm or refute much of the subjective reasoning behind tracheostomy 
insertion in the critically ill. 
 
7.10 Conclusion 
From the limited published data we have not found a significant difference in the 
incidence of TS between a range of percutaneous techniques and surgical 
tracheostomies. When considering all published data reporting long-term outcomes, 
our pooled proportions meta-analysis may indicate a tendency toward a higher rate of 
TS for ST but this finding is likely to be prone to selection bias. Similarly, in relation 
to major bleeding, we have not found a difference between the techniques commonly 
used. Again the pooled proportions meta-analysis may indicate a tendency toward 
more major bleeding for ST. In relation to wound infection we have found a reduction 
associated with CPDT compared to ST in keeping with earlier work51. Across all 
percutaneous techniques for the primary and secondary outcomes studied 
complication rates appear to be broadly similar but confidence intervals for pooled 
risk differences are wide and include clinically important differences in both 
directions. 
Whilst the reported complication rates presented within our cohort study are in 
keeping with, if not an improvement upon, those published previously, this remains a 
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single centre evaluation with its attendant limitations. It may, however, add weight to 
the gathering evidence that the STD PDT is one of the safer techniques available. Our 
rate of early technical difficulties appears to be reducing whilst long-term outcomes 
remain unchanged. 
We have demonstrated a lower rate of sub-clinical stenosis in patients following STD 
PDT than has previously been reported. Whilst we considered that some degree of 
functional limitation, in such patients, following critical care discharge might be in 
part due to an underlying prevalence of TS this would appear not to be the case. 
Those stenoses found were felt to be of doubtful clinical significance with no patients 
requiring corrective surgery and all, ultimately, discharged from further follow up. 
Routine radiological imaging and spirometry following STD PDT would appear to be 
unwarranted in asymptomatic patients. The principal limitation of this study is related 
to the small sample size being significantly underpowered for the stated intent. This 
was in a large part due to the funding limitations placed upon us. We were able to 
undertake the study due to grant monies received from the Intensive Care Society UK 
but this only allowed us to perform 50 MRI scans. It is doubtful, however, given the 
unremarkable nature of the findings of this study whether further scanning would 
have yielded significantly different results. Additionally, given the limited numbers of 
patients who experienced post-operative complications (particularly tracheal ring 
fracture) and prolonged cannulation we would have needed to both capture almost all 
patients in both categories and significantly extend the study period to provide a more 
meaningful analysis. 
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Appendix 1. 
 
Additional data extracted from systematic review papers  
 
Mean APACHE II / Mean SOFA scores 
Location of procedure 
Operator experience 
Mean duration trans-laryngeal intubation (days) 
Mean duration of tracheostomy 
Duration sedation post tracheostomy 
Mean ventilator dependent days 
Mean critical care unit length of stay 
Mean Hospital length of stay 
Mortality (1 month procedure) 
Average duration of procedure (minutes) 
Number of episodes hypoxia (SaO2 < 91%) 
Number of cardiac arrhythmia 
Incidence of hypotension (systolic blood pressure <90mmHg) 
Number of tracheal cuff punctures 
Number of paratracheal insertions 
Number of tube displacements or loss of airway 
Number of pneumothorax 
Number of pneumomediastinum 
Number of subcutaneous emphysema 
Episodes of atelectasis 
Incidence of aspiration 
Number of oesophageal injuries 
Number of posterior tracheal wall injury 
Number of peri-operative mortalities 
Number of peri-operative cardiac arrest 
Number of pneumonias 
Frequency of delayed wound healing (> three weeks) 
Number of tracheo-innominate artery fistula 
Incidence of failure to decannulate 
Number of reintubations 
Difficulty in recannulation 
Hypercapnia 
Increased airway pressure 
Stomal enlargement 
Tracheal dilatation 
Dysphagia 
Respiratory problems 
Bronchoscopic damage 
Poor visualisation of tracheal structures 
Late tracheal wall injury / haematoma / swelling 
Chyle leak (requiring intercostal drainage) 
Laryngeal perichondritis 
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Appendix 2 
 
Assessment of tracheal stenosis following percutaneous tracheostomy 
 
Outpatient appointment date:       __/___/__ 
Date of critical care admission:  __/___/__
   Date first intubated:   __/___/__ 
      
No. extubations pre-tracheostomy: ________ 
     Date of percutaneous tracheostomy: __/___/__ 
     Date of decannulation:   __/___/__ 
(Dates of re-cannulation, if applicable:                 ) 
 
Complications of tracheostomy: _____________________________________ 
 
Pre-existing respiratory disease 
Smoking history: _________ pack years   Still smoking          Y/N 
Established COPD:  Y/N  
Other respiratory disease:__________________________________________ 
Pre-ITU spirometry: FEV1_____________l  FVC________________l 
Pre-ITU Exercise tolerance on flat:_____m  Limiting factor: 
 
Current symptoms 
 Change in voice   Y/N 
 Short of breath   Y/N   Exertion/ rest 
 Stridor    Y/N   Exertion/ rest 
 Exercise tolerance on flat: ____m   Limiting factor: 
Other:  
(difficulty expectorating? difficulty swallowing? problematic scar?) 
 
Examination 
 Scar    Not visible/ Acceptable/ Disfiguring/ Tethering 
 Short of breath   Y/N   Exertion/rest 
 Stridor    Y/N   Exertion/ rest 
 
Spirometry 
        
Measured values Calculated values 
 1. 2. 3. Best  
FIF50     
FEF50     FEF50/ FIF50  
FEV1     FEV1/PEFR  
PEFR      
FVC     FEV1/FVC  
NB. Any  one  of:  FIF50  <100  l/min,  FEF50/FIF50  ≥1,  FEV1/PEFR  >  10l/ml  per  min 
Patient sticker 
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Role of routine chest radiography after percutaneous
dilatational tracheostomy
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Background. The role of routine chest radiography (CXR) after percutaneous dilatational
tracheostomy (PDT) has been questioned.
Methods. We performed a prospective observational study, on a mixed medical/surgical
critical care unit in a university teaching hospital. We studied all patients undergoing PDT as
part of their critical care management from November 1, 2003 until July 31, 2007. All PDTs
were performed under bronchoscopic guidance. After PDT, we reviewed the immediate post-
procedural films to assess the utility of routine postoperative CXR. For the purposes of CXR
review, we considered a procedure to be either uncomplicated or technically difficult.
Clinically relevant CXR findings were new barotrauma (pneumothorax, pneumomediastinum)
or a significant change in consolidation from the pre-procedure film.
Results. A total of 384 patients underwent PDT during the study period. Of these, 345 had
immediate post-procedural CXRs available for review. There were 252 PDTs (73%) documen-
ted as uncomplicated. There were 93 (27%) technically difficult procedures, with 107 adverse
events recorded. In 82 (24%) procedures, these difficulties were described as minor procedural
complications [multiple attempts at needle insertion (!3), minor bleeding or tracheal ring
fracture]. Significant complications (mal-placement in the anterior mediastinum and major
bleeding) were documented in 12 (3.5%) patients. New abnormalities were noted on 8 (2.3%)
immediate post-procedural CXRs. In only one patient was there a new CXR change in an
uncomplicated PDT.
Conclusions. Immediate CXR after uncomplicated PDT performed under bronchoscopic gui-
dance rarely reveals unexpected radiological abnormalities. The role of CXR after PDT appears
to be restricted to those patients undergoing technically difficult and complicated procedures.
A change in practice to this effect will lead to reductions in both medical costs and exposure
of staff and patients to ionizing radiation.
Br J Anaesth 2008; 100: 663–6
Keywords: complications; surgery, tracheotomy
Accepted for publication: January 2, 2008
Percutaneous dilatational tracheostomy (PDT) has become
a commonly performed procedure in the intensive care
unit (ICU) in those patients subjected to prolonged
mechanical ventilation.1 It has largely replaced the con-
ventional surgical tracheostomy in critical care patients,
with benefits in terms of cost, ease of performance, and
reduced complications.2 Significant complications associ-
ated with PDT, including haemorrhage,3 pneumothorax,4
and paratracheal placement,5 have ranged in various series
from 3 to 18%.6 7 Several authors have claimed that
bronchoscopic guidance during PDT provides a higher
degree of safety and decreases the incidence and severity
of complications.8 9 The role of the post-procedural chest
X-ray (CXR) has been investigated by other authors. Their
work concluded that there is little or no role for routine
CXR after PDT.10–13 15 However, because of the small
sample sizes used, these conclusions have been
criticized.14
Post-procedural CXR has been a standard practice
in our institution since the introduction of PDT more than
# The Board of Management and Trustees of the British Journal of Anaesthesia 2008. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
British Journal of Anaesthesia 100 (5): 663–6 (2008)
doi:10.1093/bja/aen038 Advance Access publication March 27, 2008
14 years ago. It has been our impression that this investi-
gation rarely impacts upon patient management. The aim
of this study was, therefore, to determine whether routine
CXR after insertion of a PDT resulted in the detection of
unexpected clinically significant complications. We also
sought to address criticisms of previous work by investi-
gating a larger patient population in a prospective manner.
Methods
This prospective study was undertaken at University
Hospital Aintree (UHA) Critical Care Unit, a 19 bedded
mixed medical/surgical unit performing 110–120 tra-
cheostomies per annum, 97% of which are PDTs. As no
additional interventions were performed, this was con-
sidered to be under the remit of audit and hence consent
was deemed unnecessary.
All patients undergoing PDT from November 2003 to
July 2007 were studied. All procedures were performed at
the bedside under bronchoscopic control using a Ciaglia
Blue Rhinow Percutaneous Tracheostomy Introducer Set
(Cook Medical). The CXR examined was the immediate
post-procedural film. Clinically relevant CXR findings
were considered to be new barotrauma (pneumothorax and
pneumomediastinum) and a significant change in consoli-
dation from the most recent pre-procedure film. Other data
recorded included age, sex, time to insertion of tracheost-
omy from ICU admission, and seniority of a supervising
doctor.
In defining a complicated procedure, for the purposes of
CXR review, we felt that it was important to include PDTs
that were technically challenging in addition to the more
traditional classifications of a complicated procedure. Our
institution’s tracheostomy proforma requires all procedural
related events to be documented by the operator. This
allows for recording of technical difficulties and documen-
tation of clinically insignificant events and periprocedural
events with clinical sequelae. A PDT was considered tech-
nically difficult if there was one or more of the following
during the procedure: oxygen desaturation (major if
!90%, minor if "2% desaturation from baseline), mul-
tiple attempts ("3) at tracheal cannulation, bleeding
(major if "3 swabs, minor if ,3 swabs), tracheostomy
tube misplacement, surgical emphysema, cardiovascular
instability, supra-stomal tracheal ring fracture, and pos-
terior tracheal wall injury (major if mucosal tear, minor if
single puncture).
Each PDT was, therefore, considered to be either techni-
cally difficult or uncomplicated for the purposes of CXR
analysis.
Results
During the study period, 384 patients underwent a PDT as
part of their critical care management. There were 345
(90%) immediate post-procedural films available for
review. As our institution has recently moved to a digital
radiology system, this accounts for some films being
unavailable.
The characteristics for the 345 PDT patients are shown
in Table 1. The most senior physician present during the
PDT was a consultant in 223 (67%) procedures, an
advanced level critical care trainee in 94 (28%) procedures
and a registrar in 16 (5%) procedures.
There were 107 adverse events recorded during 93 (27%)
technically difficult PDTs. The majority of these were
minor procedural complications (Table 2). Significant pro-
cedural complications occurred during 12 (3.5%) PDTs,
these consisted of significant (.3 soaked swabs) bleeding
(3), mal-positioning of the tracheostomy tube (4), severe
surgical emphysema (4), and significant posterior tracheal
wall injury (1). There were a total of eight significant new
abnormalities on immediate post-procedural CXRs. Of
these abnormalities, one occurred in the uncomplicated
group and seven occurred in the technically difficult group.
The new CXR abnormality in the uncomplicated group was
subcutaneous emphysema; however, this was overlooked
by the critical care clinicians. In this patient, a tension
pneumothorax developed within 24 h of the PDT. The
seven CXR abnormalities in the complicated group con-
sisted of two pneumothoraces, one pneumomediastinum
(after tracheostomy tube misplacement), and four episodes
of significant surgical emphysema. There were no instances
of a significant change in consolidation between the pre-
and post-procedural films.
Discussion
The overall complication rate of 27% post-PDT under
bronchoscopic guidance in our institution would initially
appear disproportionately high. However, we feel that this
can be explained by our broadening the definition of a
‘complicated’ procedure to include technical difficulties in
addition to conventional complications. Our liberal
interpretation of a complicated PDT was, we felt, necess-
ary as technical difficulties, which do not necessarily
result in clinical sequelae, are not included in the tra-
ditional description of what comprises a complication but
could feasibly result in CXR changes. The true value of
the post-procedural CXR cannot be appreciated if it is
used indiscriminately.
The data we present suggest that by targeting these tech-
nically difficult procedures, which actually means a CXR
Table 1 Patient characteristics. Data are given as mean (SD) or median [IQR]
Age (yr) 59 (15.3)
Admission APACHE II score 19 (5.3)
Male, n 196
Medical, n 160
Day to PDT 5 [4]
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for 27% of PDTs, we direct the radiological investigation
more effectively. So, when making recommendations in
the past regarding the value of post-procedural CXR, it
could be argued that poor yields were, in part, as a result
of the widespread use of this investigation. Our rate of tra-
ditionally defined significant complications was actually
3.5% and is in keeping with the low rates reported by
others.16
In this study there were two pneumothoraces detected
on the immediate post-procedural CXR, giving an inci-
dence after PDT of 0.6%. Despite the use of broncho-
scopic control, the tracheostomy tube was misplaced
during four PDTs, resulting in significant subcutaneous
emphysema. On three occasions, the tube was placed in
the anterior neck/mediastinum, resulting in a CXR finding
of pneumomediastinum in one patient, and on one
occasion the tube was inserted through the crico-thyroid
membrane. In the three cases of extra-tracheal placement,
tracheal tube sizes were such that effective ventilation of
the lungs was inadequate with a bronchoscope in situ. The
bronchoscope was, therefore, used to confirm correct pla-
cement of the guide wire within the trachea. Thereafter,
the bronchoscope was removed to allow continued venti-
lation. It was subsequently re-inserted to confirm or refute
intra-tracheal tube placement.
Given the low incidence of complications during PDT,
it is likely that routine use of CXRs post operatively will
have a low detection rate of new CXR findings. It is
therefore unsurprising that the overall detection rate for
new CXR findings after operation was 2.3% (8/345). We
have shown that in the 252 uncomplicated PDTs there
was one unexpected CXR finding on the immediate post-
procedural film which ultimately resulted in a tension
pneumothorax. Therefore, in seven of the eight cases the
new CXR changes were found in the technically difficult
group (two pneumothoraces, one pneumomediastinum and
four cases of subcutaneous emphysema). In the cases of
those patients with subcutaneous emphysema, this was
immediately diagnosed clinically. In no patient was there
an underlying pneumothorax, despite there being new
CXR changes, and so clinical management remained
unaltered.
Our study differs from earlier work in that it is both
prospective and significantly larger than earlier published
studies. In introducing the concept of a technically difficult
PDT, it is immediately apparent that more CXRs will be
performed than if one were restricting post-procedural
CXRs to traditionally defined complicated PDTs. Indeed,
previous authors have suggested that there is no role for
routine CXR after PDT.10 17 From the data presented here;
however, we would suggest that there is a role following
a technically difficult PDT, which in the current series
would amount to performing a post-procedural CXR in
27% patients. The paper by Datta and colleagues10 was
criticized for recommending that post-procedural CXR
was not necessary after a retrospective assessment of only
60 patients. Haddad and colleagues17 studied 239 patients
but used a conventional definition of a ‘complication’ and
hence may account for their only new finding of atelectasis
in 10% of patients. In our 252 patients undergoing uncom-
plicated PDT, the detection rate for new abnormalities on
CXR was 0.4%. In the 93 patients undergoing a techni-
cally difficult PDT, the detection rate for new CXR
abnormalities was 7.5%. Given that the majority of these
abnormalities were related to the presence of subcutaneous
air, which was clinically evident in all cases before CXR,
the yield of unexpected new abnormalities on CXR in this
group was still low.
Since we have found only one new abnormality in the
73% patients who underwent an uncomplicated PDT on
the immediate post-procedural CXR, there would appear
to be little utility in this investigation in this group of
patients. However, the failure to recognize this sub-
cutaneous air subsequently led to the development of a
tension pneumothorax. Had this subcutaneous air been
recognized on the immediate CXR, it is still likely that
there would have been no change in the initial post-PDT
clinical management other than a greater degree of vigi-
lance in the postoperative period. Therefore, we would still
argue that there is no role for routine CXR in the setting
of uncomplicated PDT. However, it could equally be
argued that given the subsequent gravity of this compli-
cation post-procedural CXRs are still warranted in this
group of patients.
If one accepts the argument that post-procedural CXRs
are unnecessary after a truly uncomplicated PDT, then this
will lead to modest cost savings and a reduction in the
exposure of staff and patients to ionizing radiation (a
single CXR equates to 0.1 mSv or 10 days of background
radiation) within the critical care unit. In our institution,
the distance of the tip of the tracheostomy tube from the
carina is routinely measured with the bronchoscope and so
we do not require radiographic confirmation of this
measurement.
We feel, therefore, that the rate of new CXR findings of
7.5% in the technically difficult group is high enough to
justify continued routine utilization of post-procedural
CXRs in this group. Only in truly uncomplicated PDTs,
with a new abnormality rate on post-procedural CXR of
0.4%, there is, arguably, no role for routine post-
procedural CXR.
Table 2 Technical difficulties
Technical difficulty Number
Multiple tracheal punctures (!3) 34
Tracheal ring fracture 34
Posterior tracheal wall injury 9 (1 major)
Oxygen desaturation 4
Bleeding 18 (3 major)
Tracheostomy tube misplacement 4
Surgical emphysema 4
Chest X-ray after tracheostomy
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RESPIRATION AND THE AIRWAY
Case Report
Tracheo-innominate artery fistula after percutaneous
tracheostomy: three case reports and a clinical review
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Tracheo-innominate artery fistula (TIF) is an uncommon yet life threatening complication after a
tracheostomy. Rates of 0.1–1% after surgical tracheostomy have been reported, with a peak
incidence at 7–14 days post procedure. It is usually fatal unless treatment is instituted immediately.
Initial case reports of TIF resulted from surgically performed tracheostomies. We present three
fatalities attributable to TIF, confirmed by histopathology, after percutaneous dilatational tracheo-
stomy (PDT). The use of PDT has resulted in tracheostomies being performed by specialists from
different backgrounds and the incidence of this complication may be increasing. Pressure necrosis
from high cuff pressure, mucosal trauma from malpositioned cannula tip, low tracheal incision,
radiotherapy and prolonged intubation are all implicated in TIF formation. Massive haemorrhage
occurring 3 days to 6 weeks after tracheostomy is a result of TIF until proven otherwise. We
present a simple algorithm for management of this situation. The manoeuvres outlined will
control bleeding in more than 80% of patients by a direct tamponade effect. Surgical stasis is
obtained by debriding the innominate artery proximally, then transecting and closing the lumen.
Neurological sequelae are few. Post-mortem diagnosis of TIF may be difficult, but specific
pathology request should be made to assess innominate artery abnormalities.
Br J Anaesth 2006; 96: 127–31
Keywords: complications, death; complications, fistula; complications, haemorrhage; surgery,
tracheostomy; surgery, tracheotomy
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Percutaneous dilatational tracheostomy (PDT) has become
a standard technique in critical care medicine. As a result of
its widespread use, it continues to attract controversy and
debate. The UK Intensive Care Society recently launched
the TracMan trial which concluded in its preface that PDT
is ‘a common procedure but with limited evidence base to
support its use.’ We present three fatalities resulting from
tracheo-innominate artery fistulae (TIF) after PDT.
Although possible to perform under local anaesthesia, the
majority of PDTs are performed under general anaesthesia
with neuromuscular block on Critical Care Units by non-
surgically trained operators. Complications of PDT are
traditionally divided into early and late. The majority
of publications centre on early complications including
bleeding, pneumothorax, technical failure and perioperative
hypoxia.1 The major reported late complications include
tracheo-oesophageal fistula, tracheomalacia and tracheal
stenosis.2
TIF is an uncommon yet life threatening complication
that can occur after a tracheostomy. Reported incidence
is 0.1–1% after surgical tracheostomy, with peak incidence
7–14 days post procedure.3 4 It is usually fatal unless
treatment is instituted immediately.5 6 We present a case-
series of tracheo-innominate arterial fistulae after PDT with
histopathological confirmation.
Case 1
A 43-yr-old female with a community-acquired pneumonia
presented to the Critical Care Unit requiring invasive
ventilatory support. Subsequent management included an
uneventful PDT 11 days from her critical care admission.
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Two subsequent uneventful tracheostomy tube exchanges
were performed during the admission. Thirty-two days
after this procedure, a small haemorrhage developed from
the tracheostomy site. This was self-limiting and broncho-
scopic investigation did not identify a bleeding site within
the respiratory tract. Similarly, no signs of inflammation or
infection were present in the tracheostomy wound. How-
ever, within 3 h of this initial bleed, massive oral and trach-
eal haemorrhage occurred. Bleeding did not initially appear
pulsatile but the volume of blood prevented effective
oxygenation. The trachea was intubated translaryngeally,
allowing removal of the tracheostomy tube, inspection of
the stoma and digital compression of the suspected bleeding
site. Failure to terminate the bleeding and persistent
suboptimal ventilation resulted in a fatal cardiac arrest.
Case 2
A 57-year-old male was admitted to the Critical Care Unit
following a road traffic accident. His injuries consisted of
a fractured pelvis, which required external fixation, and an
extensive retroperitoneal haemorrhage. Inability to with-
draw mechanical ventilation and an associated pneumonia
led to an uneventful PDT on Day 11. Twelve days after the
PDT, his respiratory function had improved sufficiently to
allow consideration of decannulation. However, prior to
this, sudden haemorrhage developed via the tracheostomy
tube. Adequate ventilation failed because of the amount
of blood in the major airways. Tracheal intubation was
achieved via the translaryngeal route. It was not possible
to identify a bleeding point and a double lumen endobron-
chial tube and bilateral intercostal drains were inserted.
Unsuccessful attempts, using fibreoptic bronchoscopy, to
suction the aspirated blood from the tracheobronchial tree
followed. It proved impossible to re-establish effective
ventilation, resulting in a fatal hypoxic cardiac arrest.
Case 3
A 69-yr-old female was admitted to the Critical Care Unit
after an elective oesophagogastrectomy for oesophageal
carcinoma. Her initial postoperative course was uncompli-
cated until Day 5 when she developed bronchopneumonia.
On Day 8, inspiratory stridor and acute respiratory failure
led to emergency tracheal intubation and mechanical vent-
ilation. A PDT followed on the same day. Her subsequent
management was unremarkable and artificial ventilation was
discontinued by Day 10. She was discharged to the ward
with a tracheostomy tube in situ. On Day 17, she developed
massive haemorrhage into the airway resulting in desatura-
tion and cardiac arrest. Despite translaryngeal intubation and
prolonged attempts to clear the airway, resuscitation was not
possible.
Each procedure was bronchoscopically guided and
performed in the presence of an intensive care consultant.
Ciaglia Blue Rhino! (Cook, Letchworth, UK) tracheostomy
set was used and a size 8.0 mm Crystal Clear! (Rusch,
Lurgan, UK) tracheostomy tube was used in each case.
Each PDT was considered to have been between tracheal
rings I and IV. All cuff pressures were monitored regularly,
as is our standard practice.
The occurrence of these three cases within 18 months of
each other aroused clinical suspicion of a potential link in
underlying pathology. After direction from the clinicians
involved, the subsequent post-mortem examinations looked
specifically at both the tracheostomy site and the tracheo-
innominate trunk.
As a result of their small size, post-mortem diagnosis of
TIF can be difficult. For all three patients, sections from the
tracheo-innominate artery at the level of the tracheostomy
site revealed a small focus of active chronic inflammation
extending through the full thickness of the arterial wall into
the luminal surface. Histological evidence of necrosis was
identified extending through the adjacent wall of the trachea
with consequent focal disruption of the tracheal wall. The
histopathological confirmation of a TIF was reported on the
subsequent death certificates.
Tracheo-innominate fistula
The true incidence of this rare complication is difficult to
assess. After surgical tracheostomy, the incidence has been
estimated to be 0.1–1%.4 Pooled data of 5530 tracheostom-
ies recorded the incidence of delayed massive haemorrhage
as 0.3%.7 Initial case reports of TIF resulted from surgically
performed tracheostomies. However, the incidence may
have declined because of advances in tracheostomy tube
technology and the introduction of PDT. The increased
popularity of PDT has resulted in tracheostomies being per-
formed by an increasing number of specialists from different
backgrounds. It is conceivable that the rate of such a rare
complication is perceived by different clinical groups, to be
lower than it actually is. Consequently we suggest that TIF,
although rare, should be borne in mind by all those involved
in tracheostomy management. In our institution more than
1000 PDT have been performed since 1994, giving a crude
incidence of 0.3%.
Pathophysiology
Knowledge of the anatomy of the innominate (brachioceph-
alic) artery (Fig. 1) and its relationship to a tracheostomy
tube is essential in understanding the pathophysiology
of TIF. The tracheo-innominate artery (or trunk) is the
first branch of the aortic arch. It divides into the right com-
mon carotid and right subclavian artery, 3–4 cm lateral to the
trachea, behind the right sternoclavicular joint. In its inferior
proximal portion, its relations include:
! anterior: left tracheo-innominate vein and thymus;
! posterior: trachea ("6–10th ring);
! posterior and left: left common carotid artery;
! right: right tracheo-innominate vein, superior vena cava
and pleura.
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The tracheo-innominate artery supplies blood to the right
arm and the right side of the head and neck. Its absence on
the left is explained by the direct branching of the left com-
mon carotid and subclavian arteries from the aortic arch.
A high lying innominate artery, particularly in the thin and
young, may act as a risk factor in fistula formation.
Aetiology
Pressure necrosis from high cuff pressure, mucosal trauma
from malpositioned cannula tip, low tracheal incision,
excessive neck movement, radiotherapy or prolonged
intubation have all been implicated in TIF formation.
Utilization of a high-volume low-pressure cuff may reduce
subsequent fistula formation.
Two main mechanisms are capable of producing
sufficient pressures to generate the erosive processes that
lead to fistula formation:
! A fistula may occur between the anterior tracheal wall and
artery. This is secondary to the mechanical force gener-
ated by either the tracheostomy tube cuff or tube tip
depending on the relative positioning of the tube within
the trachea.
! The second mechanism involves pressure generated
beneath the angulated neck of a tracheostomy tube.
This could produce ischaemia anteriorly on the tracheal
mucosa and into the innominate artery.
Several authors suggest that a low lying tracheostomy tube is
an obvious cause of fistula formation.8 However, even when
the tracheotomy incision is placed between the second and
third tracheal rings, as recommended, these complications
can still occur. In a post-mortem study, Oshinsky and
colleagues9 found that 10 standard vertical incisions placed
in the second and third rings resulted in all subsequently
placed tracheostomy tubes having either cuff or tip anatom-
ically adjacent to the innominate artery, suggesting the
potential presence of this complication in all patients with
tracheostomies.
Diagnosis
Any peri-stomal bleed or haemoptysis should lead to a full
clinical investigation to ascertain the underlying cause.
A differential diagnosis for attending clinicians is based
on the lag time between the tracheostomy and subsequent
haemorrhage.
Haemorrhage within 48 h is typically associated with
local factors such as traumatic puncture of anterior jugular
or inferior thyroid veins, systemic coagulopathy, erosions
secondary to tracheal suction or bronchopneumonia.
Usually, the haemodynamic stability of the patient allows
easy identification of the problem and corrective action to be
taken with minimal morbidity.10 Vascular erosion from a
tracheostomy tube, resulting in a TIF, requires at least 48 h
to develop even in the most friable mucosa.
Haemorrhage occurring 3 days to 6 weeks after tracheo-
stomy should be thought of as a result of TIF until proven
otherwise.11 Other causes of catastrophic pulmonary
haemorrhage include pulmonary artery flotation catheter
induced arterial rupture, thoracic aneurysm rupture and
less common vascular fistula (carotid artery, inferior thyr-
oid). It is likely that the majority will occur in the Critical
Care Unit, as 70% of all delayed haemorrhages occur during
the first 3 weeks.12 A sentinel bleed is reported in more
than 50% of patients who then develop massive delayed
haemorrhage.6 8 13
Haemorrhage occurring after more than 6 weeks is rarely
related to TIF and more likely to be secondary to granulation
tissue, tracheobronchitis or malignancy.
Trachea
Right common
carotid artery
Left internal
jugular vein
Left
subclavian vein
Ascending aorta
Right subclavian
artery
Tracheo-innominate
artery
Superior
vena cava
Fig 1 Tracheo-innominate artery fistula. Source: Amended from Wolfe: Complications of Thoracic Surgery: Recognition and Management. Figure 27-3
! 1992 Mosby, with permission from Elsevier.
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Clinical management
Adequate oxygenation is the mainstay of immediate
management with simultaneous identification and termina-
tion of bleeding. The basic principles of resuscitation,
together with the management of early (within 3 days)
bleeding, will not be considered here.
Management of a suspected TIF will depend upon
whether there is active bleeding into the airway hindering
adequate ventilation (Fig. 2).
We advocate the use of immediate bronchoscopy to
confirm the extent and source of bleeding. Although bron-
choscopy is unlikely to identify the fistula opening per se, it
may exclude other pathology and allows direct monitoring
of attempts to obtain a blood-free airway. Rigid broncho-
scopy to clear the tracheobronchial tree of aspirated blood
and to terminate blood flow is ideal, but this may not be
possible.
Around 50% of TIF present with a self-terminating, sen-
tinel bleed. If bronchoscopy confirms that the main bronchi
are blood-free then immediate intervention is not required
but further investigation to confirm the cause of bleeding is
vital. Other causes of haemorrhage must be excluded before
a sentinel bleed associated with TIF can be confirmed. If no
other cause is evident then a provisional diagnosis of TIF
should be made; urgent surgical advice and consideration of
stoma exploration should follow.
If, in the presence of active bleeding, bronchoscopy
indicates that the airway is clear of blood but there is
ongoing external haemorrhage, the potential for catastrophic
airway contamination is real. Overinflating the cuff provides
additional airway protection and may control the bleeding
temporarily. If, however, bleeding continues then pressure
dressings should be applied to the stoma site. These man-
oeuvres temporarily control bleeding by a direct tamponade
effect in more than 80% of patients.5 As long as the airway
remains free of blood; no attempt should be made to manip-
ulate the tracheostomy tube. Immediate surgical exploration
should follow.
Where bronchoscopy confirms that there is active bleed-
ing into the airway, from the major threat is respiratory
compromise rather than hypovolaemia.14 15 Airway pro-
tection is the primary management aim. Movement of the
tracheostomy tube may precipitate disastrous airway occlu-
sion.4 The aims must be to gain temporary control of
the bleeding, get adequate oxygenation and proceed to
immediate stomal exploration and definitive treatment.
(i) Overinflating the tracheostomy cuff is first line manage-
ment. If this measure fails to reduce internal tracheal
bleeding then proceed immediately to translaryngeal
intubation with digital compression.7 16 A cuffed oral
tracheal tube should be advanced so that the balloon
lies distal to the tracheostomy stoma (bronchoscopy
should confirm ETT tip just proximal to the carina).
The tracheostomy tube should only be withdrawn to
facilitate simultaneous translaryngeal tracheal intuba-
tion. Digital compression consists of inserting the finger
into the pretracheal space to tamponade the innominate
Manipulation of ETT
with cuff overinflation
 
Surgical exploration
Surgical exploration  
Endotracheal intubation 
Overinflate tracheostomy cuff
Bleeding controlled 
Non-contaminated trachea
Overinflate tracheostomy cuff 
Surgical exploration Pressure packs  
Surgical exploration  
Bleeding continues 
Bleeding continues Bleeding controlled 
Contaminated trachea
Digital compression via stoma  
Bleeding continues Bleeding controlled
 Bleeding continues Bleeding controlled 
Fig 2 Clinical management of TIF.
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artery against the posterior surface of the manu-
brium.11 12 This procedure should terminate bleeding
in >90% patients and if maintained, allows transfer
to the operating theatres.6 17
(ii) If digital compression fails to stem bleed, slow with-
drawal of the tracheal tube and cuff over-inflation
should follow. Manipulating the ETT tube, and its cuff
to produce tamponade is the only other manoeuvre avail-
able in this situation and attempts should persist.
If the bleeding stops temporarily, and ventilation is accept-
able, then immediate surgical intervention should follow.
Management of TIF is a surgical emergency. Mortality is
!100% without operative intervention. The paucity of evi-
dence to support any imaging leads us to recommend the
immediate surgical exploration. The index of clinical sus-
picion precludes delaying surgical intervention and any
imaging, we feel, should only be undertaken within the
theatre suite in conjunction with surgical management.
A standard median sternotomy approach is appropriate
for access. It has been suggested that in specialist units,
two separate incisions involving a right anterior thora-
cotomy and neck approach may be advantageous in terms
of prevention of mediastinitis and sternal dehiscence.13
Successful surgical interventions have included the use of
saphenous vein and innominate vein grafts, sternocleido-
mastoid patches or pedicled pericardial grafts.17 However,
the mainstay of surgical treatment is to terminate flowwithin
the innominate artery by debriding the innominate artery
proximally until healthy tissue is obtained, then transecting
and closing the lumen. There is no convincing evidence to
suggest that this leads to significant neurological or vascular
compromise.18 19 Arterial reconstruction should no longer
be considered, as arterial tie-off presents significantly better
mortality and morbidity results.
In a patient presenting with fresh haemorrhage beyond
72 h after tracheostomy, the overriding concern should be
of an underlying TIF. The simple algorithm that we have
presented may be a useful guide. Our understanding of the
long-term sequelae of the PDT is poor. We recommend that
any death that results from, or is associated with massive
haemorrhage from the respiratory tract in a patient who has
received a PDT should have a post-mortem looking specif-
ically at innominate artery pathology.
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CRITICAL CARE
Percutaneous tracheostomy: a 6 yr prospective evaluation
of the single tapered dilator technique
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Key points
† A large single-centre
service evaluation of
percutaneous dilatational
tracheostomies (PDTs) in
a critical care unit over a
6 yr period.
† PDT was attempted in
576 patients and
successfully completed in
572 patients.
† Early complication rate
was 3%, late
complications 0.7%, and
directly attributable
mortality 0.35%.
† The paper provides the
largest single-centre
evaluation of PDT and its
safety/risk profile.
Background. The single tapered dilator (STD) percutaneous dilatational tracheostomy (PDT)
technique now appears to be the single most common method of performing a
tracheostomy in the critical care unit (CCU).
Methods. A single-centre, prospective evaluation of all PDTs performed in an adult mixed
surgical and medical CCU between November 2003 and October 2009 was done. All
procedures were undertaken by critical care physicians. A proforma recorded
intraoperative complications and technical difficulties encountered during the procedure;
all patients were followed up for a minimum of 3 months for delayed complications.
Results. A tracheostomy was performed on 589 patients during the study period. PDT was
attempted in 576 patients and successfully completed in 572. PDT was abandoned in four
patients due to bleeding, with three of these subsequently undergoing surgical
tracheostomy (ST). ST was performed in 17 patients. Intraoperative technical difficulties
were encountered in 149 (26%) cases. Sixteen (3%) procedures were deemed as having
early complications. A further four (0.7%) cases had significant late complications
including two tracheo-innominate fistulae (TIF). Both TIF patients died as a result of their
complications giving a mortality directly attributable to PDT of 0.35%. There were no
differences with respect to the occurrence of complications according to grade of operator.
Conclusions. PDT performed by the STD technique is a relatively safe procedure with more
than 96% of procedures performed without any early or late complications. Using this
technique, more than 97% of tracheostomies undertaken during the study period were
performed percutaneously. Further audit at a national level is warranted to fully evaluate
long-term complications after PDT.
Keywords: complications; dilatational; percutaneous; tracheostomy
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Percutaneous tracheostomy was first performed in 19551
after Seldinger’s earlier description of a needle placement
over a guidewire for arterial cannulation.2 After Ciaglia’s
initial report of the dilatational technique in 1985,3 percuta-
neous dilatational tracheostomy (PDT) has become a com-
monly performed procedure in the critical care unit (CCU).
It has largely replaced conventional surgical tracheostomy
(ST) in critical care patients, with benefits in terms of cost,
ease of performance, and reduced complications.4 5 In
2000, the first description of a modification of the technique
was published (Blue Rhinow PercutaneousTracheotomy Intro-
ducer Kit; Cook Critical Care), whereby the series of dilators
was replaced with a single, sharply tapered, dilator with a
hydrophilic coating, permitting complete dilatation in one
step.6 The single tapered dilator (STD) method has largely
supplanted the sequential dilatational procedure and now
appears to be the single most common technique for per-
forming a PDT.7–9
Several authors have published PDT case series using a
variety of approaches. A number of papers have reported on
complications of the STD technique;10 11 further studies have
compared it with other PDT techniques12–14 or reported on its
use across multiple centres.15 To our knowledge, we report
the largest single-centre series solely utilizing the STD method.
Methods
This prospective service evaluation was carried out at Aintree
University Hospital (AUH). The CCU at AUH is a 19-bedded
mixed medical and surgical unit undertaking !100 PDTs per
British Journal of Anaesthesia 105 (6): 782–8 (2010)
Advance Access publication 2 September 2010 . doi:10.1093/bja/aeq238
& The Author [2010]. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournal.org
 at Liverpool University Library on April 8, 2012
http://bja.oxfordjournals.org/
Downloaded from 
year. The regional referral centre for head andneck cancer, the
largest such unit in the UK, is also situated at AUH.
The need for PDT in any individual case was determined by
the duty consultant intensivist. After the decision to proceed
with a tracheostomy, all patients were fully evaluated and
examined before operation. In all cases, when a tracheost-
omy is deemed appropriate, patients are assessed as to
their suitability for a PDT. Patients undergoing ST as part of
their surgical management for head and neck cancer were
not included in the study.
From November 2003 to October 2009, data were pro-
spectively collected on all PDTs performed at AUH. All PDTs
were performed by critical care physicians at the bedside.
All patients were over the age of 18 and each received i.v.
general anaesthesia with neuromuscular block. Each pro-
cedure was undertaken with bronchoscopic guidance to
ensure correct placement of the guidewire.
Before commencement of the procedure, the patient was
positioned with the head extended and the lungs were ven-
tilated with 100% oxygen. Throughout the procedure, heart
rate, arterial pressure, and oxygen saturation were moni-
tored continuously. After digital palpation of the neck,
direct laryngoscopy was performed to position the tracheal
tube (TT) above the site of the proposed PDT insertion
point. Local anaesthesia and vasoconstriction were achieved
using 2% lidocaine with 1:100 000 epinephrine administered
s.c. to the pre-tracheal tissues. A 1 cm horizontal skin incision
was made midway between the cricoid cartilage and the
sternal notch. Pre-tracheal tissues were separated by blunt
dissection. Tracheal puncture was performed with the
standard 15 gauge needle and, after bronchoscopic confir-
mation of the position, the guidewire was passed into the
tracheal lumen. A 4.5 cm 14 Fr gauge dilator was passed
over the guidewire after which the STD was used to expand
the tract between the skin and the tracheal lumen. The
appropriate-sized tracheostomy tube was introduced into
the tracheal lumen utilizing a loading dilator.
Perioperative data on each patient were recorded prospec-
tively and included age, sex, reason for admission, admission
APACHE II score, and intraoperative and postoperative com-
plications as detailed below.
A PDT was considered ‘technically difficult’ if one or more
of the listed events occurred during the procedure:16
(i) oxygen desaturation (,88%);
(ii) multiple attempts at tracheal cannulation (.3);
(iii) bleeding (.3 soaked swabs);
(iv) tracheal ring fracture evident on bronchoscopic
examination;
(v) posterior tracheal wall injury.
A PDT was considered to be ‘complicated’ if there was one or
more of the following:
(i) bleeding requiring surgical intervention;
(ii) presence of surgical emphysema;
(iii) malpositioning of tracheostomy tube;
(iv) pneumothorax.
Routine post-procedural chest X-rays (CXRs) were performed
after the first 384 PDTs. Thereafter, CXRs were limited to
those PDTs considered technically difficult as defined
above.16
After critical care discharge, further surveillance was pro-
vided by the AUH Critical Care Outreach Service and after
hospital discharge by the critical care follow-up clinic allow-
ing identification of late complications.
Results
During the study period, 590 CCU patients required a tra-
cheostomy. In 576 patients, a PDT was attempted, and in
572 (97%), the procedure was completed successfully
(Table 1). In four patients, PDT was abandoned due to
excess bleeding; three of these patients subsequently went
on to have an ST. Consequently, a total of 17 (3%) patients
underwent ST (Table 2). In the remaining patient, the pro-
cedure was abandoned and ST considered inappropriate
due to worsening multiple organ failure. All PDTs were under-
taken between the hours of 09:00 and 17:00 and 522 (91%)
Table 2 Rationale for opting for an ST rather than PDT (n¼17).
*Admission diagnoses for four patients with ‘Reason not specified’
for ST were pneumonia (three) and exacerbation of chronic
obstructive pulmonary disease (one)
Reason for surgical tracheostomy Number
PDT abandoned due to bleeding 3
Cervical spine fracture 3
Aberrant cervical innominate artery 2
Oesophagogastrectomy with cervical anastomosis 2
Soft tissue trauma to neck 1
Supraglottitis 1
Previous surgical tracheostomy with deep wound sinus 1
Reason not specified* 4
Table 1 Patient characteristic data of patients undergoing PDT
(n¼576). Data are mean (SD), mean (range), or numbers
(percentage)
Age (yr) 58 (18–86)
Male (%) 340 (59)
Admission APACHE II score 19 (5.6)
Emergency admissions (%) 521 (91)
Days to PDT insertion from day of admission 5 (1–21)
Days to PDT insertion from initial tracheal
intubation
4 (1–14)
Surgical patients (%) 288 (50)
Number surviving to ICU discharge (%) 395 (69)
Mean length of ICU stay non-survivors in days 18 (3–68)
Mean length of ICU stay survivors in days 20 (4–92)
Mean length of hospital stay survivors in days 42 (7–382)
Number surviving to hospital discharge (%) 360 (63)
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were performed on a weekday. Five hundred and twenty-one
(91%) procedures followed an emergency critical care admis-
sion. In 406 (71%) cases, the most senior clinician present
was a consultant. For the remainder, in 146 (26%) and 20
(3%) cases, the most senior clinician present was a senior
critical care trainee (clinical fellow) and a specialist anaes-
thetic registrar, respectively.
According to the definitions described above, technical
difficulties were encountered in 149 (26%) procedures
(Table 3). Sixteen (3%) procedures were deemed as having
early complications. These included six cases of significant
bleeding (including four where the PDT was abandoned),
four cases resulting in para-tracheal placement of the tra-
cheostomy tube, three with significant surgical emphysema,
one with a tension pneumothorax, one with significant pos-
terior tracheal wall injury, and one case where the tracheost-
omy tube was sited in the cricothyroid membrane. Four cases
(0.7%) were associated with significant late complications. Of
these, two patients developed a tracheo-innominate fistula
(TIF) and two patients developed a tracheal stenosis. In
only one of these procedures was the initial tracheostomy
regarded as being technically difficult (oxygen desaturation
and a tracheal ring fracture in a patient subsequently devel-
oping tracheal stenosis). The two patients who developed TIF
died as a result of massive haemorrhage whilst still patients
on the CCU and represent a mortality directly attributable to
PDT of 0.35%.
There were no significant differences demonstrated
between grade of operator and technical difficulties encoun-
tered when unsupervised procedures were excluded
(Table 4). Similarly, seniority of supervising clinician had no
bearing on outcome (Table 5).
Three hundred and sixty patients survived to hospital
discharge. Thereafter, 25 patients died before their
3 month follow-up appointment, 36 patients were referred
to AUH from outside our catchment area, eight patients
were transferred to long-term care facilities for ongoing
neuro-rehabilitation, and one patient remains an inpatient
at AUH. Of the remaining 290 patients, 202 were seen in
the critical care follow-up clinic, 59 have been seen in AUH
in non-critical care clinics, four have had subsequent inpati-
ent stays for conditions unrelated to their original critical
care admission, and 25 had no evidence of follow-up.
Discussion
To our knowledge, this study is the largest single-centre
evaluation of the STD technique to date. Earlier reports
of STD PDT involve smaller numbers,10 compared STD
with other techniques,12–14 were conducted in multiple
centres,15 or did not exclusively use the STD technique.11 15
The practice within our unit, for the critically ill patient requir-
ing a tracheostomy, is to almost exclusively perform PDT
(97%). Despite this high rate of PDT, only four (0.7%) pro-
cedures were abandoned with three proceeding to ST. It is
unclear from previous surveys of PDT practice as to what
the ratio between ST and PDT is across UK CCUs. Although
Krishnan and colleagues7 reported the results of a postal
survey that stated that 173 (97%) of UK ICUs primarily per-
formed percutaneous tracheostomy and only rarely, resort-
ing to open ST, the ratio of PDT:ST was not reported. The
authors also stated that clinicians would opt to perform an
ST in the settings of a difficult airway, morbid obesity, and
earlier failed PDT. In a later, similar study, Veenith and col-
leagues8 reported that 43% of UK units would perform a
PDT of .95% of the time. It is, therefore, possible that a
PDT rate of 97% is likely to be among the highest rates
encountered within the UK. It is likely that this rate is influ-
enced by the presence of the regional head and neck unit
on site. Although the head and neck unit undoubtedly pro-
vides a level of support should a PDT become complicated
this input is rarely required. We would not automatically
resort to ST in the settings of a difficult airway and morbid
Table 3 Adverse events encountered during 149 technically
difficult PDTs. Note more than one technical difficulty occurred
during some procedures, therefore the sum of technical
difficulties exceeds 149
Difficulty Number (% of all PDTs
performed, n5576)
Minor posterior wall injury 9 (1.6)
Tracheal ring fracture visible at
bronchoscopy
56 (9.7)
Multiple attempts (≥3) to
cannulate the trachea
57 (10)
Minor bleeding (3–5 small soaked
swabs)
25 (4.3)
Oxygen desaturation to ≤88% 17 (2.9)
Table 4 Technical difficulties by grade of operator; operator,
person performing PDT, that is, not supervising or being
supervised. P.0.05 Kruskal–Wallis
Grade of operator (number of
PDTs performed by grade as a
sole operator)
Technically difficult PDTs (% of
number performed by relevant
grade)
Consultant (149) 33 (22)
Fellow (151) 44 (29)
Registrar (120) 31 (26)
Table 5 Technical difficulties encountered by most senior
physician present during PDT. P.0.05 Kruskal–Wallis
Grade of most senior
physician present (number
of PDTs)
Technically difficult PDTs (% of
number performed by relevant
grade)
Consultant (406) 107 (26)
Fellow (146) 38 (26)
Registrar (20) 4 (20)
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obesity as described above. Indeed, where there is doubt
over whether to perform an ST or a PDT, the decision as to
which to proceed with would usually be a two-consultant
decision. Additionally, as a group of intensivists, much of
our practice involves head and neck patients which inevitably
leads to an awareness that factors which are known to con-
tribute to a difficult PDTare also likely to cause significant dif-
ficulties for the surgical operator.
Despite our collective willingness to take on more complex
procedures, this does not appear to have resulted in an
increase in complications. During an earlier study, assessing
the use of routine chest radiography after PDT, we described
the concept of a technically difficult but not necessarily com-
plicated tracheostomy.16 We felt that the incidence of post-
procedural CXR changes was more likely if a procedure was
technically difficult than if it were entirely straightforward.
Consequently, we have utilized the same classification for
the present study. The incidence of technical difficulties on
initial examination of our data seems high at 26%.
However, when we consider conventionally described compli-
cations, such as pneumothorax, significant bleeding, surgical
emphysema, para-tracheal placement, and posterior tra-
cheal wall injury, this figure reduces to 3% for early compli-
cations and to 0.7% for significant late complications. This
is comparable with the published literature in both rate and
type of reported complications.10 11 15 Fikkers and col-
leagues10 reported a major complication rate of 6% due to
bleeding, pneumothorax, and dilatation of a false tract.
More recently, they have quoted rates of 1.4% for s.c. emphy-
sema and 0.8% for pneumothorax.17 Our rates for the corre-
sponding complications were 0.5% (3 of 572) and 0.2% (1 of
572), respectively. Similarly, Kost15 reported a complication
rate of 6.5% with the STD technique, the most significant
being oxygen desaturation and bleeding. There were,
however, no reports of either pneumothorax or pneumome-
diastinum which she attributed to the use of fibreoptic
bronchoscopy. Although the use of fibreoptic bronchoscopy
was used for all procedures in the current study, we have
found that para-tracheal placement of the tracheostomy
tube and barotrauma still occurred. In the absence of pos-
terior tracheal wall injury, the most likely cause of the
reported surgical emphysema is the use of a tracheostomy
tube that is too short allowing air to escape into the s.c.
tissues around the stoma. For each occurrence of malposi-
tioning (excluding the case where the tube was passed
through the cricothyroid membrane), a 7.0 mm TT was
in situ. Although this allowed the passage of the broncho-
scope to visualize the catheter and guidewire entering the
trachea, effective mechanical ventilation with the broncho-
scope in position was not possible. In each of these cases,
therefore, the bronchoscope was removed after confirmation
of wire placement and re-introduced to confirm tracheost-
omy tube placement whereupon the error was detected.
We feel that this reiterates the importance of continuous
bronchoscopic guidance throughout the procedure and if
the TT is of insufficient calibre to allow ongoing mechanical
ventilation during the procedure, the TT must either be
changed before commencing the PDT or a paediatric
bronchoscope must be available.
The comparison of our data with the existing literature
becomes more difficult when considering minor compli-
cations, or technical difficulties, as many such problems are
not reported in comparable studies. Of the larger published
series,10 11 15 the reported rate of minor bleeding varies
from 1.6%11 to 14%10 compared with our rate of 4.3% (25
of 576). It is possible that the bleeding rate may be affected
by an operating technique. In our series, after skin incision,
our practice was to divide the pre-tracheal tissues by blunt
dissection in a manner similar to that described by Kost15
and as recommended by the manufacturers of the Blue
Rhinow STD (www.cookmedical.com/cc/home.do). Some
operators, however, prefer to proceed to the dilatational
phase of the PDT immediately after skin incision. In the
report by Fikkers and colleagues,10 48 patients underwent
STD PDT without blunt dissection of the pre-tracheal
tissues, whereas 52 had pre-tracheal dissection. There was
no difference in the bleeding rate between the two groups.
There was, however, a significant increase in the difficulty
of dilatation (requiring unusual force) when pre-tracheal dis-
section was not performed.
Minor posterior tracheal wall injury was only reported by
Kost15 (0.6%) and Fikkers and colleagues10 (2%) in compari-
son with our rate of 1.6%. Oxygen desaturation during PDT
was only reported by Kost15 with a rate of 2.8% (14 of 500)
almost identical to our own of 2.9% (17 of 576). None of
these authors10 11 15 has reported rates of the tracheal ring
fracture or number of attempts to cannulate the trachea.
Other authors have, however, reported rates of the tracheal
ring fracture in association with STD PDT with incidences
varying from 5.3% to 36%18–20 in comparison with our rate
of 9.7%. Such a wide variation in the reporting of tracheal
ring fracture rate is almost certainly related to how closely
this complication is sought by the bronchoscopist during
the PDT. Some authors have suggested that the incidence
of the tracheal ring fracture is higher with STD PDT when
compared with the Ciaglia technique.19 20 However, it is
likely that all clinical reporting of tracheal ring fractures rep-
resents an underestimate of the actual incidence. In a cada-
veric study of 42 patients who had had a PDT by the Ciaglia
method, Walz and Schmidt found 12 patients with tracheal
ring fractures and 10 specimens where a cartilaginous
defect was demonstrated at the tracheal stoma.21 The sig-
nificance of the tracheal ring fracture after PDT with
respect to long-term complications remains unclear. In the
paper by Higgins and colleagues,18 16 patients with tracheal
ring fractures (four after STD PDT) were followed up until a
mean time of almost 9 months after PDT. None of these
patients developed a tracheal stenosis which led the
authors to conclude that the tracheal ring fracture was not
associated with subsequent development of tracheal steno-
sis. Given the small number of patients in the study, the
likely under-reporting of tracheal ring fractures, and the
rarity of tracheal stenosis after PDT, this seems to be an over-
interpretation of the data. In the present study, one of the
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two patients subsequently developing tracheal stenosis had
a clinically evident ring fracture at the time of PDT (see
below).
Long-term follow-up of this patient cohort may initially
appear poor with only 202 patients out of a potential 360
attending the critical care follow-up clinic. Of these 360
patients, 25 died before follow-up could be arranged, 36
were transferred to AUH from other hospitals and were sub-
sequently referred back to the referring hospital for ongoing
care after discharge from the CCU, eight were transferred to
neuro-rehabilitation facilities, and one patient remains as an
inpatient at AUH. The actual number of patients, therefore,
who we could realistically expect to follow up was 290. We
have therefore managed to see almost 70% of these patients
in our follow-up clinic with a further 63 (22%) patients being
seen within the hospital in some other capacity after CCU
discharge. In only 25 of these patients was there no evidence
of follow-up. The problem facing critical care follow-up clinics
with non-attendance is well recognized. In a review of seven
studies of CCU follow-up clinics, Williams and Leslie found
that among hospital survivors who had not been on a CCU,
67% attended clinic within 8 weeks, this figure decreased
to 30% for patients discharged alive after a CCU stay.22 Non-
attendance rates for critically ill follow-up patients varied
from 10% to 30%. Placed in this context, achieving a post-
discharge review rate of close to 70% is unusual. Addition-
ally, one of the authors (T.M.J.) has a tertiary referral subspe-
cialist interest in the management of tracheal stenosis. We
are therefore confident that if any of the 36 patients repa-
triated to their base hospitals, within the locality, had sub-
sequently developed a clinically relevant tracheal stenosis,
they would have been referred back to AUH for further
management.
Reports relating to late complications after PDT in large
case series are again difficult to interpret due to the infre-
quency of most of these complications and the fact that
many studies report predominantly early complications.15
In the present series, there were four significant long-term
sequelae—two TIF and two tracheal stenoses.
Our incidence for clinically evident tracheal stenosis:
0.35% (0.6% for those surviving to hospital discharge) is
comparable with earlier series of both PDT10 11 and ST.23
The first case of tracheal stenosis was in a 41-yr-old male
requiring admission to the CCU after an episode of near
drowning. He underwent a PDT with no reported technical
difficulties or complications. The tracheostomy remained
in situ for 8 days. The second case was a 32-yr-old male
admitted after a closed head injury. During his PDT, a tra-
cheal ring fracture was noted at bronchoscopy; the pro-
cedure was otherwise complicated by a minor oxygen
desaturation. His trachea remained cannulated for a total
of 55 days. His critical care stay was complicated by a
severe hospital acquired pneumonia and acute respiratory
distress syndrome. It is likely that in the latter case, the
factor of note is the prolonged duration of cannulation. As
noted by Koitschev and colleagues,24 the incidence of tra-
cheal stenosis after PDT may be higher after prolonged
cannulation. In comparison, during the study period, we
have had one case of tracheal stenosis associated with trans-
laryngeal tracheal intubation in our unit.
Similarly, the incidence of TIF was also 0.35%. Again, in
keeping with the published literature, where the rate is
reported to be between 0.1% and 1%.25 Each of these
patients underwent essentially uneventful PDTs and was
cannulated for 10 and 12 days, respectively, before the
occurrence of their TIF.26 Since both patients with TIF
subsequently died of their complications, unlike earlier
papers, we are able to report a death rate of 0.35% directly
attributable to the PDT itself.
There remains a paucity of information pertaining to the
occurrence of uncommon but significant long-term compli-
cations after PDT. The incidence of these complications
may, at least in part, depend upon the clinical setting and
duration of tracheal cannulation.24 It is possible, in the scen-
ario of closed head injury (given the differences in incidence
of tracheal stenosis between PDT and ST) described by
Koitschev and colleagues,24 where prolonged cannulation
will be required, that ST may be the most appropriate
means of securing the airway. Given this dearth of infor-
mation relating to longer term outcome after PDT, a more
extensive audit of the role of PDT in critical care, to the stan-
dards set out by the Royal College of Anaesthetists,27 is now
justified at a national level.
Our low incidence of reported complications may also, in
part, be due to the routine PDT practice within the unit. A
majority of the current consultant body regularly anaesthe-
tize for major head and neck surgery with its attendant prob-
lems of difficult airway management. All procedures are
performed with a minimum of two experienced clinicians,
one to manage the airway (including TT manipulations and
bronchoscopy) and the other to perform the procedure. All
procedures are carried out between the hours of 09:00 and
17:00, with in excess of 90% also occurring between
Monday and Friday.
The timing of PDT in the current study is, compared with
previous work,10 11 15 somewhat early with a mean time to
PDT of 5 and 4 days from CCU admission and tracheal intuba-
tion, respectively. Our practice of early PDTmay, however, not
be too different to UK practice with Krishnan and colleagues7
reporting that 50% of units perform a tracheostomy within
the first week after admission and Veenith and colleagues8
reporting that 21% of units will perform the procedure
within 5 days.
Optimal timing of PDT in the critically ill remains a subject
of debate and considerable controversy within the literature
with the indications and timing frequently based on personal
preference.28 Indeed, even the definition of early/late tra-
cheostomy is difficult to reach consensus on.29 There would
be little doubt, however, that the vast majority, if not all, of
PDTs described herein would fit in to the early category.
Scales has recently reported the findings of a retrospective
analysis of almost 11 000 patients over a 12-yr-period,
using the Ontario health database, comparing the mortality
of early (≤10 days) vs late (.10 days) tracheostomy in
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critical care.30 They reported modest reductions in 90 day
and 1 yr mortality associated with early tracheostomy,
along with faster weaning times and more ventilator free
days. Another study in critically ill medical patients showed
that early PDT was associated with reductions in duration
of mechanical ventilation, CCU stay, morbidity, and mor-
tality.31 More recently, a meta-analysis has challenged the
positive beneficial effects of early PDT on the risk of develop-
ing pneumonia and mortality but did show a reduction in the
duration of mechanical ventilation and length of CCU stay.32
It has always been our belief that the risks of early PDT were
outweighed by the benefits accrued resulting from significant
reductions or cessation of sedative drugs leading to the
advantages described above and improved resource utiliz-
ation.33 The TracMan study in the UK reported no effects of
early tracheostomy (days 1–4) compared with late tra-
cheostomy (after day 10) on 30 day mortality.
In conclusion, we have performed the largest single-
centre evaluation of the STD PDT technique to date. It
would appear to be a relatively easy and safe technique
when performed at the bedside. The complication rates
described herein are similar to earlier reports of both PDT
and ST. When taking into account the fact that the STD
PDT was considered for all patients undergoing tracheostomy
in our unit, with no absolute contraindications and with only
four procedures being abandoned, the low complication rate
is all the more remarkable. However, further large-scale audit
on a national level is justified to fully evaluate the long-term
outcomes after PDT.
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Despite widespread adoption of the single 
tapered dilator (STD) technique for percutaneous 
dilatational tracheostomy (PDT) in critical care, 
there is uncertainty about longer-term complications, 
such as tracheal stenosis (TS). Whilst the incidence 
of TS is evident from a number of long-term cohort 
studies1–3, the issue of missed or subclinical stenoses 
KDVQRWEHHQIXOO\DGGUHVVHG1RQVSHFLÀFV\PSWRPV
are common following critical care admission 
and PDT, with frequent reports of voice changes, 
VZDOORZLQJ GLIÀFXOWLHV FRXJK DQG VKRUWQHVV RI
breath4,5. We hypothesised that in this cohort of 
patients, there were a number of patients with 
undetected TS. 
Earlier studies have attempted to identify the 
prevalence of TS following PDT using computed 
tomography (CT)4,6, magnetic resonance imaging 
(MRI)7, plain linear tomography8, spirometry with 
ÀEUHRSWLF ODU\QJRVFRS\9 RUÀEUHRSWLF ODU\QJRVFRS\
alone10. Norwood’s study4 using CT evaluation of 
tracheal anatomy after sequential dilatation PDT 
and correlation with symptoms found an incidence 
of TS of 31%, 20% of whom were symptomatic, 
but could not determine whether voice changes 
or respiratory problems were a result of critical 
illness or PDT itself. Spirometry has been variably 
described as straightforward but with unproven 
utility in detecting stenosis11 and, as unhelpful in 
detection of TS in patients after critical illness, 
ZLWK SRRU FRUUHODWLRQ EHWZHHQ VSLURPHWU\ ÀQGLQJV
and endoscopic features9. The forced expiratory 
YROXPH LQRQH VHFRQG WRSHDN H[SLUDWRU\ÁRZ UDWH
ratio (FEV1:PEFR) was demonstrated by Empey to 
be useful in distinguishing upper airway obstruction 
from lower airway disease but has not been widely 
adopted12. 
Despite the above attempts to delineate tracheal 
post-PDT changes, there are limited data pertaining 
to STD PDT. Although Fikkers et al used MRI to 
evaluate long-term outcome, only 14 STD patients 
were evaluated7. We believe the present study is 
the largest to exclusively radiographically evaluate 
tracheal changes following STD PDT in an attempt 
WREHWWHUGHÀQHWKHSUHYDOHQFHRIVXEFOLQLFDO76
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Tracheal stenosis following percutaneous dilatational trache-
ostomy using the single tapered dilator: an MRI study
E. YOUNG*, R. PUGH†, R. HANLON‡, E. O'CALLAGHAN§, C. WRIGHT**, P. JEANRENAUD††, 
T. M. JONES‡‡, G. A. DEMPSEY§§
Department of Critical Care, Aintree University Hospital NHS Foundation Trust, Liverpool, United Kingdom
SUMMARY
Despite widespread adoption of percutaneous dilatational tracheostomy within the critical care setting, there 
is still uncertainty regarding long-term complications, particularly in relation to missed or subclinical tracheal 
stenosis. In this study, all patients underwent tracheostomy using a single tapered dilator  three months prior to 
enrolment and were evaluated using magnetic resonance imaging, spirometry and questionnaire. Tracheal area 
was recorded and deemed to be stenotic if a reduction of 10% was found. Fifty patients underwent magnetic 
resonance imaging and 49 attended for interview. Five patients were diagnosed with tracheal stenosis—none 
were symptomatic. Six of the 50 tracheostomies were technically difficult. Spirometry was not predictive of 
stenosis. A post critical care exercise tolerance of less than 100 metres was found in four tracheal stenosis 
patients. The prevalence of subclinical tracheal stenosis following percutaneous tracheostomy is low, with 
limited clinical significance. No patients required corrective surgery for tracheal stenosis. Routine airway follow-
up in asymptomatic patients appears to be unwarranted.
Key Words: tracheostomy, percutaneous, dilatational, complications, critical care 
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MATERIALS AND METHODS
This prospective cohort study was carried out 
at Aintree University Hospital NHS Foundation 
Trust (AUH). The critical care unit at AUH is a 23-
bed, mixed medical and surgical unit undertaking 
approximately 80 to 100 PDTs per year. The regional 
referral centre for head and neck cancer, the largest 
such unit in the United Kingdom, is also situated at 
AUH.
A database of all patients receiving PDT, including 
associated outcome data, undertaken within the 
critical care unit at AUH has been kept since 2003. All 
PDTs are performed by critical care physicians at the 
bedside using the STD technique with bronchoscopic 
guidance. All patients were over the age of 18 and 
each received intravenous general anaesthesia with 
neuromuscular blockade during the procedure. 
Following ethical approval (Liverpool [UK] 
Research Ethics Committee: Reference No. 08/
H1005/121), patients surviving for a minimum of three 
PRQWKV IURP WKH LQVHUWLRQ RI 3'7 ZHUH LGHQWLÀHG
from the database. Cross-referencing with the AUH 
clinical records system (System C Medway Sigma, 
Maidstone, UK) and information provided from 
contact with the patient’s general practitioner, when 
UHTXLUHGFRQÀUPHGZKHWKHUSDWLHQWVZHUHVWLOODOLYH
They were then contacted by telephone, informed of 
the nature of the study and invited to AUH to complete 
a simple questionnaire and undergo spirometry and 
MRI scanning (Figure 1).
Following written informed consent, background 
data including age, sex, admission illness severity 
(Acute Physiology and Chronic Health Evaluation 
[APACHE] II), duration of orotracheal intubation 
SULRUWR3'7FRPSOLFDWLRQVDQGWHFKQLFDOGLIÀFXOWLHV
during PDT3, duration of cannulation and length of 
critical care and hospital stay were collected. A PDT 
was considered complicated if there were one or more 
WHFKQLFDOGLIÀFXOWLHVPXOWLSOHWUDFKHDOSXQFWXUHV>
three], tracheal ring fracture, minor bleeding [> three 
VRDNHG JDX]H VZDEV@ RU VLJQLÀFDQW FRPSOLFDWLRQV
(pneumothorax, subcutaneous emphysema, 
major bleeding  [need for surgical intervention 
or transfusion]). A Health Status Screening 
Questionnaire (Appendix 1) was devised and used 
to ascertain evidence of pre-existing respiratory 
disease, respiratory symptoms after critical care 
and current exercise tolerance. Simple spirometry 
was then undertaken using a micro-loop spirometer 
(CareFusion Health UK 232 Ltd, Basingstoke, United 
Kingdom) to obtain values for forced expiratory 
volume in 1 second (FEV1 SHDN H[SLUDWRU\ ÁRZ
rate (PEFR) and forced vital capacity. The best of 
three readings obtained were used to calculate the 
FEV1:PEFR ratio. This constitutes the Empey Index 
FiGuRe 1: Recruitment to study. MRI=magnetic resonance imaging.
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(EI) (EI=FEV1:PEFR) and previous data have 
UHSRUWHGDUDWLR!WHQWREHFOLQLFDOO\VLJQLÀFDQW12.
MRI scanning was undertaken using a Siemens 
MAGNETOM 1.5 T Avanto scanner (Providian 
Medical Equipment LLC, Willowick, OH, USA). 
A T2-weighted coronal scan using 5 mm slices was 
FDUULHGRXWDORQJZLWKD7ÁDVKVDJLWWDO'YROXPH
scan with 1 mm slices. Multiplanar reformats were 
constructed from the volume scan in the axial and 
coronal planes. All sequences included the trachea 
from the inferior border of the cricoid cartilage to the 
carina. All images were reviewed by a single consultant 
radiologist, unaware of the clinical details of the 
patient pertaining to the PDT. Coronal and sagittal 
measurements were reported at the narrowest section 
of the trachea at or above the level of the tracheostomy 
and compared to normal tracheal dimensions above 
or below the abnormality. Tracheal cross-sectional 
area (TCSA) at each level was calculated using the 
Picture Archiving and Communications System 
(PACS) (CARESTREAM Vue PACS, Carestream 
+HDOWK ,QF 5RFKHVWHU 1< 86$ $ VLJQLÀFDQW
stenosis amounting to a reduction in the TCSA of 
10% or more when compared to normal trachea 
DERYH RU EHORZ WKH DEQRUPDO VHJPHQW ZDV GHÀQHG
as TS for the purpose of this study in common with 
previous, similar studies4,8,9$OOSDWLHQWVZLWKLGHQWLÀHG
TS on MRI were then referred to a consultant head 
and neck surgeon for further evaluation. In these 
cases, each patient was initially investigated with 
ÀEUHRSWLF ODU\QJRWUDFKHRVFRS\ FRQWLQXLQJ WR ULJLG
tracheobronchoscopy under general anaesthesia if 
this was considered necessary.
Statistical analysis
Data were analysed initially using Microsoft® 
Excel software (Redmond, WA, USA). GraphPad 
(GraphPad Software Inc., La Jolla, CA, USA) was 
used to carry out Fisher’s exact test for categorical 
data and Mann–Whitney U tests for continuous 
data. A P-value of <0.05 was considered statistically 
VLJQLÀFDQW
RESULTS
At the time of the study, the database contained 
745 patients who had undergone STD PDT more 
than three months previously. Four hundred and 
eighty-three of these patients survived to hospital 
discharge. A further 178 died within six months 
of hospital discharge, leaving 305 eligible for 
inclusion. One hundred and twenty patients were 
contacted by telephone. Seventy patients declined 
the invitation or were unable to attend for MRI 
scanning, including 11 who failed to present for 
pre-arranged appointments. The remaining 50 
patients underwent MRI (Figure 1). Of these, 49 
also attended for interview, during which a stan- 
dardised questionnaire was completed (Appendix 1).
Of the 50 patients who underwent MRI scanning, 
ÀYH SDWLHQWV   &,  WR  ZHUH
diagnosed with TS as per the study criteria. Patient 
characteristics of those with and without TS (TS: nTS) 
and non-attenders are presented in Table 1. Median 
reduction in TCSA for those with TS was 30% with 
individual stenoses documented as 16%, 24%, 30%, 
38% and 46% respectively (Table 2). There were no 
differences between the groups with respect to age, 
sex, illness severity, number of days of orotracheal 
intubation prior to PDT insertion or time from PDT 
to MRI scan. The difference in median duration 
of cannulation of 15 days in the TS group and nine 
GD\V LQQRQ76JURXSZDVQRW VWDWLVWLFDOO\ VLJQLÀFDQW
Table 1
Characteristics of patients with TS compared to those without and 
patients declining the invitation to attend for MRI scanning
Stenosis 
(n=5)
No stenosis 
(n=45)
Non-attenders 
(n=70)
Age, median 
(IQR), years
51 (39–59) 58 (48–72) 58 (42–67)
Male, n (%) 2 (40) 26 (58) 45 (64)
Admission 
APACHE II 
score, median 
(IQR)
14 (14–15) 16 (14–19) 16 (13–21)
Orotracheal 
intubation prior 
to PDT, days, 
median (IQR)
4 (4–5) 4 (2–5) 4 (3–5)
Duration of 
cannulation, 
days, median 
(IQR)
15 (12–21) 9 (6–15) 15 (11–23)
Time from 
decannulation 
to MRI, months, 
median (IQR)
22 (12–58) 24 (10–45) __
Perioperative 
complications, 
n (%)
4 (80)* 2 (4)* 22 (31)
Bleeding 1 (20) 0 (0) 4 (6)
Multiple tracheal 
punctures
2 (40) 1 (2) 9 (13)
Tracheal ring 
fracture
1 (20) 1 (2) 9 (13)
*P=0.002 Fisher’s exact test. TS=tracheal stenosis, MRI=magnetic 
resonance imaging, IQR=interquartile range, APACHE=Acute 
Physiology and Chronic Health Evaluation, PDT=percutaneous 
dilational tracheostomy. 
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(P=0.17).
Overall, six of the 50 PDTs were complicated as 
GHÀQHGDERYH)RXURIWKHÀYHSDWLHQWVGLDJQRVHGZLWK
TS in comparison with two of 45 without, underwent 
complicated STD PDT (Table 1). When complications 
were considered individually, patients with TS may be 
more likely to have had multiple attempts at tracheal 
puncture (2/5 versus 1/45) but there was no apparent 
difference between the groups in relation to tracheal 
ring fracture (1/5 versus 1/45) or minor bleeding (1/5 
versus 0/45) rates.
Results from the questionnaire revealed no 
differences in the presence of voice changes (2/5 
versus 16/45) and shortness of breath (4/5 versus 
17/45) between those with TS and those without. Two 
patients reported the presence of inspiratory noise 
– neither were found to be stridulous or have TS on 
MRI scaning. Data pertaining to exercise tolerance 
was provided by 44 patients (5 TS and 39 nTS). Four 
RI WKH ÀYH SDWLHQWV ZLWK 76 UHSRUWHG DQ H[HUFLVH
tolerance of 100 m or less, two of whom reported 
unlimited exercise tolerance prior to critical care 
admission. In contrast, nine of the 39 nTS patients 
(23%) reported an exercise tolerance of 100 m or less. 
Mean values for FEV1, PEFR and EI are shown in 
Table 1. Neither FEV1, PEFR nor EI were predictive 
of TS. 
7KH ÀYH SDWLHQWV IRXQG WR KDYH 76 RQ 05,
scanning were referred to a consultant head and 
neck surgeon for further evaluation and to assess the 
QHHGIRUDGGLWLRQDOLQWHUYHQWLRQ$WLQLWLDOÀEUHRSWLF
ODU\QJRWUDFKHRVFRS\WKUHHRIWKHÀYHZHUHGHHPHGWR
have an adequate airway and further intervention was 
deemed unnecessary. The remaining two underwent 
rigid tracheobronchoscopic examination under 
general anaesthesia and were again found to have 
an adequate airway. It was felt that further surgical 
LQWHUYHQWLRQ ZRXOG QRW VLJQLÀFDQWO\ LPSURYH WKH
airway, in a clinically meaningful way, in any of the 
ÀYHSDWLHQWVZLWK76
DISCUSSION
:HKDYH IRXQGD76 UDWHRI  LQÀIW\SDWLHQWV
investigated, ranging from a 16% to 46% reduction 
LQ 7&6$ $OO SDWLHQWV ZLWK 76 KDG ÀEUHRSWLF
ODU\QJRWUDFKHRVFRSLF HYDOXDWLRQ DQG WZR RI WKH ÀYH
had rigid tracheobronchoscopy. No patient required 
any therapeutic intervention and all were felt to have 
an adequate airway and were discharged from further 
follow-up. The low incidence and the subclinical 
nature of the stenoses is reassuring, indicating the 
underlying prevalence of undiagnosed TS in patients 
IROORZLQJ67'3'7LVRIGRXEWIXOFOLQLFDOVLJQLÀFDQFH
There are limited studies in the literature reporting 
long-term follow-up of PDT patients using radiological 
imaging (CT/MRI), with very few studying tracheal 
calibre in patients who have had STD PDTs, even 
though this is now probably the most frequently used 
technique13–15. The 10% rate of TS described herein 
was less than that found in another MRI study7. 
Fikkers et al compared long-term outcome of patients 
randomly allocated to either guide-wire dilating 
forceps or STD PDTs. Sixty patients were assigned to 
each group, 31 patients underwent MRI scanning (14 
patients in the STD group), with 12 (39%) showing 
tracheal narrowing. Whilst the absolute number of 
patients with tracheal narrowing demonstrated by 
Fikkers et al is larger than our own, the degree of 
stenosis is similar in that all cases were felt to be of 
limited clinical consequence.
Two further studies utilised CT assessment. 
Norwood et al4 studied 100 patients who had 
undergone PDT using the sequential dilators of the 
original Ciaglia technique (CPDT)16. Forty-eight of 
these patients underwent CT scanning. Fifteen (31%) 
patients were found to have more than 10% TS on CT 
 Table 2
TS, spirometric and questionnaire data
Tracheal stenosis 
(n=5)
No tracheal 
stenosis (n=45)
Tracheal measurements 
median
Reduction in tracheal 
cross sectional area (%) 
(range)
30 (16–46) —
Pulmonary function tests 
(median, IQR) 
FEV1, l 2.06 (1.69–2.52) 2.3 (1.77–2.84)
PEFR, l/minute 235 (219–249) 337 (222–427)
FVC, l 2.42(1.89–3.27) 3.06 (2.52–3.49)
Empey index 7.96 (7.19–9.4) 6.89 (6.08–8.28)
Empey index >10, n 
(%)
1 (20%) 3 (7%)
Pre-ICU exercise 
tolerance 100 m or less, 
n (%)
1 (20%) (n=5) 4 (10%) (n=39)
Post-ICU exercise 
tolerance 100 m or less, 
n (%)
4 (80%)* (n=5) 9 (23%)* (n=39)
Voice change, n (%) 2 (40%) 16 (38%)
Shortness of breath 
reported, n (%)
4 (80%) 17 (40%) 
*P=0.022 Fisher’s exact test. TS=tracheal stenosis, 
IQR=interquartile range, FEV1=forced expiratory volume in 
1 second, PEFR=peak expiratory flow rate, FVC=forced vital 
capacity, ICU=intensive care unit.
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with ten (21%) of these being mild (tracheal narrowing 
of 11% to 25%), four (8%) moderate (26% to 50% 
narrowing) and one (2%) severe (>50% narrowing). 
In Karvandian et al’s study, 20 patients were assessed 
XVLQJ &7 DQG ÀEUHRSWLF ODU\QJRWUDFKHRVFRS\ DIWHU
CPDT6. Only three of the 20 patients had cannulation 
times of less than three weeks (none of whom had 
76DQGKDGVLJQLÀFDQWVXEJORWWLFVWHQRVLV
with <50% narrowing). The study group appeared 
different from our own, with a mean duration of 
cannulation of nine weeks. Additionally, 54 of 86 
patients surviving four months after discharge from 
hospital required permanent or long-term mechanical 
ventilation. 
van Heurn et al described a TS prevalence of 
26% in a study of 54 patients undergoing plain 
linear tomography following CPDT8. Law et al used 
VSLURPHWU\ DQG ÀEUHRSWLF ODU\QJRWUDFKHRVFRS\
without any radiological assessment in 41 patients 
after CPDT9. Three patients were found to have 
tracheal narrowing of between 10% and 30% and one 
with a 40% stenosis. After a median cannulation time 
of 20 days, a 10% rate of TS was reported. 
The 10% rate of TS we describe is at the lower end 
of incidences reported above (10% to 85%). Part 
of this difference may be accounted for by differing 
GHÀQLWLRQVRIWUDFKHDOVWHQRVLV+RZHYHUWKHGHÀQLWLRQ
of TS as tracheal narrowing of >10% is common to 
most of the studies cited above, with only Fikkers et 
al7 and Karvandian et al6QRWVSHFLÀFDOO\VWDWLQJWKHLU
GHÀQLWLRQRI767KHGLIIHUHQFHPLJKWDOVRSDUWO\EH
attributed to shorter tracheal cannulation times. In 
each of the studies described above, the duration of 
tracheal cannulation was longer than that described 
in our study (15 days in the TS group and nine days 
in the nonTS group). Cannulation times ranged from 
18 days in Fikkers et al’s guide-wire dilating forceps 
group7 to nine weeks in Karvandian et al’s paper6. 
Those studies reporting a lower prevalence of TS or 
only minor tracheal changes appear to have shorter 
cannulation times7,9. A further consideration to take 
into account is the duration of tracheal intubation 
prior to the insertion of PDT. PDT was carried out 
early in our patients (median four days), whereas 
previous studies have reported durations from 7 to 
18 days4,7–9. Another factor to be considered is the 
PDT insertion technique used. Most of the studies 
described above have used CPDT with only Fikkers 
et al7 evaluating guide-wire dilating forceps and 
STD techniques radiologically, and then in only 15 
and 14 patients respectively. It is possible, given the 
paucity of data available, that the incidence of post 
3'776PD\GLIIHU VLJQLÀFDQWO\ EHWZHHQ FRPPRQO\
used techniques. Considering the widespread use of 
these techniques, the lack of long-term radiological 
outcome data would appear somewhat surprising.
The TS patients appear more likely to have 
XQGHUJRQH D FRPSOLFDWHG RU WHFKQLFDOO\ GLIÀFXOW
PDT compared to the nonTS group (Table 1). The 
PRVW IUHTXHQW GLIÀFXOW\ HQFRXQWHUHG ZDV WKH QHHG
for multiple tracheal punctures to the site required 
by the cannula for guided-wire insertion. Whilst the 
VLJQLÀFDQFHRIWKLVÀQGLQJLVXQFOHDUWKHDVVRFLDWLRQ
between multiple tracheal punctures and later tracheal 
narrowing has not been made previously. It is possible 
that several attempts to position the cannula may 
ultimately lead the operator to settle for a suboptimal 
position for the tracheostomy tube, potentially causing 
tracheal injury and later narrowing. 
As all cases of TS detected were clinically 
asymptomatic, with none requiring surgical 
FRUUHFWLRQ LW LV GLIÀFXOW WR H[SODLQ WKH VLJQLÀFDQFH
and relevance of the reduced exercise tolerance 
IRXQG LQ WKHVH SDWLHQWV IRXU RXW RI ÀYH UHSRUWLQJ
VLJQLÀFDQWO\OLPLWHGH[HUFLVHWROHUDQFHWZRRIZKRP
had previously been unlimited). Conventionally, TS 
is expected to become evident clinically when the 
tracheal narrowing reaches 50% to 75%. However, 
many critical care survivors are likely to have 
VLJQLÀFDQW LPSDLUPHQW RI FDUGLRUHVSLUDWRU\ DQG
neuromuscular function. It is possible, in the setting 
of such limited physiological reserve, that post critical 
care patients may be symptomatic at lesser degrees 
of tracheal narrowing than would usually be the case. 
8QGHUQRUPDOFLUFXPVWDQFHVIRUJDVWRÁRZWKURXJK
the trachea a pressure gradient exists to overcome the 
resistance of the respiratory system. Flow within the 
trachea is usually turbulent and in such conditions the 
resistance is inversely related to r5,17. Therefore, the TS 
patient has to generate a greater pressure gradient to 
overcome this added resistance. Consequently, for the 
post critical care patient, the symptoms of the TS may 
EHPRUHLQNHHSLQJZLWKVLJQLÀFDQWIDWLJXHWKDQWKRVH
usually associated with upper airway obstruction. 
The principal limitations of the current study are 
sample size, as discussed above, and patient selection 
in that the study population may have self-selected 
WR VRPH H[WHQW EHLQJ OLPLWHG WR WKRVHZKRZHUH ÀW
enough to travel to hospital to take part in the study. 
Rates or severity of TS might be greater in those 
patients unable to come to hospital. Conversely, 
those who were well enough to have returned to full-
time employment may not have been contactable 
E\ WHOHSKRQH DW KRPH GXULQJ RIÀFH KRXUV VR PD\
have been missed. We were, however, unable to 
demonstrate any differences in patient characteristics 
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between those attending for scans and those unable 
to do so (Table 1). Additionally, we are unaware of 
the cause of death in those patients surviving their 
critical care stay but dying prior to an invitation 
to attend for scan. It is possible some of these 
patients may have had some degree of upper airway 
obstruction. Given that our institution houses the 
regional head and neck service, and such patients 
would have been referred back should they develop 
airway obstruction, this seems less likely. 
Our initial intention was to assess 60 patients 
IROORZLQJ 67'3'7 VSHFLÀFDOO\ UHFUXLWLQJ  DIWHU
uncomplicated procedures, 20 after PDT complicated 
by tracheal ring fracture and a further 20 after more 
than 14 days cannulation. The incidences of ring 
fracture and of cannulation for more than 14 days 
were too low for the original aim to be achievable. 
Consequently, we recruited 50 eligible patients from 
the database. Whilst we were unable to study these 
factors as initially intended, analysis of the limited 
data obtained would appear to suggest that tracheal 
ring fracture is not obviously implicated in TS. Data 
pertaining to the length of tracheal cannulation may 
indicate a possible relationship between prolonged 
cannulation and TS (nTS nine days versus 15 days 
76 EXW WKLVZDV QRW VWDWLVWLFDOO\ VLJQLÀFDQW:KLOVW
ZH FRXOG QRW GHPRQVWUDWH D VWDWLVWLFDOO\ VLJQLÀFDQW
association between duration of cannulation and TS, 
further studies with larger numbers may be able to 
do so. Such studies are likely to be confounded by 
differences in timing of PDT between institutions. 
The long follow-up required to detect post 
tracheostomy tracheal stenosis would be another 
limiting factor, as would cost—particularly if only 
10% of cases prove positive for TS which then may 
EHUHJDUGHGWRKDYHOLPLWHGFOLQLFDOVLJQLÀFDQFH
We have demonstrated a lower rate of subclinical 
stenosis in patients following STD PDT than has 
previously been reported. Whilst we considered 
that functional limitation in such patients following 
critical care discharge may be in part due to an 
underlying prevalence of TS, this would appear not 
to be the case. Those stenoses found were felt to be 
RI GRXEWIXO VLJQLÀFDQFH ZLWK QR SDWLHQWV UHTXLULQJ
corrective surgery, and all ultimately discharged from 
further follow-up. Routine radiological imaging and 
spirometry following STD PDT would appear to be 
unwarranted in asymptomatic patients.
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 PaƟent sƟcker Outpatient appointment date: __/___/__ 
Date of critical care admission: __/___/__ 
Date first intubated: __/___/__ 
No. extubations pre-tracheostomy: ________ 
 Date of percutaneous tracheostomy: __/___/__ 
 Date of decannulation: __/___/__ 
Dates of re-cannulation (if applicable):  
______________________________________________________________ 
Complications of 
tracheostomy: 
___________________________________________________________
____ 
Pre-existing respiratory 
disease 
  
Smoking history: _________ pack years                Still smoking:   Y/N 
Established COPD:   Y/N   
Other respiratory disease: 
_______________________________________ 
 
Pre-ITU spirometry: FEV1_____________l                 FVC________________l 
Pre-ITU Exercise tolerance on flat:_____m                  Limiting 
factor:  
 
Current symptoms   
Change in voice : Y/N  
Short of breath: Y/N Exertion/rest 
Stridor Y/N Exertion/rest 
Exercise tolerance on flat: ______m Limiting factor: 
Other (difficulty expectorating? difficulty swallowing? problematic scar?): 
Examination   
Scar: Not visible/Acceptable/Disfiguring/Tethering 
Short of breath: Y/N Exertion/rest 
Stridor: Y/N Exertion/rest 
Spirometry 
Measured values Calculated values 
 1. 2. 3. Best  
FIF50     
FEF50     FEF50/ FIF50  
FEV1     FEV1/PEFR  
PEFR      
FVC     FEV1/FVC  
NB. Any one of: FIF50 <100 l/minute, FEF50/FIF50 1, FEV1/PEFR >10l/ml per minute. 
 
appeNdix 1: assessMeNt oF tRaCheal steNosis FolloWiNG peRCutaNeous tRaCheostoMy
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Objectives: The prevalence and impact of longer-term outcomes 
following percutaneous tracheostomy, particularly tracheal steno-
sis, are unclear. Previous meta-analyses addressing this problem 
have been confounded by the low prevalence of tracheal stenosis 
and a limited number of studies.
Design: Embase, PubMed-Medline, and the Cochrane Central 
Register of Clinical Trials were searched to identify all prospective 
studies of tracheostomy insertion in the critically ill. To reflect con-
temporary practice, the search was limited to studies published 
from 2000 onward. We scrutinized the bibliographies of returned 
studies for additional articles. Meta-analyses were undertaken to 
estimate the pooled risk difference of tracheal stenosis, bleeding, 
and wound infection comparing different techniques.
Measurements and Main Results: We identified a total of 
463 studies, 29 (5,473 patients) of which met the inclusion crite-
ria. Nine were randomized controlled trials, six were nonrandom-
ized comparative studies, and 14 were single-arm cohort studies. 
Risk of wound infection was greater for the surgical tracheostomy 
than for the Ciaglia multiple dilator technique, pooled risk differ-
ence 0.12 (95% CI, 0.02–0.23). We did not identify significant 
risk differences in other meta-analyses. Pooling across all studies 
according to the random-effects proportion meta-analysis sug-
gests a higher prevalence of tracheal stenosis, wound infection, 
and major bleeding for surgical tracheostomies.
Conclusions: Considering comparative data, there was no sig-
nificant difference in the prevalence of tracheal stenosis or major 
bleeding between percutaneous and surgical tracheostomy. In 
relation to wound infection, we have found a reduction associ-
ated with the original Ciaglia technique when compared with that 
with the surgical tracheostomy. Considering all published data 
reporting long-term outcomes pooled proportion meta-analysis 
indicates a trend toward a higher rate of tracheal stenosis and an 
increased risk of major bleeding and wound infection for surgical 
tracheostomies. This finding may be biased as a result of tar-
geted patient selection, and further, high-quality long-term com-
parative data are needed to confirm these findings. (Crit Care 
Med 2015; XX:00–00)
Key Words: complications: tracheal stenosis, infection, bleeding; 
critical care: systematic review; tracheostomy: surgical, percutaneous
Percutaneous dilatational tracheostomy (PDT) has become widely adopted in critical care units (CCUs) since Ciaglia first described the dilatational technique 
(1). Since then multiple percutaneous techniques have been 
described, introduced, and widely evaluated in compari-
son with both each other and surgical tracheostomy (ST). 
Although the short-term complications of these techniques 
are well described, the prevalence and impact of longer-term 
outcomes, particularly tracheal stenosis (TS), are unclear. Pre-
vious meta-analyses have attempted to address this problem 
but have been confounded by the low prevalence of TS and, in 
particular, the limited number of studies reporting long-term 
outcomes (2–6).
On examination of current evidence, a meta-analysis pub-
lished by Delaney et al (2) found a significantly decreased rate 
of wound infection after all commonly performed percutane-
ous techniques when compared with ST. In addition, there 
were reductions in mortality and bleeding in patients under-
going percutaneous tracheostomy in the CCU as opposed to 
ST in the operating theatre. Higgins and Punthakee (3) also 
reported a tendency toward a reduction in overall complica-
tions for percutaneous procedures. In contrast, Oliver et al (4) 
found an increased prevalence of minor early complications 
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associated with percutaneous techniques but insufficient evi-
dence to suggest a difference in late complications of poor cos-
metic results and tracheocutaneous fistulae. Cabrini et al (5) 
found that the six percutaneous techniques analyzed (Ciaglia 
multiple dilator method [CPDT], guide wire dilating forceps 
[GWDF], single tapered dilator [STD], translaryngeal trache-
ostomy [TLT], balloon dilator [BD], single step rotational dila-
tor [SSRD]) were largely comparable with the exception of the 
TLT, which was associated with an increased conversion rate 
to ST or other percutaneous technique and more severe early 
complications. They also found that the STD was associated 
with fewer complications and failures. In a later analysis, the 
same authors reported less operative bleeding and fewer tech-
nical difficulties associated with the STD technique than those 
associated with the GWDF technique (6).
The meta-analyses described above included only random-
ized controlled trials (RCTs). The only exception was the anal-
ysis by Oliver et al (4), which also included nonrandomized 
prospective studies. The largest single study incorporated into 
the previous analyses comprised 346 patients (7). It is perhaps 
unsurprising, therefore, that none of the previous meta-analy-
ses have reported differences in TS rates. The exact prevalence 
of TS following tracheostomy procedures in the critically ill is 
difficult to quantify due to the associated mortality of critical 
illness, the subclinical nature of many stenoses and the diffi-
culty maintaining follow-up of these cohorts. From a number 
of prospective cohort series, it would appear that subclinical 
disease is found in around 10% of survivors (8) with clinically 
evident lesions presenting in 0–0.35% (9–11).
Despite its low prevalence, TS causes significant ongoing 
morbidity and healthcare costs associated with its manage-
ment. The management of choice for TS has been segmental 
tracheal resection since Grillo (12) and Pearson et al (13) dem-
onstrated good outcomes. However, in some patients, stenoses 
may not be amenable to surgery. Management of such patients 
presents a challenge; alternative treatments include endoscopic 
dilatation, laser ablation, tracheal stenting, and cryosurgery 
(14). These interventions may temporarily alleviate the symp-
toms of TS but as restenosis is a frequent occurrence repeated 
procedures are often necessary. Given this associated mor-
bidity and the cost associated with the management of TS, a 
clearer picture of the risk associated with each tracheostomy 
technique performed within the critical care setting is required.
There is little direct evidence for the association of any peri-
operative complications with the etiology of TS. In a study, 
predating the widespread introduction of PDT, assessing the 
impact of prolonged tracheal intubation and tracheostomy, 
Stauffer et al (15) identified a high prevalence of complica-
tions associated with ST (36% for stomal bleeding, 36% for 
stomal infection) and a 65% TS prevalence. Despite a number 
of moderate-sized case series from tertiary centers reporting 
of the management of TS, none have specifically looked at the 
role of perioperative events in the initiation of TS (16–19). 
The only perioperative event that has been postulated to have 
a role in the genesis of TS is tracheal ring fracture. Although a 
number of authors (19–21) have suggested that tracheal ring 
fracture may be of significance, this is not necessarily borne 
out within large cohort studies (9). Further studies have con-
sidered a role for infection in the initiation of TS. In an animal 
model of TS, Squire et al (22) inoculated the tracheas of rab-
bits with Staphylococcus aureus. When compared with those 
without bacterial inoculation, the prevalence of TS was higher 
and the resultant lesions narrower. In addition, Welkoborsky 
et al (23) examined operative specimens removed from 18 
patients undergoing surgical resection for TS and felt infection 
at the stenotic segment played a part in its initiation in four 
patients. Despite this work and evidence to suggest a greater 
prevalence of stomal infections for ST than for PDT (2), there 
is no evidence that the prevalence of TS differs between the 
two techniques or that antimicrobial treatment reduces the 
prevalence of TS.
Despite this lack of direct evidence for the association of 
perioperative events with the development of TS, we postu-
lated that some complications maybe surrogate markers for a 
more severe tracheal injury at the time of tracheostomy and 
thus affect the healing process. When considering such prob-
lems, it is possible that many of the events listed in Appendix 
1 may lead the operator to settle for suboptimal tracheostomy 
tube positioning, which may have an impact on later healing 
or predispose to infection. We, therefore, felt that the role such 
factors may play in the initiation of TS was worthy of further 
study.
Therefore, we performed a systematic review of all prospec-
tive studies that reported long-term outcomes and assessed 
potential predisposing factors. Our aim was to determine 
whether longer-term complication rates, with particular refer-
ence to TS, differed between percutaneous and ST techniques 
in the critical care setting.
METHODS
Search Strategy
We searched Embase, PubMed-Medline, and the Cochrane 
Central Register of Clinical Trials for prospective studies 
involving humans in the critical care setting that reported 
tracheostomy outcome data and included patients who had 
received at least one PDT either alone or in comparison with 
ST or another percutaneous technique. To reflect contempo-
rary practice, we limited the search to studies published from 
the year 2000 onward. The search was restricted to full-text 
reports of articles published in English in peer-reviewed jour-
nals. In addition, reference lists of those studies returned in the 
above search were scrutinized for additional relevant articles.
Study Selection
Titles and abstracts of the references obtained were reviewed 
by three independent reviewers (G.A.D., B.M., C.H.). Studies 
were categorized as for inclusion, possible inclusion and exclu-
sion. In the absence of a decision by two investigators to exclude 
an article, data extraction of full-text articles was undertaken 
by two of the three reviewers independently. Discrepancies 
between reviewers prompted a re-evaluation of the article. 
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Ongoing disagreement was resolved by the third reviewer. If 
the outcome data in the original article were unclear, the cor-
responding author was contacted for clarification. Our proto-
col relating to study selection and data extraction is published 
on http://www.crd.york.ac.uk/PROSPERO/display_record.
asp?ID=CRD42014008830
Data Extraction and Outcomes
A database was constructed to incorporate outcomes common 
to previous systematic reviews of percutaneous tracheostomy 
(additional parameters not presented in the main text of this 
article can be found in Appendix 1). Outcomes were defined 
a priori. The primary outcome was TS. Secondary outcomes 
were wound infection requiring treatment and bleeding (major 
and minor). Additional data were extracted but not included 
within the main text of this article due to space restrictions 
(Appendix 1).
Internal Validity and Risk of Bias Assessment
The internal validity and risk of bias for RCTs was assessed 
using the Oxford Quality Scoring System (Jadad Score) (24). 
The score is based on randomization (0–2 points), blinding 
(0–2 points), and withdrawals/dropouts (0–1 point). Studies 
scoring less than 3 are considered to be of low quality (25). 
Nonrandomized cohort studies were assessed using the New-
castle-Ottawa Scale score for cohort studies (26). The scale 
assesses patient selection (0–4 stars), comparability of patient 
cohorts (0–2 stars), and outcomes (0–3 stars). Responses indi-
cating high quality earn a star resulting in a maximum possible 
quality summary score of 9. Assessments were undertaken and 
confirmed by two independent reviewers. There is a lack of 
formal assessment tools for observational studies; therefore, no 
assessments were performed on the single-arm observational 
studies.
Data Analysis
For each complication, we calculated the risk difference (RD) 
and 95% CI in each study that had compared two or more 
techniques. Studies that specifically reported that no events 
of a particular type had occurred were included in analyses 
as zero events. The RD was used as the measure of effect as 
the data were sparse in many studies, and we wanted to ensure 
that studies with zero events in both arms contributed to meta-
analyses. We used a random-effects meta-analysis to pool the 
RD across multiple studies (27). Analyses were performed in 
STATA version 9.2 (Stata Statistical Software 2005: Release 9; 
Stata LP, College Station, TX).
As we were interested in estimating the complication risks 
associated with each technique, we calculated the proportion 
of total patients with a complication and 95% CI in each study 
that provided data for a particular technique. Proportions 
were first transformed via the Freeman-Tukey double arcsine 
method (28), which were then pooled using random-effects 
meta-analysis (27). Analyses were performed in StatsDirect sta-
tistical software version 2.7.9 (2013; StatsDirect, Altrincham, 
Cheshire, England).
We assessed statistical heterogeneity through visual inspec-
tion of the forest plot and interpretation of the I2 statistic (per-
centage of variation across studies that is due to heterogeneity 
rather than chance) (29) and the Cochrane Q test. Where a 
sufficient number of studies were included in analyses, funnel 
plots were examined and Egger test applied to assess potential 
bias in meta-analyses (30). A sensitivity analysis was performed 
to compare results when restricted to RCTs only.
RESULTS
Search Results
Database search results yielded 463 studies that were sub-
sequently assessed for eligibility (Fig. 1). One hundred and 
twenty-four studies were subjected to full-text review with 94 
failing to meet inclusion criteria. One study was excluded due 
to possible duplication of results and a lack of response to a 
clarifying e-mail query (Fig. 1). A total of 29 articles reporting 
on 5,473 patients were included in the analysis (Table 1) (9–11, 
31–56).
Study Characteristics
Of the 29 studies included, nine (n = 1,023 patients) were 
RCTs that evaluated two or more percutaneous techniques 
(32, 35, 37, 39, 40, 43, 46, 48, 53). Of the remaining 20 stud-
ies, one was a prospective cohort study comparing three 
techniques (ST, TLT, and CPDT; n = 100 patients) (42), two Figure 1. Study selection flow chart.
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compared prospective PDT techniques with historical sur-
gical control groups (n = 421; the retrospective ST patients 
were not included in our analysis) (34, 52), three were prospec-
tive observational studies reviewing more than one technique 
(n = 1,513) (10, 11, 54), and 14 were single-arm prospective studies 
(n = 2,416) (9, 31, 33, 36, 38, 41, 44, 45, 47, 49–51, 55, 56). Further 
details of study characteristics including risk of bias assessments 
can be seen in Table 1. The mean Jadad score for RCTs was 2.4, 
and mean Newcastle Ottawa score for the cohort studies was 6.25.
In all studies evaluating the CPDT, the Ciaglia Percutaneous 
Tracheostomy Multiple Dilator set (Cook Critical Care, 
Bloomington, IN) was used. All studies assessing the GWDF 
technique used the Portex kit (SIMS Portex, Hythe, Kent, 
United Kingdom). For studies evaluating STD, the Ciaglia 
Blue Rhino Percutaneous Tracheostomy Introducer set (Cook 
Critical Care) was used in six (9, 11, 33, 35, 43, 52), and 
the Portex Ultraperc (Smith Medical, Hythe, Kent, United 
Kingdom ) was used in one (40). For the TLT technique, two 
studies did not specify the equipment used (42, 53) and in the 
third the Mallinckrodt kit (Mallinckrodt Medical, Mirandola, 
Italy) was used (55). The study evaluating the BD technique 
(43) used the Ciaglia Blue Dolphin Percutaneous Tracheotomy 
Introducer Kit (Cook Critical Care), whereas the PercuTwist 
Set (Rüsch GmbH, Kennen, Germany) was used for the SSRD 
study (32). For ST, two studies used a modified Bjork flap tech-
nique (37, 39): one used a midline vertical incision (46), one 
used an H shaped incision (48); whereas in three others, the 
technique used was not described (42, 53, 54).
Three studies were conducted in multiple centers (11, 35, 42), 
four were undertaken within multiple units within the same 
hospital (34, 45, 48, 52) and 22 were conducted within a single 
CCU (9, 10, 31–33, 36–41, 43, 44, 46, 47, 49–51, 53–56). Of the 
26 studies conducted within a single institution, 23 were in a 
university/teaching center (9, 10, 31–34, 36–38, 40, 41, 43–48, 
Figure 2. Forest plot comparing risk of tracheal stenosis for different percutaneous tracheostomy and surgical tracheostomy (ST) techniques. RD = risk 
difference, CPDT = Ciaglia multiple dilator method, RCT = randomized controlled trial, GWDF = guide wire dilating forceps, TLT = translaryngeal trache-
ostomy, STD = single tapered dilator, SSRD = single step rotational dilator, BD = balloon dilator, D+L = DerSimonian & Laird (27).
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50, 51, 53–56). There were two studies, respectively, report-
ing findings from neuro (31, 55) and cardiac surgical (49, 51) 
populations; the remaining studies were of mixed populations. 
In 12 studies, the primary operators were CCU physicians/
anaesthetists (9, 32, 35, 36, 40, 43, 46, 48, 50, 52, 53, 56); in six 
studies, they were surgically trained (11, 31, 34, 39, 45, 47); in 
a further nine studies, there was a mixture of both surgical and 
CCU personnel (10, 37, 38, 41, 42, 44, 49, 51, 54); and two stud-
ies failed to specify the background of the operator (33, 55).
Data Analysis
Comparative Analyses. Figures 2, 3, 4, and 5 summarize meta-
analyses of studies that provide comparative data (RCT and 
prospective cohort data) between individual techniques for the 
complications of TS, total bleeding episodes, major bleeding, and 
wound infections, respectively. Overall, there are few studies, all 
with small sample sizes, that provide data comparing the different 
techniques, particularly in relation to those described more recently 
(STD, SSRD, and BD). We did not identify direct comparisons 
between STD, BD, or SSRD versus ST. A statistically significant 
RD was not identified for any of the meta-analyses, apart from the 
comparison between ST and CPDT in relation to wound infection 
(Fig. 5), with a pooled RD (95% CI) of 0.12 (0.02–0.23) in favor of 
CPDT. There was evidence of heterogeneity for several compari-
sons, which could not be explored in detail due to the limited num-
ber of studies. However, heterogeneity was accounted for by using 
a random-effects meta-analysis. A sensitivity analysis restricting 
meta-analyses to only RCTs suggested that results and conclu-
sions were similar, although for the bleeding complication, results 
were statistically significant for two comparisons when restricted 
to RCTs only (ST vs GWDF: RCTs and prospective observational 
studies, –0.06 [–0.25 to 0.12]; RCTs only, –0.15 [–0.23 to –0.08] 
and ST vs TLT: RCTs and prospective observational studies, 0.05 
(–0.02 to 0.11); RCTs only, 0.08 [0 to 0.16]).
Figure 3. Forest plot comparing risk of all bleeding (major and minor) episodes reported for different percutaneous tracheostomy and surgical trache-
ostomy (ST) techniques. RD = risk difference, CPDT = Ciaglia multiple dilator method, RCT = randomized controlled trial, GWDF = guide wire dilating 
forceps, TLT = translaryngeal tracheostomy, STD = single tapered dilator, SSRD = single step rotational dilator, BD = balloon dilator, D+L = DerSimonian 
& Laird (27).
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Single-Arm Studies. To supplement the comparative 
analyses, a crude overall summary of prevalence of TS, bleed-
ing episodes (total and major) and wound infection, pooled 
across all studies (single-arm studies and the relevant arm 
data from comparative studies) according to the random-
effects proportion meta-analysis, is given in Tables 2–5. There 
is a high degree of heterogeneity (measured by the I2 statis-
tic) between studies suggesting that the complication risk 
could vary according to setting or patient. Direct comparisons 
between the complication prevalence for different techniques 
should not be made based on these pooled estimates due to 
their observational nature.
DISCUSSION
We have investigated the prevalence of long-term TS in patients 
undergoing tracheostomy in a critical care setting. In addition, 
we have estimated prevalence of periprocedural complications 
(bleeding and wound infection) that we have postulated may 
have a role in the development of TS. When considering pub-
lished RCTs and comparative observational studies reporting 
long-term outcomes, we have found ST and all percutaneous 
techniques (CPDT, GWDF, STD, TLT, SSRD, and BD) broadly 
similar in terms of TS and bleeding. In keeping with earlier meta-
analyses, we have also found a higher prevalence of wound infec-
tion when comparing ST with CPDT. Despite the frequency with 
which percutaneous tracheostomies are performed within the 
critical care setting, there appear to be relatively few high-quality 
studies assessing long-term outcomes between techniques.
When considering the pooled proportion meta-analysis 
across all studies, the TS rate reported varies from 2.8% to 
0.6% for ST and STD, respectively, with all percutaneous tech-
niques being broadly comparable (Table 2). The point estimate 
of rate for total bleeding episodes varies from 12.1% for STD 
to 2% for TLT (Table 3), but the CIs around some of these esti-
mates are wide with a substantial degree of between-study het-
erogeneity. Major bleeding ranges from 4.7% for ST to 0.6% 
for TLT, whereas wound infection for ST is 9.9% and 1.1% 
for CPDT, again with wide 95% CIs and substantial between-
study heterogeneity.
By incorporating cohort studies and RCTs into our anal-
ysis, we have adopted a different methodology to earlier 
Figure 4. Forest plot comparing risk of major bleeding (requiring blood transfusion or surgical intervention) episodes reported for different percutaneous 
tracheostomy and surgical tracheostomy [ST] techniques). RD = risk difference, CPDT = Ciaglia multiple dilator method, RCT = randomized controlled 
trial, GWDF = guide wire dilating forceps, TLT = translaryngeal tracheostomy, STD = single tapered dilator, SSRD = single step rotational dilator,  
BD = balloon dilator, D+L = DerSimonian & Laird (27).
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meta-analyses. The majority of studies incorporated into pre-
vious analyses were RCTs of relatively small samples sizes and 
as such, given the low prevalence, were limited in their ability 
to detect a difference in risk of TS. Although the incorporation 
of nonrandomized studies may introduce an element of bias, 
work by Golder et al (57) has suggested that this effect may 
be minimal. In a meta-analysis of meta-analyses, they found a 
high degree of concordance between meta-analyses of adverse 
events comparing data solely from RCTs with those from 
both RCTs and observational studies (with less discrepancy 
for larger studies), concluding that meta-analyses of adverse 
events should not, necessarily, be confined to a specific study 
types. In a sensitivity analysis, we excluded the nonrandom-
ized studies and compared meta-analysis results with those 
that include both RCT and prospective observational studies. 
Overall, results were similar but changed from being nonsig-
nificant to statistically significant for bleeding complication for 
two comparisons, suggesting that there may be important dif-
ferences between RCTs and observational studies (see below).
Another potential limitation to accurate determination of 
the prevalence of TS, following percutaneous tracheostomy, in 
the current study, is the possibility that patients who are per-
ceived to be predisposed to a difficult tracheostomy may be 
assigned to the ST group in nonrandomized studies. In sup-
port of this concern, of the seven studies assessing ST, five were 
RCTs (37, 39, 46, 48, 53) reporting a TS prevalence of 1.4% 
(4/328) and two were prospective nonrandomized studies with 
a TS prevalence of 8.4% (7/90) (42, 54). In addition, the RD 
estimates for TS from the prospective nonrandomized stud-
ies were each more extreme than corresponding estimates 
from RCTs in those comparisons between ST and percutane-
ous tracheostomy. Of the nonrandomized studies, the study 
by MacCallum et al (42) (reporting two stenoses) provides no 
information on group allocation other than stating that pro-
cedures were performed consecutively. In contrast, Polderman 
et al (54) (five stenoses) reports that seven patients were allo-
cated to the ST group because of perceived difficult anatomy, 
whereas the remainder of patients were allocated randomly. No 
Figure 5. Forest plot comparing risk of wound infection for different percutaneous tracheostomy and surgical tracheostomy (ST) techniques. RD = risk 
difference, CPDT = Ciaglia multiple dilator method, RCT = randomized controlled trial, GWDF = guide wire dilating forceps, TLT = translaryngeal trache-
ostomy, STD = single tapered dilator, SSRD = single step rotational dilator, BD = balloon dilator, D+L = DerSimonian & Laird (27).
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TABLE 1. Characteristics of Studies Included in Analysis
References
Mean  
Age (yr) Men (%)
Study  
Design
Techniques  
(Patients)
Bronchoscopic 
Control
Stated  
Length of  
Follow-Up
Risk of  
Bias  
Assessmenta
Díaz-Regañón et al (10) 62b 570 (71) PO CPDT (51), GWDF (749) 35/800 
procedures
6 mo 6
Kost (11) Not  
reported
280 (56) PO CPDT (191), STD (309) Yes 3–4 mo 7
Chen et al (31) 44 14 (67) PO GWDF (21) No 6 mo —
Yurtseven et al (32) 61 83 (64) RCT CPDT (44), GWDF (41), 
SSRD (45)
Yes 6 mo 3
Fikkers et al (33) 57 70 (70) PO STD (100) Yes 12 mo —
Donaldson et al (34)c 64 39 (72) PO CPDT (54) Yes 3 mo —
Añón et al (35) 63 38 (72) RCT STD (27), GWDF (26) No 282 dd 2
Sviri et al (36) 56 66 (62) PO GWDF (106) No 30 mob —
Lukas et al (37) 65 125 (61) RCT GWDF (100), ST (105) No 6 mo 2
Kearney et al (38) 56 519 (63) PO CPDT (824) Selected cases 461 dd —
Heikkinen et al (39) 65 40 (71) RCT GWDF (30), ST (26) No 18 mo 2
Fikkers et al (40) 62b 81 (68) RCT GWDF (60), STD (60) Yes 3 mo 3
Fikkers et al (41) 62b 99 (58) PO GWDF (171) Yes 2.5 yrb —
MacCallum et al (42) 63 65 (65) PNR ST (50), TLT (37),  
CPDT (13)
Only TLT group 6 mo 6
Cianchi et al (43) 61b 52 (74) RCT STD (35), BD (35) Yes LTOR 2
Dempsey et al (9) 58 340 (59) PO STD (576) Yes 3 mo —
Ben Nun et al (44) 62 90 (58) PO GWDF (154) No 6 mo —
Velmahos et al (45) 42 72 (72) PO CPDT (100) First 14 cases 10 mod —
Silvester et al (46) 64b 137 (69) RCT CPDT (100), ST (100) 80% CPDT 20 mob 3
Mittendorf et al (47) 54 45 (63) PO CPDT (71) No 3 mo —
Melloni et al (48) 57 31 (62) RCT ST (25), CPDT (25) 100% CPDT 6 mo 2
Gatti et al (49) 71 18 (55) PO CPDT (33) No 3 mo —
Escarment et al (50) 52 117 (72) PO GWDF (162) 13% (selected 
cases)
3 mo —
Dollner et al (20, 51) 65 21 (55) PO GWDF (162) Yes 22 mod —
Beltrame et al (52)c 65 26 (72) PO STD (367) Yes 10 mod —
Antonelli et al (53) 64 83 (60) RCT TLT (67), ST (72) No 1 yr 3
Polderman et al (54) 54 N/A PO GWDF (173), ST (40) GWDF 77% 14 mod 6
Stocchetti et al (55) 47 14 (70) PO TLT (20) Yes 3 mo —
Joshi et al (56) 35 18 (45) PO CPDT (40) No LTOR —
PO = prospective observational, CPDT = Ciaglia multiple dilator method, GWDF = guide wire dilating forceps, STD = single tapered dilator, RCT = randomized 
controlled trial, SSRD = single step rotational dilator, ST = surgical tracheostomy, PNR = prospective nonrandomized, TLT = translaryngeal tracheostomy,  
BD = balloon dilator, LTOR, length of follow-up not stated but long-term outcomes reported.
aRisk of bias assessments: RCT, Jadad score (0–5).
b Reported as median.
c Also reviewed surgical tracheostomy patients retrospectively: not included in analysis.
d Reported as mean.
The score is based on randomization, blinding, and withdrawals/dropouts. Studies scoring < 3 are considered to be of low quality (25) (see text for details). 
Observational studies: Newcastle Ottawa Scale (0–9). The scale assesses patient selection, comparability of patient cohorts, and outcomes. Responses 
indicating high quality earn a star with a maximum possible score of 9 (see text for details). Single-arm studies: no assessment. Scores for RCTs and 
observational studies are not directly comparable.
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information as to whether those patients with difficult anat-
omy were also the patients who developed TS was provided. 
The choice between surgical and percutaneous tracheostomy 
in most situations is not a random event with most operators 
opting for the surgical approach when potential difficulties or 
safety concerns are anticipated. It is probable, therefore, that 
many of the surgical tracheostomies described within the stud-
ies herein would be more prone to the occurrence of compli-
cations. It is possible, therefore, that the observed differences 
in complication rates we have demonstrated in our analyses 
could be due to patient factors rather than the operative tech-
nique per se. However, as discussed above, other than a poten-
tial role for tracheal ring fracture, there is little evidence for 
perioperative complications causing TS.
Accepting these potential limitations, we contend that in 
the critical care setting, there is a trend toward increased risk 
of TS for ST patients.
Our data confirm our view that in the critical care setting, 
in common with previous authors, a percutaneous procedure 
should be the technique of choice (2) as it is both safe and cost 
effective.
It is somewhat surprising (and a common theme across all 
previous meta-analyses), given the frequency with which PDTs 
are now undertaken, that we have only identified 29 studies 
reporting upon the long-term outcomes of 5,473 patients 
over the preceding 14 years. We find it concerning that some 
techniques in relatively widespread use (SSRD, BD, and TLT) 
have such sparse long-term outcome data. When specifically 
considering the issue of TS and the possibility of unrecognized 
subclinical TS in this patient population, very few studies have 
undertaken comprehensive radiological imaging to determine 
the underlying prevalence of stenosis. Considering that the 
STD technique appears to be currently the most widely used 
approach (58–60), until recently, there were only 14 patients 
described in the literature who had undergone radiological 
imaging after STD tracheostomy to determine the underlying 
prevalence of both clinical and subclinical TS (40). This has, in 
part, been addressed by a recent study from the UK (8).
Reporting of complications across studies remains far 
from standardized and posed significant problems during 
data extraction. We had initially set out to collect data for 
a significant number of secondary outcomes (Appendix 1). 
TABLE 2. Tracheal Stenosis According to Tracheostomy Technique: Random-Effects 
Proportion Meta-Analysis
Tracheostomy Technique
No. of Studies  
(Patients Included)
No. of  
Stenoses Pooled Estimate (%) (95% CIa) I2% (95% CI)
Surgical tracheostomy 7 (418) 11 2.8 (0.8–5.9) 57.9 (0–80)
Guide wire dilating forceps 13 (1,831) 10 0.9 (0.3–1.7) 50.3 (0–72)
Ciaglia technique 12 (1,546) 15 1.0 (0.4–1.9) 33.7 (0–66)
Single tapered dilator 7 (1,474) 7 0.6 (0.2–1.2) 22.6 (0–67)
Translaryngeal tracheostomy 3 (124) 1 1.5 (0.1–4.3) 0 (0–73)
Single step rotational dilator 1 (45) 0 — —
Balloon dilator 1 (35) 0 — —
a Calculated from random-effects model.
TABLE 3. Total Bleeding Episodes According to Tracheostomy Technique: Random-Effects 
Proportion Meta-Analysis
Tracheostomy Technique
No. of Studies  
(Patients Included)
Total No. of  
Bleeding Episodes
Pooled Estimate (%) 
(95% CIa) I2% (95% CI)
Surgical tracheostomy 7 (418) 29 7.3 (4–11.4) 52.1 (0–78)
Guide wire dilating forceps 11 (1,687) 100 9.2 (5–14.4) 88.8 (82–92)
Ciaglia technique 11 (1,355) 64 6.6 (4–9.7) 62.9 (12–79)
Single tapered dilator 6 (1,165) 80 12.1 (3.3–25.3) 96.3 (95–97)
Translaryngeal tracheostomy 3 (124) 2 2 (0.3–5.3) 0 (0–73)
Single step rotational dilator 1 (45) 1 — NA
Balloon dilator 1 (35) 20 — NA
NA = not applicable (only one study).
a Calculated from random-effects model.
Studies not reporting bleeding: guide wire dilating forceps (Dollner et al [20, 51] and Sviri et al [36]); bleeding events not attributable to technique: Kost (11) 
(Ciaglia multiple dilator method and single tapered dilator).
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However, lack of uniform reporting made this aim much 
more difficult and ultimately of little value as many compli-
cations are reported infrequently with marked differences in 
prevalences across studies. Even reporting of our primary and 
secondary outcomes was inconsistent with some studies fail-
ing to quote a prevalence for TS, bleeding, and wound infec-
tion. One study appeared to describe an apparent prevalence 
of TS (presence of stridor with spirometry findings in keep-
ing with upper airway obstruction) but failed to ascribe these 
findings to a diagnosis of TS (36). A lack of a consistent defi-
nition for significant versus minor bleeding lead us to ana-
lyze total bleeding episodes and those categorized as major. 
In addition, one study reported stomal decay as an outcome, 
interpreted as infection for our analysis (37). In addition, we 
were unable to explore the possible relationships between 
bleeding and stomal infection and TS. Although most of the 
studies included in the analysis reported TS, bleeding, and 
stomal infection rates, there were little, if any, supplemen-
tal data reported for us to ascertain whether these events 
were associated and occurring within the same patients or 
not. A number of other studies that detailed complications 
of multiple techniques reported composite outcomes where 
the complication rate for a given technique was impossible 
to ascertain. In this circumstance, we wrote to the author for 
clarification. In some instances, this resolved the problem 
either completely or partially. In others, where there was no 
reply from the corresponding author, the study was excluded 
from the analysis. These limitations highlight the vital need 
to develop and report core standardized outcome measures 
to improve synthesis of trial data (61).
It is highly unlikely that an RCT will be performed to deter-
mine the prevalence of long-term outcome measures such as 
TS in the future. TS has a low prevalence, critical illness mortal-
ity is high, and long-term follow-up is difficult. An adequately 
powered study would require at least 2,000 patients to detect a 
reduction in TS from 2.8% to 1% (α = 0.05; β = 0.8), and this 
figure excludes dropout. Thus, we believe our study, despite the 
limitations described, is currently best placed to inform clini-
cians in this area, but further good quality comparative studies 
reporting complication rates are now needed.
From the limited published data, we have not found a sig-
nificant difference in the prevalence of TS between a range 
of percutaneous techniques and surgical tracheostomies. 
When considering all published data reporting long-term 
TABLE 4. Major Bleeding Episodes (Need for Surgical Cautery or Blood Transfusion) 
According to Tracheostomy Technique: Random-Effects Proportion Meta-Analysis
Tracheostomy Technique
No. of Studies  
(Patients Included)
Major Bleeding 
Episodes
Pooled Estimate (%) 
(95% CIa) I2% (95% CI)
Surgical tracheostomy 7 (418) 17 4.7 (2.8–7.1) 7 (0–64)
Guide wire dilating forceps 11 (1,687) 36 3.4 (1.4–6.3) 82 (66–89)
Ciaglia technique 11 (1,355) 18 1.8 (0.7–3.5) 55.7 (0–78)
Single tapered dilator 6 (1,165) 10 1.1 (0.2–2.7) 65.1 (0–85)
Translaryngeal tracheostomy 3 (124) 0 0.6 (0.01–2.6) 0 (0–73)-
Single step rotational dilator 1 (45) 0 — —
Balloon dilator 1 (35) 0 — —
a Calculated from random-effects model.
TABLE 5. Wound Infection According to Tracheostomy Technique: Random-Effects 
Proportion Meta-Analysis
Tracheostomy Technique
No. of Studies  
(Patients Included)
No. of Tracheostomy 
Wound Infections
Pooled Estimate (%) 
(95% CIa) I2% (95% CI)
Surgical tracheostomy 7 (418) 36 8.5 (4.1–14.4) 71.5 (18–85)
Guide wire dilating forceps 10 (1,666) 16 1.5 (0.6–2.8) 61.5 (1.6–79)
Ciaglia technique 11 (1,355) 11 1.0 (0.36–2.1) 32.5 (0–66)
Single tapered dilator 4 (554) 6 1.7 (0.02–5.9) 80.1 (17.4–90.6)
Translaryngeal tracheostomy 3 (124) 4 3.9 (1.26–8) 0 (0–73)
Single step rotational dilator 1 (45) 0
Balloon dilator 1 (35) 0
a Calculated from random-effects model.
Studies not reporting infection: guide wire dilating forceps (Sviri et al [36], Chen et al [31], and Dollner et al [20, 51]) and single tapered dilator (Cianchi et al 
[43] and Dempsey et al [9]). Infection episodes not attributable to technique: Kost (11) (Ciaglia multiple dilator method and single tapered dilator).
Copyright © 2015 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Review Article
Critical Care Medicine www.ccmjournal.org 11
outcomes, our pooled proportion meta-analysis may indicate 
a tendency toward a higher rate of TS for ST, but this is likely 
to be prone to selection bias. Similarly, in relation to major 
bleeding, we have not found a difference between the tech-
niques commonly used. Again the pooled proportions meta-
analysis may indicate a tendency toward more major bleeding 
for ST. In relation to wound infection, we have found a reduc-
tion (RD, –6% [95% CI, –12% to 1%]) associated with CPDT 
when compared with ST in keeping with earlier work. Across 
all percutaneous techniques for the primary and secondary 
outcomes studied, complication rates appear to be broadly 
similar, but CIs for pooled RDs are wide and include clini-
cally important differences in both directions.
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Appendix 1: Additional Data Extracted From 
Articles
Mean Acute Physiology and Chronic Health Evaluation II/ 
 mean Sequential Organ Failure Assessment scores
Location of procedure
Operator experience
Mean duration translaryngeal intubation (d)
Mean duration of tracheostomy
Duration sedation post tracheostomy
Mean ventilator dependent days
Mean critical care unit length of stay
Mean hospital length of stay
Mortality (1-mo procedure)
Average duration of procedure (min)
Number of episodes hypoxia (SaO2 < 91%)
Number of cardiac arrhythmia
Incidence of hypotension (systolic blood pressure < 90 mm Hg)
Number of tracheal cuff punctures
Number of paratracheal insertions
Number of tube displacements or loss of airway
Number of pnuemothoraces
Number of pneumomediastinum
Number of subcutaneous emphysema
Episodes of atelectasis
Incidence of aspiration
Number of esophageal injuries
Number of posterior tracheal wall injury
Number of perioperative mortalities
Number of perioperative cardiac arrest
Number of pneumonias
Frequency of delayed wound healing (> 3 wk)
Number of tracheoinnominate artery fistula
Incidence of failure to decannulate
Number of reintubations
Difficulty in recannulation
Hypercapnia
Increased airway pressure
Stomal enlargement
Tracheal dilatation
Dysphagia
Respiratory problems
Bronchoscopic damage
Poor visualization of tracheal structures
Late tracheal wall injury/hematoma/swelling
Chyle leak (requiring intercostal drainage)
Laryngeal pericondritis
